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Abstract 
Tendon injury is common in humans and horses, and incidence increases with age. The 
high-strain energy storing equine superficial digital flexor (SDFT) is injured more 
frequently than the low-strain positional common digital extensor (CDET). However, 
previous work indicated that matrix turnover is greater in the CDET than in the SDFT. It 
was hypothesised that matrix turnover is programmed by the cells’ strain environment; 
therefore high-strain energy storing tendons would have a lower rate of matrix turnover 
than low-strain positional tendons and the rate of matrix turnover would decrease with 
increasing age. The rate of matrix turnover was investigated by measuring the potential of 
the cells to synthesise and degrade matrix proteins, measuring the half-life of the 
collagenous and non-collagenous matrix proteins and assessing collagen turnover at the 
protein level. In vitro cell phenotype was also assessed in 2D and 3D culture and the effect 
of load on cells within native tissue was determined. The results show that turnover of 
collagenous and non-collagenous matrix proteins is differentially regulated in the 
functionally distinct SDFT and CDET. CDET tenocytes show greater potential for collagen 
turnover, whereas SDFT tenocytes have a greater potential for proteoglycan turnover; 
differences that are also present at the protein level. The differences in cell phenotype 
identified in vivo were lost in 2D and 3D culture, but tendon organ culture resulted in the 
maintenance of tenocyte phenotype. The cells’ ability to turnover the matrix does not 
decrease with increasing age, but collagen within the SDFT appears to become more 
resistant to degradation with ageing. This results in the accumulation of partially degraded 
collagen within the SDFT which may have a detrimental effect on tendon mechanical 
properties. These findings will help to elucidate the mechanisms behind the development of 
age-related tendinopathy and will be of use when developing treatment regimes.
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1. Introduction 
1.1 General Introduction 
The primary function of most tendons is to transfer force generated by a muscle to a bone 
in order to facilitate movement around a joint. For efficient function tendons must be 
relatively inextensible and able to resist high forces (Ker 2002). This property is conferred 
by the molecular composition; tendons are comprised mainly of type I collagen molecules 
organised into a hierarchical structure which results in high tensile strength. Historically, it 
had been assumed that tendons are simple structures with a simple function. However, 
recent work has found that this is far from true, in addition to transferring force specific 
tendons have other functions including energy storage (Alexander 1991). Recent studies 
have focused on understanding tendon formation and development; however there is much 
that is not known about mature tendon in terms of tendon turnover and maintenance of 
properties required for efficient function. This is important as tendon injury is one of the 
most common musculoskeletal injuries both in athletes and the general population 
(Jarvinen et al., 2005). The incidence of injury increases with age (Kannus et al., 1989) and 
recurrence of injury is common as the tendon healing response is slow and inadequate; the 
defect is replaced by scar tissue which is likely to be weaker than the original tissue (Corr 
et al., 2009). Tendon injury is frequently preceded by degenerative changes to the 
extracellular matrix (Birch et al., 1998) rather than occurring as the result of a single 
overloading event, but it is not clear what causes this initial degeneration. The initial 
degeneration is not usually accompanied by an inflammatory response, and so degenerative 
conditions that affect tendons are now referred to as tendinopathies rather than tendinitis 
(Riley 2008), which would imply an inflammatory component. Specific tendons are more 
prone to injury than others; for example energy storing tendons such as the Achilles tendon 
are injured far more frequently than tendons that function purely to position the limb, such 
as the anterior tibialis tendon (Kausch and Rütt 1998). Tendon injury is also a common 
cause of wastage in the equine athlete; with a similar epidemiology and aetiology to human 
tendon injury. In horses, the majority of injuries occur to the energy storing superficial 
digital flexor tendon (SDFT), while the positional common digital extensor tendon (CDET) 
is rarely injured (Ely et al., 2009). The horse is a good model for studying the effect of 
tendon type and age on extracellular matrix turnover which is likely to be important in the 
aetiology of tendinopathy, the initiation and progression of which appears to be similar 
between horses and humans. 
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1.2. Anatomy of the Equine Forelimb 
The horse is a cursorial animal, i.e. ‘designed’ to run at high speed. Evolution has resulted 
in the lengthening of the limbs, in particular the distal portion, and reduction of muscle 
mass and digits in this region. In the forelimb all muscles are situated proximal to the 
carpus, and are connected to the distal part of the limb by long tendons.  The four main 
tendinous structures in the distal part of the equine forelimb are shown in Figure 1-1. The 
SDFT is situated on the palmar aspect of the forelimb just below the skin. The superficial 
digital flexor muscle originates on the medial epicondyle of the humerus and inserts via its 
long tendon onto the proximal and middle phalanges, the tendon also receives an accessory 
branch from the radius. The SDFT is superficial to the deep digital flexor tendon (DDFT); 
the deep digital flexor muscle also originates on the medial epicondyle of the humerus and 
its corresponding tendon inserts onto the distal phalanx, also receiving an accessory branch 
from the carpus. At the level of the metacarpophalangeal joint the SDFT forms a sleeve 
around the DDFT. The suspensory ligament (SL) is also known as the interosseus muscle, 
although it contains little muscular tissue, and is situated deep to the DDFT. It originates on 
the proximopalmar aspect of the third metacarpal bone. It divides proximal to the 
metacarpophalangeal joint; the main branches insert onto the proximal sesamoid bones 
while the extensor branches extend around the limb to insert onto the CDET. The CDET is 
situated on the dorsal aspect of the third metacarpal; the common digital extensor muscle 
originates on the lateral epicondyle of the humerus and its corresponding tendon inserts 
onto the proximal and distal phalanges (Budras et al., 2001; Goody 2001). On the lateral 
border of the CDET there is a thin accessory branch of the extensor tendon (Denoix 2000), 
approximately 5 mm in diameter. Although not well documented, this accessory tendon is 
also often present on the medial border of the CDET (Birch H.L, personal communication). 
In some horses either the medial or lateral accessory branch, or both branches, are fused to 
the CDET, whereas in others they are completely separate from the CDET proper. It is 
likely that as the horse has evolved to have fewer toes these vestigial tendons have persisted 
to a greater extent in some horses than in others; in animals with a greater number of toes, 
such as the cow and goat, the extensor tendon divides to insert onto each toe (Dyce et al., 
2002). 
25 
 
 
Figure 1-1: Anatomy of the equine forelimb showing the four main tendinous structures. Adapted from 
Wilson et al. (2001). 
1.3. Tendon Function 
Tendons in the equine forelimb act mainly to position the limb correctly during locomotion 
and prevent hyperextension of the metacarpophalangeal joint (Butcher et al., 2007). Some 
tendons have an additional function, acting as springs to store and release energy as they 
are stretched and recoil during the stance and swing phase of each stride such that the 
energetic cost of locomotion is reduced (Alexander 1991). In humans, the tendon that acts 
as the main energy store is the Achilles tendon (Lichtwark and Wilson 2005). The SDFT 
and SL are the main energy storing structures in the equine forelimb and are subjected to 
higher strains than the DDFT and CDET, which do not contribute significantly to energy 
storage (Wilson et al., 2001). Energy storing tendons experience much higher strains than 
positional tendons; strains of up to 10.3% have been recorded in the Achilles tendon 
(Lichtwark and Wilson 2005), whereas the anterior tibialis tendon, which functions purely 
as a positional tendon, experiences maximum strains of 3.1% (Maganaris and Paul 1999). 
Similar results have been reported in the horse; during gallop, in vivo strains of 16% in the 
SDFT have been recorded (Stephens et al., 1989), which is similar to the failure strains of 
15-17% recorded in vitro (Dowling et al., 2002; Gerard et al., 2005). In contrast, maximum 
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in vivo strain for the positional CDET has been estimated at 2.5% (Birch et al., 2008b), 
which is almost four times lower than the failure strain of 9.7% recorded in vitro (Batson et 
al., 2003). Although the DDFT is situated on the palmar aspect of the limb between the 
SDFT and SL, its corresponding muscle exhibits differences in muscle architecture and 
fibre type compared to the SDF muscle, and its functions appear to be flexion of the distal 
phalangeal joint during late swing and stabilisation of the metacarpophalangeal joint rather 
than storage and return of energy (Butcher et al., 2007; Butcher et al., 2009). 
Correspondingly, in vivo studies have shown than the DDFT experiences lower peak forces 
and strains during locomotion than the SDFT or SL (Butcher et al., 2007; Platt et al., 1994). 
Energy storing tendons are therefore subjected to significantly higher stresses than 
positional tendons; the failure stress of most tendons is approximately 100 MPa and while 
the majority of tendons in the equine forelimb only experience stresses up to 30 MPa, and 
those in the human leg experiences stresses of about 20 MPa (Ker et al., 1988), it is 
possible the equine SDFT and human Achilles tendon may experiences stresses as high as 
90 MPa (Brown et al., 2003; Ker et al., 1988).  
1.3.1. Tendon Biomechanics 
The function of a tendon is reflected in the mechanical properties of the tendon tissue. 
Tendon is a viscoelastic composite material consisting of collagen fibrils embedded in a 
softer non-collagenous matrix (Puxkandl et al., 2002). The elastic component is provided 
mainly by the collagenous matrix whereas viscosity is provided largely by the non-
collagenous fraction of the matrix (Puxkandl et al., 2002). When tendon is loaded, the 
initial lengthening is due to extension of the collagen fibres (Screen et al., 2004; Silver et 
al., 2003), however above strains of 3% the dominant mechanism of extension is fibre 
sliding (Screen et al., 2004). Sliding between fibres is thought to be controlled by the non-
collagenous proteins (mainly proteoglycans) within the matrix as they provide interactions 
between adjacent collagen fibres (Scott 2003; Screen et al., 2005a; Screen et al., 2006; 
Screen 2008). These studies indicate that the viscoelastic response of tendon is dependent 
on both the amount and rate of applied strain. The response of tendons to loading will also 
depend on their specific mechanical properties, which have been shown to differ between 
tendons with different functions; the SDFT is composed of a less stiff material than the 
CDET, for example (Birch 2007). These differences in mechanical properties arise from 
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variation in the structure and molecular composition of the tendon matrix; which in healthy 
tendon is synthesised and maintained by tendon fibroblasts (tenocytes).   
1.4. Epidemiology of Tendon Injuries 
Tendon injury is one of the most common forms of musculoskeletal injuries that occur to 
horses competing in all disciplines, although tendon injuries in racehorses are the most 
investigated. Injuries to the musculoskeletal system have been found to account for 82% of 
all injuries to racehorses competing in National Hunt and flat races, and of these 46% 
involved tendons or ligaments (Ely et al., 2004; Williams et al., 2001). Another study 
reported that tendon or ligament strain accounts for 53% of musculoskeletal injuries that 
occur during hurdle and steeplechase races (Pinchbeck et al., 2004). A 12 year 
epidemiological study found that tendon injury was the most common reason for retirement 
in racing Thoroughbreds in Hong Kong (Lam et al., 2007). Furthermore, it has been found 
that, over the period of one season, 15% of both National Hunt horses (Ely et al., 2004) and 
Thoroughbred flat racehorses (Kasashima et al., 2004) in training suffered from a tendon or 
ligament injury as diagnosed by ultrasound.  
The majority of tendon injuries (97-99%) occur to the forelimb tendons (Kasashima et al., 
2004; Lam et al., 2007), with  the energy storing SDFT being injured in 75-93% of cases, 
and the remaining injuries occurring to the SL (Ely et al., 2004; Kasashima et al., 2004). 
Prevalence of SDFT pathology has been found to be 24% in National Hunt horses in 
training that were assessed ultrasonographically over two seasons (Avella et al., 2009). 
Injuries to the mid-metacarpal tensional region of the positional DDFT and CDET are rare 
although injures to the DDFT at both the phalangeal level (Murray et al., 2006a) and within 
the digital sheath (Smith and Wright 2006) are reported, however the prevalence of such 
injuries is not yet clear. The risk of tendon injury increases with increasing age (Ely et al., 
2004; Ely et al., 2009; Kasashima et al., 2004; Perkins et al., 2005), and is more common 
in National Hunt horses than in those racing on the flat (Williams et al., 2001). There are 
several differences between National Hunt horses and flat racehorses which may account 
for the higher incidence of tendon injury in National Hunt racing. National Hunt horses 
tend to be older than those that race on the flat, and compete over longer distances and over 
a greater number of seasons (Williams et al., 2001). Their tendons are also likely to be 
placed under higher strains when landing over fences. Some studies have reported a higher 
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risk of tendon injury in entire male horses (Kasashima et al., 2004; Lam et al., 2007; 
Perkins et al., 2005) but other studies do not support this finding as they are unable to 
differentiate between entire males and geldings due to the small number of entire males 
studied (Ely et al., 2004; Ely et al., 2009). Tendon re-injury is a common problem; it has 
been reported that 23% to 67% of horses with a tendon injury treated using conservative 
methods will re-injure their tendons within two years of the original injury (Dyson 2004; 
Marr et al., 1993), and many horses never recover sufficiently from a tendon injury to 
compete at the same level as they did previously. 
There is little information available regarding tendon injury in horses competing in other 
disciplines. However it has been reported that tendon injury accounts for 43% of injuries 
that occur to event horses in training, with 33% of injuries to the SDFT, 31% to the SL and 
17% to the DDFT (including injuries to the accessory ligament) (Singer et al., 2008). Elite 
show jumpers have been reported to have a high risk of injury to the forelimb SDFT and 
DDFT, whereas horses competing in dressage have a high risk of injury to the hind limb SL 
based on cases referred to one referral centre with orthopaedic injury (Murray et al., 
2006b). 
Epidemiology of human tendon injury is similar to that reported in horses; overuse injuries 
occur in athletes, both elite and recreational, and are also a common problem in the 
workplace (Ferretti 1986; Frost et al., 2002). The majority of overuse injuries occur to the 
energy storing Achilles tendon; the incidence of Achilles tendinopathy is reported as 6% in 
the general population, but increases to over 50% in elite endurance athletes, where it is 
positively correlated with hours of training (Knobloch et al., 2008; Kujala et al., 2005). The 
incidence of tendinopathy also increases with increasing age and is more common in males 
(Clayton and Court-Brown 2008; Kannus et al., 1989). Running surface is also a factor in 
the epidemiology of Achilles tendinopathy, with increased risk of injury when running on 
sand (Knobloch et al., 2008). Recurrence of tendon injury is also a common problem, and 
symptoms can persist for several years in some cases (Kettunen et al., 2002). In contrast, 
positional tendons such as the anterior tibialis tendon are not prone to tendinopathy 
(Kausch and Rütt 1998). 
Identification of factors associated with tendon injury gives important clues to the 
underlying causes of the injury. Almost all tendon injuries occur to the forelimb tendons 
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and this is likely to be due to several factors. The forelimbs of the horse carry 60% of the 
horse’s bodyweight when standing and can experience loads in excess of 170% bodyweight 
when galloping (Swanstrom et al., 2005). There are also differences in function between 
the hindlimbs and forelimbs which may contribute towards the greater incidence of injury 
to forelimb tendons; the hindlimbs provide propulsion whereas the forelimbs are involved 
in braking (Dutto et al., 2004) and therefore are likely to experience higher strains. 
Forelimb tendons are also likely to experience extremely high strains when landing over 
fences. It is evident that energy storing tendons such as the equine SDFT and human 
Achilles are more prone to overload injury than positional tendons such as the equine 
CDET and human anterior tibialis; this may be due to the fact that energy storing tendons 
experience much higher strains than those that act purely to position the limb. Ageing has 
also been identified as an important factor that might predispose an individual to tendon 
injury; however it is not clear why this is important. There may be an accumulation of 
micro-damage within the tendon extracellular matrix or alternatively there may be a 
reduction in the ability of cells in aged tendons to maintain and repair the matrix, possibly 
due to a decrease in the activity of aged cells (Smith et al., 2002a). 
1.5. Tendon Composition and Structure 
The specialised molecular composition and organisation of tendon results in a high strength 
structure able to resist uni-directional forces. Tendons consist of a dense fibrous 
extracellular matrix with a high water content, which is synthesised and maintained by a 
small population of tenocytes. The matrix is composed mainly of type I collagen, with a 
small percentage of other collagens and non-collagenous proteins. Collagen fibrils are 
orientated in the direction of force application and are arranged in a hierarchical structure 
(Kastelic et al., 1978) which results in high tensile strength (Figure 1-2). Tropocollagen 
molecules are synthesised by tenocytes and self-assemble to form fibrils, which then form 
fibres and then fibre bundles (fascicles). Fascicles are surrounded by the endotenon, and are 
grouped together to form the tendon, which is surrounded by a connective tissue sheath 
called the epitenon (Kastelic et al., 1978).  
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1.5.1. Molecular Composition 
The main component of tendon is water, which makes up 55 - 70% of the wet weight of the 
tendon. The dry weight of the tendon is comprised mainly of collagen (60% - 85%); 
currently 28 different types of collagen have been identified but type I collagen is the most 
abundant in tendon (approximately 95%) with varying amounts of collagen types III, V, 
XII and XIV depending on tendon type (Kjaer 2004). Approximately 5% of the dry weight 
is made up of non-collagenous glycoproteins and proteoglycans, the most abundant 
proteoglycans being the small leucine rich proteoglycans (SLRPs) decorin, biglycan, 
fibromodulin and lumican with small amounts of aggrecan (Vogel and Meyers 1999). The 
most abundant glycoproteins found in tendon are collagen oligomeric matrix protein 
(COMP), tenascin-C and tenomodulin (Docheva et al., 2005; Jarvinen et al., 2000; Smith et 
al., 1997).  
1.5.1.1. Collagen 
The majority of collagen in tendon is the fibril forming type I collagen, which gives the 
tendon its high tensile strength. The second most abundant collagen found in tendon is 
another fibrillar collagen, type III, which comprises up to 10% of the total collagen, 
Figure 1-2: Schematic showing the hierarchical structure of tendon.   
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depending on several factors including tendon type and age (Birch et al., 1999a; Riley et al., 
1994). Collagen type III has been shown to be essential for normal fibrillogenesis and is 
thought to regulate the size of type I fibrils (Kadler et al., 1990). This is supported by 
evidence of higher type III content in immature and healing tendons (Banos et al., 2008; 
Riley et al., 1994). Collagen type V is often located in the core of type I fibrils and is 
thought to provide a template for fibrillogenesis (Riley 2004). Types XII and XIV collagen 
are Fibril-Associated Collagens with Interrupted Triple helices and are found associated 
with type I collagen. It is thought they provide a molecular bridge between fibrillar 
collagens and other matrix molecules and are involved in stabilising fibrils during 
development (type XII) and limiting fibril diameter (type XIV) (Banos et al., 2008). The 
fibrillar collagens are dominated by long triple helical regions and are formed of three 
polypeptide chains; type I collagen consists of two α1 chains and one α2 chain and 
therefore there are two genes involved in collagen synthesis, one that codes for the α1 chain 
(Col1A1) and one for the α2 chain (Col1A2).  
Collagen Synthesis 
Synthesis of collagen begins with the transcription of the genes that code for the α1 and α2 
chains from DNA to messenger RNA (mRNA). The mRNA is transported from the nucleus 
to a ribosome within the cytoplasm of the cell (Hendershot and Bulleid 2000) (Figure 1-3). 
The ribosome then attaches to the rough endoplasmic reticulum for translation of the 
mRNA into pro-polypeptide α chains before assembly of three chains into pro-collagen 
molecules (Walter and Johnson 1994). The pro-collagen molecule consists of a triple 
helical region with non-helical amino (N-) and carboxy (C-) terminal telopeptides at each 
end (Hendershot and Bulleid 2000). Each polypeptide chain that forms the triple helical 
pro-collagen molecule has a repeating Gly-X-Y triplet, where X and Y are normally proline 
and hydroxyproline, respectively (Canty and Kadler 2005). Glycine is one of the smallest 
amino acids and this allows three polypeptide chains to wind together in a triple helix with 
glycine residues at the core to form 300 nm long pro-collagen monomers.  
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Figure 1-3: Diagram showing synthesis of pro-collagen polypeptide chains, post-translational modifications 
and formation of the triple helical pro-collagen monomers within the cell. From Banos et al. (2008). 
Post-translational Modifications 
Formation of the triple helical pro-collagen monomers is preceded by several post-
translational modifications to the polypeptide chains, including hydroxylation of proline 
and lysine residues (Myllyla et al., 1981) (Figure 1-3). The three polypeptide chains are 
then folded into a triple helical structure; the C-terminal pro-peptide plays an important role 
in this process as it acts as a nucleation site, initiating the formation of disulphide bonds 
between the polypeptide chains (Bellamy and Bornstein 1971). Once the polypeptide chains 
have assembled into a triple helix they are transported to the Golgi apparatus in vesicular 
tubular clusters (Bannykh and Balch 1997), where they aggregate laterally to form pro-
collagen bundles (Cho and Garant 1981). The last step in the post-translational 
modification of pro-collagen is the cleavage of the non-triple helical C- and N-terminal pro-
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peptides to form tropocollagen. The Kadler model proposes that this occurs intracellularly 
(Kadler et al., 1996) whereas in the Birk model the cleavage occurs extracellularly (Birk et 
al., 1995). Cleavage of the pro-peptides and subsequent fibril formation are complex 
processes; this is an area currently under much investigation (Banos et al., 2008).  
Collagen Fibril Formation 
Once collagen bundles have been secreted into the extracellular environment they then 
assemble in a quarter stagger pattern to form fibrils (Figure 1-4). Assembly of collagen 
molecules into fibrils is precisely organised and results in a characteristic D-band 
periodicity. This process, known as fibrillogenesis, can also occur spontaneously in vitro. It 
has been proposed that fibronectin and integrins act as organisers during fibrillogenesis, 
determining the site of fibrillogenesis, while collagen type V and XII are nucleators, 
initiating the process (Kadler et al., 2008). This would allow the precise control of fibril 
formation in a variety of tissues. Fibril growth occurs by the lateral and longitudinal fusion 
of the collagen fibrils results in the formation of larger mature fibrils (Banos et al., 2008). 
Several molecules have been shown to be involved in the regulation of fibrillogenesis in 
tendon, these include collagen type III and the SLRPs (Canty and Kadler 2002). Fibril 
bundles are organised into a variety of complex structures, including orthogonal layers to 
form structures such as the cornea, basket weaves to form skin and bone, or in parallel to 
form tendon (Canty and Kadler 2002).       
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Figure 1-4: Synthesis of collagen fibrils from pro-collagen chains results in the formation of a repeating unit 
consisting of five collagen molecules arranged in a staggered pattern. When fibrils are stained they exhibit a 
periodic banding pattern; the repeating light and dark zones are due to preferential stain penetration into areas 
with lowest collagen packing (gap regions). The D-band is 67 nm long and consists of adjacent overlap and 
gap regions, where the overlap region is 0.4D and the gap region is 0.6D. Adapted from Kadler et al., (1996) 
and Canty and Kadler (2005). 
Collagen Cross-linking 
The fibril structure is stabilised by the formation of crosslinks, which also increase the 
tensile strength of the tendon. There are two distinct types of crosslinks that form in 
collagenous tissue, enzymatic and non-enzymatic adventitious crosslinks (also known as 
glycated crosslinks) (Figure 1-5). Enzymatic crosslinking occurs during growth of 
immature tendon and is initiated by lysyl oxidase. Initially, the immature crosslinks formed 
are divalent, but it is thought that they react with other crosslinks to form more stable 
Collagen Fibril 
Tropocollagen 
Molecule 
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trivalent crosslinks (Bailey et al., 1998; Bailey 2001). These crosslinks form between lysine 
residues in the N- and C-terminal telopeptides and bind collagen molecules in the quarter 
stagger pattern. The crosslinks increase tendon strength by preventing the collagen 
molecules sliding past each other when the tendon is loaded (Avery and Bailey 2005), 
instead the triple-helical regions of the collagen molecules stretch contributing to extension 
of the tendon (Silver et al., 2003). Glycated crosslinks are formed when sugar molecules 
present in the matrix react with the side-chains of lysine and arginine residues to form 
advanced glycation end-products (AGEs), which results in crosslinks that can occur along 
the length of the collagen molecule (Figure 1-5). AGEs form in tissues with a low rate of 
matrix turnover, such as bone, cartilage and tendon (Avery and Bailey 2005). The 
concentration of these AGEs increases with age, and cause tendon stiffness to increase so 
the tendon may be too stiff to function optimally (Avery and Bailey 2006).  
 
Figure 1-5: Diagram showing the formation of enzymatic and non-enzymatic (glycated) crosslinks between 
collagen molecules. From Avery and Bailey (2005). 
Formation of Enzymatic Crosslinks 
Enzymatic crosslinks are formed mainly during growth and maturation and are mediated by 
the enzyme lysyl oxidase, which deaminates N- and C- terminal lysine residues to form 
lysyl aldehyde (Bailey et al., 1998). Further maturation of enzymatic crosslinks is 
spontaneous and the specific crosslinks formed depend on the degree of hydroxylation of 
the telopeptide lysine residues (Bailey 2001); tendon has a high proportion of lysyl 
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hydroxylation and so the initial crosslinks are mainly dehydro-
hydroxylysinohydroxynorleucine (deH-HLHNL), which forms when the hydroxylysyl-
aldehyde reacts with another hydroxylysyl residue. This crosslink is spontaneously 
converted to the more stable divalent hydroxylysino-keto-norleucine (HLKNL) via an 
Amadori rearrangement. This divalent cross-link then reacts with another hydroxylysine–
aldehyde to form the mature trivalent crosslink hydroxylysyl-pyridinoline (HP) (Figure 1-
6). Alternatively, the HLKNL can react with a lysine-aldehyde to form another type of 
crosslink, hydroxylysyl-pyrrole, the structure of which is undetermined as it is unstable 
during isolation procedures (Bailey 2001). If the hydroxylysyl-aldehyde forms a divalent 
crosslink with a lysine residue, dehydro-lysinohydroxynorleucine (deH-LHNL) will be 
formed and convert to lysino-keto-norleucine (LKNL). LKNL then either reacts with a 
lysine or hydroxylysine residue to form lysyl-pyridinoline (LP) or lysyl-pyrrole. The 
structure of HP and LP crosslinks are shown in Figure 1-7. 
 
 
 
 
HYL HYL-ALD 
deH-HLHNL 
deH-LHNL 
Lysyl Oxidase 
+LYS 
+HYL 
HLKNL 
LKNL 
Amadori 
Rearrangement LP 
L-Pyrrole 
  HP 
H-Pyrrole 
+HYL-ALD 
+LYS-ALD 
+HYL-ALD 
+LYS-ALD 
Figure 1-6: Formation of pyridinoline and pyrrolic crosslinks in collagen is mediated by lysyl oxidase and 
depends on the proportion of lysyl-hydroxylation in the collagen molecule. HYL, hydroxylysine; HYL-ALD, 
hydroxylysine-aldehyde; LYS, lysine; deH-HLHNL, dehydro-hydroxylysinohydroxynorleucine; deH-LHNL, 
dehydro-lysinohydroxynorleucine; HLKNL, hydroxylysino-keto-norleucine; LKNL, lysino-keto-norleucine; 
LYS-ALD, lysine-aldehyde; HP, hydroxylysyl-pyridinoline; LP, lysyl-pyridinoline. Adapted from Bailey et 
al. (1998). 
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Figure 1-7: Structure of the 2 major enzymatic crosslinks that form in tendon collagen, hydroxylysyl-
pyridinoline (HP) and lysyl-pyridinoline (LP). Adapted from Urena and De Vernejoul (1999). 
Formation of Non-Enzymatic Crosslinks 
Non-enzymatic crosslinks (also known as AGEs) are formed by spontaneous reaction with 
naturally occurring sugars present in the matrix. As they accumulate with age in tissues 
with a low rate of matrix turnover they can be used as a marker of matrix age. Pentosidine 
is the best characterised AGE and is well established as a matrix age marker; it has been 
shown to accumulate with age in articular cartilage and skin collagen (Verzijl et al., 
2000b), connective tissue in the eye (Glenn et al., 2007), intervertebral disc collagen (Sivan 
et al., 2006a) and tendon (Bank et al., 1999). Pentosidine is formed when a pentose sugar 
reacts with lysine residues throughout the collagen molecule to form the Schiff base 
glucosyl–lysine, which undergoes an Amadori rearrangement to form fructose-lysine. 
Fructose-lysine then undergoes oxidation and reacts with ribose and an arginine residue on 
an adjacent collagen molecule, forming a pentosidine crosslink (Figure 1-8) (Robins and 
Bailey 1972; Sell and Monnier 1989). Unlike enzymatic crosslinks, glycation can occur at 
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lysine and hydroxylysine residues throughout the triple helix and telopeptide regions, 
although glycation occurs preferentially on specific residues (Sweeney et al., 2008). 
Pentosidine is present at very low concentrations (1 pentosidine molecule per 200-300 
collagen molecules) (Bailey et al., 1995; Dyer et al., 1991) and so is unlikely to alter the 
mechanical properties of the matrix significantly. However, there are other more recently 
characterised AGEs such as glucosepane (Figure 1-8), which is present in much greater 
concentrations (Sell et al., 2005), and has been shown to have a detrimental effect on tissue 
function, resulting in increased stiffness and resistance to degradation (Monnier et al., 
2008). AGEs will also accumulate in non-collagenous proteins including proteoglycans if 
they are present in the matrix for a sufficient amount of time; pentosidine has been shown 
to accumulate with age in articular cartilage aggrecan (Verzijl et al., 2001) and 
intervertebral disc aggrecan (Sivan et al., 2006a). 
 
Figure 1-8: Structure of the AGEs pentosidine and glucosepane. From Avery and Bailey (2006). 
Additional Age Related Modifications     
In addition to the formation of AGEs, modification of the matrix also occurs due to amino 
acid racemization. All amino acids are incorporated into tissues in the L- form, but over 
time they slowly convert spontaneously to the D- form. The most rapidly racemizing amino 
acid is aspartic acid, which has been shown to accumulate with age in human cartilage and 
tendon (Maroudas et al., 1992; Riley et al., 2002). The ratio of D- to L- aspartate can also 
be used to calculate half-life of proteins present in the matrix (Sivan et al., 2006b; Sivan et 
al., 2008). 
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1.5.1.2. Non-Collagenous Components 
The non-collagenous components of the extracellular matrix are mainly glycoproteins and 
proteoglycans (Yoon and Halper 2005). Glycoproteins are compounds consisting of a 
protein covalently linked to a carbohydrate, which may range from a monosaccharide to 
polysaccharides. Proteoglycans are a specific class of glycoprotein, where the core protein 
is attached to one or several polysaccharide chains which contain amino sugars. These 
chains are commonly referred to as glycosaminoglycan (GAG) side chains (Sharon 1986).  
Proteoglycans within Tendon 
Most of the proteoglycans found in the tensile region of tendon are the SLRPs (biglycan, 
decorin, fibromodulin, lumican) whereas there are higher concentrations of aggrecan in 
regions of tendon that are exposed to compressive forces (Rees et al., 2000). Aggrecan is 
the largest proteoglycan found in tendon, consisting of a large core protein (molecular 
weight of approximately 220 kDa) attached to which are up to 100 chondroitin sulphate 
side chains and 60 keratan sulphate side chains. The SLRPs have smaller core proteins 
(molecular weight of about 40 kDa) and fewer side chains. Decorin has the smallest core 
protein attached to which is one dermatan or chondroitin sulphate GAG side chain, whereas 
biglycan has two dermatan sulphate side chains (Scott 1992). Fibromodulin and lumican 
may have up to five covalently bound keratin sulphate side chains, but typically 
fibromodulin has four side chains and lumican has two to three side chains (Yoon and 
Halper 2005). The basic structures of the SLRPs are shown in Figure 1-9. 
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Figure 1-9: Representation of the basic structure of the SLRPs present in tendon. From Yoon and Halper 
(2005). 
The SLRPs are involved in regulating fibrillogenesis and organising the collagenous 
matrix; the protein core binds to the collagen fibril at specific sites and the 
glycosaminoglycan side-chains interact with side-chains from other proteoglycans, holding 
the fibrils at defined distances from each other (Scott 1995).  
Decorin is the most abundant proteoglycan found in regions of tendon that experience 
tensile forces and has a role in maintaining and regulating collagen fibril structure, as well 
as regulating cell proliferation (Yoon and Halper 2005). Decorin is also thought to align 
and stabilise fibrils during fibrillogenesis (Scott 1996); it inhibits lateral fusion of collagen 
fibrils and therefore high concentrations of decorin result in the formation of thinner 
collagen fibrils (Birk et al., 1995). Decorin-null mice exhibit severe tendon defects 
characterised by the formation of severely disorganised collagen fibrils and bone fragments 
within the tendon (Kilts et al., 2009). These data suggest that decorin plays a crucial role in 
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collagen fibrillogenesis and stability. Decorin may also play a role in regulating the 
formation of enzymatic crosslinks; the decorin binding site is in the C-terminal region of 
the collagen fibril and is in close proximity to the predominant site for intermolecular 
crosslink formation (Sweeney et al., 2008). 
Biglycan, like decorin, is able to bind to fibrillar collagen and has been implicated in 
regulation of fibrillogenesis (Yoon and Halper 2005). However, the nature of biglycan 
collagen interactions have not been fully determined (Zhang et al., 2005). Biglycan 
knockout mice exhibit tendon defects characterised by thin, disorganised collagen fibrils 
and ectopic ossification, although this is not as severe as seen in decorin knockout mice 
(Corsi et al., 2002; Kilts et al., 2009). In addition, biglycan synthesis is upregulated in 
decorin-null mice, suggesting it may be able to partially compensate for the absence of 
decorin (Young et al., 2006). 
The class II SLRPs, namely lumican and fibromodulin, also interact with fibrillar collagen. 
These proteoglycans are differentially expressed during tendon development (Ezura et al., 
2000) and it has been proposed they are involved in the regulation of fibril fusion; in vitro 
studies have shown they are able to inhibit fibril fusion (Hedbom and Heinegard 1989). 
Lumican and fibromodulin deficient mice exhibit tendon defects, although these are not as 
severe as in decorin or biglycan knockout models (Ezura et al., 2000). Aggrecan is found 
predominantly in areas where the tendon is placed under compressive loads, for example 
where the tendon wraps round a joint (Rees et al., 2000). Aggrecan is also present in the 
tensile region of tendon at low concentrations; it is thought to reduce collagen stiffness by 
increasing the water content within the matrix and may also be able to protect fibrils from 
collagenases (Jones and Riley 2005; Yoon and Halper 2005). 
In addition to regulating collagen fibrillogenesis during tendon development and 
remodelling it has been suggested that proteoglycans, in particular decorin contribute 
directly to tendon mechanical properties by aiding in the transfer of strain between 
discontinuous collagen fibrils. Decorin consists of a horseshoe shaped core protein, 
attached to which is a single chondroitin or dermatan sulphate side chain; the side chain 
binds to one edge of the molecule such that the GAG chain can align parallel or 
perpendicular to the axis of the collagen fibril (Weber et al., 1996). Studies have 
established that the core protein is able to bind non-covalently to a single collagen triple 
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helix at a specific amino acid sequence in the gap region (D-band) of the fibril, such that 
decorin molecules bind approximately every 68 nm along the collagen fibril (Scott 1992; 
Sweeney et al., 2008; Weber et al., 1996). The side chain interacts with the side chain of 
another decorin molecule bound to a collagen molecule within an adjacent fibril, forming 
an interfibrillar bridge (Scott 1992) (Figure 1-10). Individually, these bonds are weak, but 
combined they are thought to resist sliding between fibres (Gupta et al., 2010).  
 
Figure 1-10: Schematic showing interaction between two collagen molecules from adjacent fibrils via 
decorin core proteins (white horseshoe shaped) and their GAG side chains (black lines). (a) Transverse view 
of collagen fibrils showing connections formed by decorin. (b) Longitudinal view of collagen fibrils showing 
decorin binding in the gap region of the collagen fibrils. (c) 3D representation of the decorin protein collagen 
molecule complex within a microfibril. From Vesentini et al. (2005). 
It has been shown that modelling collagen fibres as a discontinuous composite material 
where stress is transferred between collagen molecules by decorin molecules via 
chondroitin sulphate side chains results in similar values for elastic modulus and ultimate 
stress as those recorded in mature tendon (Redaelli et al., 2003). However, it has not been 
established if collagen fibrils within tendon are discontinuous or if they span the length of 
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the tendon (Provenzano and Vanderby, Jr. 2006). It is clear that fibrils within immature 
tendon are discontinuous (Birk et al., 1995) and some tendons, including the equine SDFT 
and human Achilles vary in cross-sectional area along their length (Birch et al., 2002), 
suggesting that not all fibrils run the entire length of the tendon. However, histological 
studies have not identified any fibril ends in mature tendon (Provenzano and Vanderby, Jr. 
2006). Imaging of tendon is difficult, and as fibrils interweave and are not confined to one 
plane the likelihood of identifying an end is extremely low (Legerlotz et al., 2010). There is 
also controversy regarding the strength of the decorin protein and the interactions of this 
protein with collagen and other decorin molecules, it has been postulated that the bonds 
formed would be too weak to contribute significantly to strain transfer (Provenzano and 
Vanderby, Jr. 2006). However, modelling studies have suggested that the structure of 
GAGs is such that they have a suitable stiffness to transfer stress between fibrils. Collagen 
fibril mechanical properties have also been linked to fibril length; as fibril length increases 
there is also an increase in the number of GAGs able to bind to the fibrils and transfer force 
laterally (Redaelli et al., 2003). A more recent modelling study has reported that the 
binding strength between the decorin core protein and collagen molecule to be 
approximately three orders of magnitude greater than the ultimate strength of the GAG 
chain, indicating that overloading is likely to decrease the mechanical integrity of the 
collagen fibril by disrupting the GAG side chains rather than causing the decorin core 
protein to detach from the collagen fibril (Vesentini et al., 2005). 
Although modelling studies suggest a mechanical role for proteoglycans, experimental 
studies have not provided unequivocal data to support this. Several studies have used 
chondroitinase ABC, which removes the dermatan sulphate and chondroitin sulphate side 
chains of decorin and biglycan, to disrupt proteoglycans within tendon matrix. Removal of 
GAGs from rat tail tendon fascicles did not result in changes in fascicle elastic modulus or 
dynamic viscoelastic properties (Fessel and Snedeker 2009). In contrast, GAG depleted 
murine Achilles tendons exhibited decreases in elastic modulus, but only in the distal 
region of the tendon (Rigozzi et al., 2009). Further, analysis of tendon mechanical 
properties in decorin knock-out mice did not identify differences in the maximum stress or 
modulus of tail tendon fascicles or flexor digitorum longus tendons when compared to wild 
type controls (Robinson et al., 2004a). However, the patellar tendons from decorin knock-
out mice had higher modulus and stress relaxation when compared to controls. In addition, 
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tail tendon fascicles from decorin deficient mice have been shown to have reduced 
sensitivity to the rate of applied strain, whereas fascicles from the tail tendons of immature 
mice, which have a higher proteoglycan content, are more sensitive to alterations in strain 
rate (Brent et al., 2003; Robinson et al., 2004b). These conflicting data suggest that the 
contribution of proteoglycans to tendon mechanical properties may be dependent on tendon 
type and function, and may also vary throughout the length of the tendon. The alterations in 
strain rate sensitivity and stress relaxation suggest that proteoglycans may impart 
viscoelasticity without altering tendon material properties dramatically. However, the 
mechanisms by which this occurs are yet to be elucidated.  
Glycoproteins within Tendon 
Collagen oligomeric matrix protein (COMP) is the most abundant glycoprotein present in 
tendon (Smith et al., 1997). COMP is a large pentameric protein, consisting of 5 sub-units 
which are arranged as arms around a central cylinder. The precise function of COMP 
within tendon is unknown, but it has been suggested that it interacts with collagen, cells and 
other matrix proteins (Smith et al., 2002b) and it is also thought to play a role in 
fibrillogenesis (Sodersten et al., 2005). The concentration of COMP within tendon is 
correlated with ultimate tensile stress and elastic modulus in SDFTs from skeletally 
immature horses, but shows no correlation with mechanical properties of SDFTs from 
mature horses (Smith et al., 2002b). COMP has also been proposed to contribute to transfer 
of strain between collagen fibrils. Mutations in the COMP gene are associated with 
pseudoachondroplasia, a disease characterised by joint laxity and bone abnormalities 
(Maddox et al., 2000). The mechanisms by which COMP mutations induce this disease are 
unknown; but it has been shown that COMP mutations affect proteoglycan synthesis in 
cartilage (Kwak et al., 2009).  However, knockout studies have found that COMP-null mice 
do not exhibit any tendon abnormalities (Svensson et al., 2002) and so this protein may not 
play a critical role in the function or maintenance of mature tendon matrix.  
Tenascin-C is an extracellular matrix glycoprotein that is expressed in low levels in mature 
musculoskeletal tissues including tendon (Taylor et al., 2009) and shows high expression in 
immature tissue as well as in disease states and in healing tissue (Jarvinen et al., 2000). Its 
precise function is as yet unclear but it has been demonstrated that concentration of 
tenascin-C is greatest in areas that experience high mechanical forces and so it has been 
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postulated that this protein provides elasticity to the tendon tissue (Jarvinen et al., 2000). 
Studies have also shown that expression of tenascin-C can be modulated by mechanical 
loading in vivo; immobilisation resulted in a decrease in tenascin-C expression in the rat 
Achilles tendon, whereas treadmill running caused an increase in tenascin-C compared to 
controls (Jarvinen et al., 2003). This protein may therefore have a more important role in 
tendons that experience high strains. 
The glycoprotein tenomodulin is a transmembrane protein which is also found in relatively 
high concentrations in tendon; it has been shown to be essential for normal tenocyte 
proliferation and formation of regular collagen fibrils (Docheva et al., 2005). Expression of 
tenomodulin is positively regulated by scleraxis and it is a late marker of tendon formation 
(Shukunami et al., 2006). In mature tendon, tenomodulin expression is restricted to 
elongated tenocytes within dense regular collagen fibrils (Shukunami et al., 2006) and 
tenomodulin null mice exhibit uneven fibril surfaces within their tendons (Docheva et al., 
2005), suggesting that tenomodulin is involved in collagen fibril alignment and 
organisation. 
Scleraxis is expressed at high levels in all tendon cells and their progenitors (Brent et al., 
2003; Cserjesi et al., 1995; Murchison et al., 2007). The scleraxis gene encodes a basic 
helix loop helix transcription factor that binds tendon-specific element 2, which is required 
for Col1A1 expression in tenocytes (Lejard et al., 2007). Scleraxis-null mice exhibit severe 
tendon defects with a reduced and disorganised matrix, especially in tendons that act to 
transfer force (Murchison et al., 2007), suggesting it is critical for normal tendon 
differentiation and development of tendon mechanical properties, possibly via regulation of 
type I collagen synthesis. However, after maturity the function scleraxis plays in the 
maintenance of tendon matrix is unknown. 
1.5.2. Tenocytes 
In healthy tendon the matrix is maintained and repaired by a small resident population of 
tenocytes which are situated between the collagen fibres within fascicles (intra fascicular) 
or reside between the collagen fascicles (inter fascicular) (Figure 1-11). Cell density is 
relatively low in tendon compared to other soft tissues, and numbers decrease during 
maturation (Stanley et al., 2007). Tenocytes have long cytoplasmic processes which link to 
other tenocytes via gap junctions, which allows them to communicate with one another and 
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presumably respond appropriately to mechanical stimuli (Stanley et al., 2007). It is likely 
that intra-fascicular and inter-fascicular cells within the tendon have different functions 
although this has not been shown and in general tendon cell phenotype is poorly defined.  
 
Figure 1-11: Longitudinal haemotoxylin and eosin stained section of a normal mid-metacarpal region of 
equine SDFT showing areas containing A) Inter-fascicular tenocytes and B) Intra-fascicular tenocytes. 
Histological studies have attempted to further characterise cells within tendon by grouping 
tenocytes into three types according to their morphology (Webbon 1978). Type I cells are 
elongated with thin nuclei and are the predominant cell type in mature tendon (Stanley et 
al., 2008). Type 2 cells are often referred to as tenoblasts rather than tenocytes; these cells 
have ovoid rather than elongated nuclei and are present in greatest concentrations in 
immature tendons, with a decrease in numbers in mature tendons (Stanley et al., 2007). It 
has been shown that type 2 cells from human patellar tendons proliferate more rapidly and 
have higher expression levels of pro-collagen and matrix degrading enzymes than type I 
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cells from the same tendon (Chuen et al., 2004), suggesting that type 2 cells have greater 
levels of metabolic activity than type I cells. Type 3 cells are restricted to areas of tendon 
that experience significant levels of compression and exhibit a morphology that is 
chondrocyte like; cells in these areas are much more rounded than type 1 or 2 cells 
(Webbon 1978). In a recent study of the equine SDFT and CDET, it was reported that cells 
in the tensile mid-metacarpal region of these tendons were either type 1 or 2, with increases 
in the percentage of type I tenocytes with increasing age (Stanley et al., 2008), suggesting 
that overall cell activity declines with ageing. 
1.5.2.1. Matrix Degradation 
Tenocytes are able to remodel tendon matrix by synthesising matrix molecules, including 
collagen and proteoglycans, and enzymes responsible for degradation, including matrix 
metalloproteinases (MMPs), a disintegrin and metalloproteinases (ADAMs) and a 
disintegrin-like and metalloproteinase with thrombospondin motifs (ADAMTS). The 
activity of matrix degrading enzymes is tightly regulated by a number of mechanisms. 
These include the presence of tissue inhibitors of metalloproteinases (TIMPs), whether the 
molecules are in their active or pro-form and their location within the matrix (Nagase et al., 
2006).  
MMPs are synthesised as inactive pro-enzymes and consist of a pro-peptide region 
approximately 80 amino acids in length, a catalytic domain about 170 amino acids long, a 
linker peptide or hinge region and a hemopexin domain about 200 amino acids long (Figure 
1-12). Pro-MMPs are inactive as the pro-peptide contains a cysteine switch which binds to 
the zinc binding motif in the catalytic domain and prevents a water molecule binding to the 
zinc atom, a step which is essential for activation (Nagase et al., 2006). Once the MMP has 
been activated by cleavage of the pro-peptide, a water molecule is free to bind to the zinc 
atom. The substrate binding site is adjacent to the zinc atom and varies in size between 
MMPs, which determines the substrate specificity. ADAMs consist of a metalloproteinase-
like domain, which has proteolytic activity, a disintegrin-like domain which enables 
binding for integrins and other receptors, a cysteine-rich domain which may enable 
membrane fusion and a cytoplasmic tail (Wolfsberg et al., 1995). ADAMs are able to 
cleave a variety of matrix proteins and have also been implicated in control of cell-cell and 
cell-matrix interactions (White 2003). ADAMTSs are similar in structure to ADAMs, with 
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up to fourteen additional thrombospondin motifs (Figure 1-12) (Jones and Riley 2005) and 
also have proteolytic activity against several components of tendon extracellular matrix 
(Jones and Riley 2005).  
 
Figure 1-12: Representation of the domain organization of MMPs, ADAMs and ADAMTSs. TSR, 
thrombospondin type 1-like repeat; EGF, epidermal growth factor; TM, transmembrane. From Jones and 
Riley (2005). 
While some MMPs are activated intracellularly, the majority are secreted as inactive pro-
enzymes (Nagase et al., 2006). The pro-peptide can be cleaved by a variety of molecules, 
including proteinases present within the matrix. As disruption of the cysteine switch is 
required for activation, addition of agents that affect protein structure, such as 
aminophenylmercuric acetate (APMA) and sodium dodecyl sulphate (SDS), are also able to 
activate MMPs without proteolysis of the pro-peptide (Nagase and Woessner, Jr. 1999). 
Other MMPs are often responsible for activation; for example pro-collagenase is activated 
by MMP-3 (Suzuki et al., 1990). Once activated, MMPs can still be inhibited by TIMPs, 
which bind to the active site of the enzyme in a stochiometric ratio (Nagase et al., 2006). 
TIMPs are also able to inhibit ADAMs and ADAMTSs (Roy et al., 2004). 
Matrix degrading enzymes are specific for different components of the matrix. The only 
enzymes capable of degrading intact triple helical collagen are the collagenases (MMP-1, -
8 & -13) (Lauer-Fields et al., 2000; Visse and Nagase 2003). These enzymes cleave the 
collagen into characteristic three-quarter and one-quarter fragments; these fragments can 
then be further degraded by other enzymes such as the gelatinases (MMP-2 & -9) (Visse 
and Nagase 2003). However, collagen degradation is further hampered by the hierarchical 
structure of the tendon; intact fibrillar collagen is highly resistant to degradation and only 
collagen molecules on the surface of the fibril are accessible for enzymatic degradation 
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(Perumal et al., 2008). Computational and visualization studies suggest that the C-terminal 
telopeptide of collagen must be proteolytically cleaved before collagenases can gain access 
to degrade the triple helical region of the collagen molecule (Perumal et al., 2008). Once 
the telopeptide has been cleaved the collagenases can then unwind the triple helix to gain 
access to all three collagen chains (Chung et al., 2004). MMP-3 has been implicated in the 
cleavage of the C-terminal telopeptide (Sweeney et al., 2008) suggesting that this enzyme 
may have a role in the control of collagen breakdown. This is likely to be an important 
regulatory mechanism which would prevent the enzymatic degradation of intact collagen in 
favour of collagen that is partially damaged such that the triple helical region is more 
accessible to collagenase. The stromelysin MMP-3 is likely to play an important role in 
tendon matrix degradation; as well as degrading a variety of matrix proteins, it is also 
involved in the activation of collagenases and gelatinases (Olson et al., 2000; Suzuki et al., 
1990) and is thought to assist in collagen degradation (Sweeney et al., 2008). In contrast, 
the gelatinase MMP-2 is thought to be a regulator of collagen fibril formation; it has been 
shown that levels of active MMP-2 increase during fibrillogenesis, and incubating fibrils 
with the activated form of the enzyme results in lateral growth of the fibrils (Jung et al., 
2009). It is possible that MMP-2 is able to influence fibril size and growth by degrading 
molecules that are regulators of lateral and longitudinal fibril growth, including the SLRPs. 
As well as degrading collagen fragments generated by collagenases, gelatinases are also 
able to degrade proteoglycans, as are the stromelysins (MMP-3 & -10), and specific 
ADAMs and ADAMTSs (Kashiwagi et al., 2004). These studies indicate that degradation 
of specific components within tendon matrix is tightly controlled; this is important to 
prevent unregulated degradation which may have a detrimental effect on tendon mechanical 
integrity. It is therefore likely that concentration and activity of matrix degrading enzymes 
differ between functionally distinct tendons; previous work has shown greater MMP 
concentration in the injury prone supraspinatus tendon than the rarely injured biceps brachii 
tendon (Riley et al., 2002). 
1.5.3. Differences in Matrix Composition between Tendons 
In order to achieve specificity, the SDFT and CDET have different matrix compositions. 
The mature SDFT has higher GAG content, water content and cellularity than the CDET 
(Batson et al., 2003). The SDFT also has a greater proportion of type I and type 2 tenocytes 
than the CDET, both in immature and mature tendon (Stanley et al., 2008). There are also 
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differences in matrix composition between the SDFT and DDFT (Birch et al., 1999a), 
although these are not as great as the differences between the SDFT and the CDET. The 
DDFT has a lower cellularity, percentage of type III collagen and pyridinoline crosslinks, 
and higher GAG content and percentage of large diameter collagen fibrils than the SDFT. It 
is thought that small diameter fibrils are more able to prevent interfibrillar slippage due to 
an increased surface area compared to fibrils with a larger diameter (Birch et al., 1999a), 
and so this, accompanied by higher levels of type III collagen, may enable the SDFT to be 
more elastic than the DDFT. The differences in proteoglycan content between functionally 
distinct tendons may also contribute directly to tendon mechanical properties. Although 
there is a large variation in SDFT strength and stiffness between individual horses (Birch 
2007); within an individual the SDFT invariably has a lower elastic modulus (less stiff 
material) than the CDET. The lower elastic modulus of the SDFT tissue means it can store 
and return energy more efficiently as it is stretched throughout the stance phase and recoils 
during the swing phase, returning the stored energy at an appropriate point in the stride 
cycle (Batson et al., 2003). However, at birth and in very young animals, the properties of 
the digital flexor and extensor tendons are very similar; Shadwick (1990) found no 
differences between the extensibility, elastic modulus, strength and energy storing ability of 
pig digital flexor and extensor tendons at birth, but at maturity the tendons were stronger, 
stiffer and less extensible. The properties of the flexor tendons changed to a much greater 
degree compared to those of the extensor tendons. The mechanical properties of the flexor 
and extensor tendons may be modulated by the forces they experience; the flexor tendons 
are loaded to a greater extent and at a different rate when compared to the extensor tendons 
so they develop properties that allow them to cope with these loads and also store and 
return energy efficiently. A more recent study of equine tendon (Batson et al., 2001) found 
that the SDFT and CDET had similar mechanical properties at birth, but after three days the 
CDET had a higher elastic modulus than the SDFT, suggesting that the tendon matrix 
undergoes rapid changes in response to the new loads placed upon it. 
COMP levels also differ between the functionally distinct tendons in the equine forelimb. 
COMP is differentially distributed throughout the SDFT and the highest concentration is 
found in the mid-metacarpal region, which experiences the highest tensile stress, whereas 
lower levels are found in the CDET (Smith et al., 1997). COMP levels are correlated with 
the number of small diameter collagen fibrils, which may be an adaptation to increased 
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loading (Sodersten et al., 2005). The ECM composition of the SDFT also differs along its 
length; collagen content, amount of degraded collagen, cellularity and water content are 
higher in the mid-metacarpal region than the sesamoid region, whereas GAG levels are 
lower in the mid-metacarpal region (Birch et al., 2002; Lin et al., 2005b). This may be 
because the mid-metacarpal region experiences tensile forces, whereas the sesamoid region 
experiences both tensile and compressive forces (Lin et al., 2005b), so the different regions 
adapt to fulfil their specific roles. 
1.6. Characteristics of Tendon Degeneration 
1.6.1. Alterations in Matrix Composition 
Degeneration of the SDFT is characterised by discolouration of the central core region of 
the tendon (Figure 1-13). This is frequently seen at post mortem in horses that exhibit no 
clinical signs of tendon injury, such as lameness or swelling (Birch et al., 1998; Webbon 
1977). Recent attempts to detect these early changes in vivo using ultrasonography were not 
able to predict SDFT injury, although where SDFT pathology was identified an acute injury 
was more likely to occur (Avella et al., 2009). Abnormal colouration is accompanied by 
changes in matrix composition; the central core region has increased levels of GAG, type 
III collagen and cellularity, and decreased collagen-linked fluorescence (a marker of matrix 
age) compared to the peripheral region of degenerated tendon and the core of normal 
tendon (Birch et al., 1998). Similar changes occur in degenerated and painful human 
tendons, with upregulation of collagen types I and III (Ireland et al., 2001), increased 
proteoglycan content and disorganised collagen fibrils (Riley et al., 2001). Increased 
production of inflammatory cytokines (Gotoh et al., 2001) and lower concentrations of 
molecules that are used as markers of matrix age (Bank et al., 1999; Riley et al., 2002) are 
also common features of tendinopathy.  
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Figure 1-13: Mid-metacarpal region section of A) Normal SDFT and B) Injured SDFT showing central core 
discolouration. 
1.6.2. Alterations in Gene Expression  
There are several genes that show changes in expression level with tendon injury; Ireland et 
al. (2001) reported increases in expression of collagen types I and III and the proteoglycan 
biglycan in samples taken from humans with chronic Achilles tendinopathy. This was 
accompanied by a decrease in MMP-3 expression. A study that profiled mRNA expression 
of all the known MMPs, and a selection of ADAMs, ADAMTS genes and TIMPs found 
differences in gene expression levels in tissue from normal, painful and ruptured human 
Achilles tendons (Jones et al., 2006). Interestingly, the pattern of gene expression differed 
between painful and ruptured tendons; the collagenase MMP-1 was found to be upregulated 
in ruptured tendon, as was the gelatinase MMP-9, along with MMP-19 and -25. Expression 
of MMP-3 was found to decrease in both ruptured and painful tendon, and mRNA levels of 
MMP-10 were lower in painful tendons when compared to normal. Painful tendon also 
showed upregulation of MMP-23 and ADAM-12 when compared to normal tendon (Jones 
et al., 2006). The increased expression of genes coding for collagen suggests that the cells 
are attempting to remodel the matrix and repair any micro-damage. These data also suggest 
that MMPs play an important regulatory role in tendon matrix turnover. The changes in 
matrix composition that occur with degeneration suggest an increased rate of matrix 
turnover, which may be an inadequate healing response or an inappropriate cellular 
response, resulting in the degradation of normal matrix. The stimulus for this change is not 
known but suggested causes include mechanically induced micro-damage to collagen 
fibrils, hyperthermia and hypoxia. 
1.7. Micro-damage to Collagen Fibrils 
Localised damage can occur to the collagen fibrils when tendons are exposed to high strains 
as in the SDFT during high speed locomotion. In vitro experiments have shown that 
loading tendon fascicles at 80% of failure strain resulted in isolated fibrillar damage and 
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fibril sliding (Lavagnino et al., 2006). This micro-damage was accompanied by a localised 
increase in MMP-1 gene expression and production. An in vivo model of tendon overload 
fatigue damage has demonstrated that low levels of damage result in the formation of 
kinked collagen fibres, which span several fibrils. As damage increases, the matrix 
becomes disorganised, eventually resulting in the formation of voids between fibres and 
fibre thinning (Fung et al., 2010a; Fung et al., 2010b), which is accompanied by an 
increase in MMP-13 expression (Sun et al., 2008). The hierarchical structure of tendon is 
such that, during a loading cycle, some fibrils may experience higher strains and therefore 
be at higher risk of damage than others (Kastelic et al., 1978); modelling studies have 
predicted that there are large strain distributions within the tendon matrix and small overall 
deformations may be amplified locally (Screen and Evans 2009). Therefore, isolated 
fibrillar damage may not affect the tendon’s gross mechanical properties, but may alter 
local cell-matrix interactions (Arnoczky et al., 2008a). However if the micro-damage is not 
repaired by the resident tenocytes it will accumulate and may then result in clinical injury. 
It may be expected therefore that high strain tendons have a greater capacity for matrix 
repair than low strain tendons. Although the SDFT has a higher cellularity than the CDET, 
the cells in the CDET exhibit increased mRNA expression of type I collagen and 
collagenases, and there are higher levels of the cross-linked carboxy-terminal telopeptide of 
type I collagen (ICTP), a marker of collagen degradation (Birch et al., 2008b), suggesting 
the potential for, and the rate of, matrix turnover is higher in the CDET than in the SDFT. It 
is unclear why tenocyte activity is lower in the SDFT when this tendon is at higher risk of 
micro-damage, and there are two main hypotheses that need to be considered. Structures 
that require high mechanical strength to function, such as the SDFT, may be protected from 
remodelling as this would cause them to weaken transiently as the collagen molecules are 
degraded and replaced (Laurent 1987). The alternative hypothesis is that cell activity is 
compromised by changes to the cells’ physiochemical or mechanical environment that 
occur during high speed exercise and with increasing age. 
1.8. Changes to Physiochemical Environment 
Due to the viscoelastic nature of tendon, some of the energy stored by the SDFT is released 
as heat, rather than being returned as kinetic energy (Ker 1981), which causes the 
temperature in the tendon core to increase, and temperatures of 45 °C have been recorded 
in the core of the SDFT in vivo during gallop exercise (Wilson and Goodship 1994). 
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Although exposing most cell types to temperatures above the normal physiological range 
would result in cell death, tenocytes from the SDFT cultured in vitro in suspension have 
been shown to be heat resistant up to 48 °C for a period of 10 minutes (Birch et al., 1997b) 
(Figure 1-14). However, cells may be more sensitive to heating in situ where they are able 
to communicate via their gap junctions (Burrows et al., 2009). Other studies have shown 
that above 45 °C equine tenocytes produce more pro-inflammatory cytokines, which will 
increase the production of matrix degrading enzymes (Hosaka et al., 2006). No studies have 
measured temperature in the CDET in vivo but as this tendon experiences low strains and 
has a relatively small cross sectional area (mean CSA of 28 ± 7 mm
2
 in the CDET 
compared to 96 ± 35 mm
2
 in the SDFT (Batson et al., 2003)) it is unlikely high 
temperatures would be reached. The poor blood supply in tendon contributes to the increase 
in temperature as the heat is dissipated relatively slowly, exposing the cells to high 
temperature for a longer period of time. The poor blood supply may also result in low 
oxygen levels in the tendon core which may further compromise cell activity. Tenocytes are 
capable of oxidative energy metabolism (Birch et al., 1997a), which suggests their 
synthetic and degradative activity may be compromised by low oxygen levels.   
 
Figure 1-14:  A) Hysteresis loop during cyclical loading and unloading of tendon. The energy lost is 
represented by the area within the loop. B) Equine tendon fibroblast survival following exposure to 
hyperthermia (10 min.). Different symbols represent fibroblasts grown from different horses. Data replotted 
from Birch et al. (1997b). 
1.9. Changes to Mechanical Environment 
The mechanical deformation experienced by the cells within the SDFT depends on the 
coupling between the cell and extracellular matrix and this in turn affects cell activity. It 
has for example been shown that the strain experienced by individual cells is not the same 
as that applied to tendon fascicles (Screen et al., 2004). It is well established that cells are 
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able to respond to changes in their mechanical environment by altering synthesis and 
degradation of matrix components. This response was first documented in bone cells, which 
increase or decrease bone mass according to the amount of load placed on the bone. Frost 
proposed that osteoblasts have a pre-set sensitivity to deformation such that if strain-
induced signals are above or below a certain level, termed the ‘mechanostat set-point’, the 
cells will remodel the matrix accordingly (Frost 1987). Recently, it has been shown that 
tendon cells have a similar ability to remodel the matrix according to the strain they 
experience (Lavagnino and Arnoczky 2005). Cells sense matrix deformation by 
mechanotransduction, which converts a mechanical signal into a biological response. 
Receptors on the cell surface will detect deformation, and this information will be passed to 
the nucleus via the internal cytoskeleton, where the appropriate response will be initiated 
(Ingber 1997). Recent studies have shown that there are large strain distributions within the 
tendon matrix, particularly compressive and shear strains which, due to complex local 
deformations, can, in some areas, exceed the overall strain applied to the tendon (Cheng 
and Screen 2007; Screen and Evans 2009).  
While physiological strains may be expected to result in tendon adaptation unusually high 
strains may result in a damage response. In vitro studies have shown that exposing 
tenocytes to high strains causes them to alter their production of specific proteins. Exposing 
human tenocytes to 3.5% cyclical strain at a frequency of 1 Hz for 2 hours caused increased 
expression of MMP-3, which degrades proteoglycans, and interleukin 1-Beta (IL1-β), a 
cytokine that is able to induce expression of MMPs (Tsuzaki et al., 2003). Cyclically 
stretching human tendon cells from 4-12% at a frequency of 0.5 Hz caused an increased 
production of prostaglandin E2, which is an inflammatory mediator of tendinopathy (Wang 
et al., 2003). It has also been found that loading rabbit tenocytes at 5% cyclical strain with a 
frequency of 0.33 Hz causes increased expression of MMP-1 and MMP-3. However, this 
upregulation only occurred with the addition of IL1-β (Archambault et al., 2002). The 
strains used in these studies may not appear to be high relative to the strains seen by the 
SDFT in a galloping horse however it is difficult to recreate in vitro the strains experienced 
by cells in vivo. Visualising cells in fascicles exposed to 8% strain has shown that the local 
strain experienced by most cells does not appear to exceed 2% (Screen et al., 2004), 
although there may be areas within the matrix where strains are amplified (Screen and 
Evans 2009). Cells in these in vitro studies are therefore being exposed to strains equivalent 
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to those that might be experienced in vivo by tenocytes in a high strain energy storing 
tendon such as the SDFT. However, cells in the SDFT may have a high mechanostat set-
point, such that they have adapted to perceive high levels of strain as ‘normal’. SDFT 
tenocytes may therefore only exhibit a degradative response when exposed to extremely 
high strains, generated as a result of micro-damage to the matrix or in regions of high stress 
concentrations within the tendon.  
Alternatively, it has been proposed that it is the under-stimulation of cells rather than over-
stimulation that causes the upregulation of matrix degrading enzymes. Micro-damage 
results in the unloading of the damaged fibrils (Lavagnino et al., 2006), and fibril 
disruption will alter the cell-matrix interactions, which may result in the localised stress-
shielding of some cells. Stress deprivation causes increased expression of the collagenase 
MMP-13, alterations in cell morphology and pericellular environment (Arnoczky et al., 
2008b), and increased apoptosis (Egerbacher et al., 2007). It has also been reported that 
stress deprivation alters the cells' response to loading; cells in stress deprived tendons that 
were then cyclically loaded were found to express significantly higher levels of MMP-13 
mRNA than cells that had not been stress deprived (Arnoczky et al., 2008b). This suggests 
that under-stimulation causes the cells to alter their ‘set point’, so they may be unable to 
respond appropriately to mechanical stimuli and so will not repair any micro-damage. The 
cells may also actively degrade the matrix, which may accelerate the rate of micro-damage 
accumulation. 
1.10. Abnormal Loading Events 
Micro-damage has been shown to occur in vitro after a single loading event at 80% of 
failure strain (Lavagnino et al., 2006). It is possible that during repetitive loading (i.e. 
during high speed exercise) one abnormal loading cycle may result in strains of a high 
enough magnitude to induce isolated micro-damage without clinical injury (Arnoczky et 
al., 2008a). This abnormal loading may be as a result of muscle fatigue, changes in the 
neuromuscular response or exercise on an uneven surface (Kai et al., 1999). This suggests 
that tendon injury is more likely to occur towards the end of a race, when racing over 
longer distances or over fences, and this is supported by studies that have found increased 
tendon injury in these situations (Peloso et al., 1994; Pinchbeck et al., 2004; Takahashi et 
al., 2004; Williams et al., 2001). Recently, it has been proposed that the SDFT may be at 
increased risk of injury due to fatigue of the deep digital flexor muscle. During high speed 
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locomotion, the DDFT stores little energy, but acts to stabilise the metacarpophalangeal 
joint during hyperextension. However, its corresponding muscle has a high percentage of 
fast twitch muscle fibres, and so is more susceptible to fatigue. If this occurs, the 
metacarpophalangeal joint will be de-stabilised and so the SDFT will be subjected to higher 
strains which may result in fibril micro-damage (Butcher et al., 2007). These findings 
indicate that as the SDFT experiences high strains which are close to failure strains 
recorded in vitro, very small increases in strain may be sufficient to cause micro-damage 
and lead to clinical injury.       
 
1.11. Injury Prevention and Treatment 
1.11.1. Prevention 
One of the most effective ways of preventing injury to musculoskeletal tissues is to increase 
tissue strength by undertaking a training programme which results in a tissue that is able to 
resist higher forces. However, this assumes that the cells within the tendon are able to 
remodel the matrix and it has been found that, unlike other skeletal tissues such as bone and 
muscle, mature tendon has a limited ability to undergo hypertrophy in response to exercise. 
However, mechanical loading is essential for development of tendons; foals that were 
confined in a stall from the ages of 1 week to 5 months were found to have smaller and 
weaker SDFTs than foals that were maintained at pasture (Cherdchutham et al., 2001). 
Interestingly, foals kept at pasture also had stronger and more extensible tendons than foals 
that were housed in stalls and exposed to episodes of high intensity exercise daily, 
suggesting that longer periods of low intensity exercise may be required for the 
development of optimal tendon mechanical properties (Cherdchutham et al., 2001). 
Kasashima and colleagues (2002) measured the changes in tendon CSA of foals aged 2-15 
months; the CSA of the immature SDFT in foals exposed to high intensity exercise was 
found to increase to a greater extent when compared to foals that were allowed pasture 
exercise. However, a more recent study reported that exposing immature horses to 
additional exercise from birth had no effect on tendon matrix composition or mechanical 
properties (Kasashima et al., 2008). Tendons appear to reach maturity at a relatively early 
age; in a study of 2 year old horses (Birch et al., 1999b) neither the SDFT nor the DDFT 
underwent hypertrophy in response to high-intensity exercise. However, the CSA of the 
CDET increased significantly in the horses on the high-intensity training program. The 
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study indicated that the tendons reach maturity at different times; the SDFT reached 
maturity by the age of 2, whereas the DDFT and CDET reach maturity between the ages of 
2 and 3. It is possible that pasture exercise is sufficient for the tendons to develop optimal 
mechanical properties (Kasashima et al., 2008), and additional exercise does not increase 
the CSA of the mature SDFT as this would result in increased stiffness which would 
decrease the energy storing capacity of the tendon (Birch et al., 1999b). As it does not 
appear possible to improve tendon mechanical properties by exposing the horse to different 
exercise intensities, it is important to develop training programmes that allow optimal 
adaptation of other musculoskeletal tissues without resulting in tendon overstrain injury.  
1.11.2. Current Treatments 
The earliest reported treatment for tendon injury is cautery, where heat or acid is applied to 
the skin adjacent to the injured tendon. This treatment is recorded in the earliest printed 
work on veterinary anatomy (Artis veterinariae; 500 AD), and is still in use today, although 
its effectiveness and use is controversial. Tendon blood supply is generally poor, and so 
this treatment is proposed to work by increasing circulation to the injured tendon. The use 
of cautery is supported by much anecdotal evidence, but the only long term experimental 
study concluded that it is no more effective than the conservative treatment consisting of a 
period of rest followed by an incrementally increasing exercise protocol (Silver et al., 
1983). In the last decade, several new treatments for equine tendon injury have been 
developed; these include extracorporeal shock wave therapy (ESWT) and injection of 
autologous bone marrow derived mesenchymal stromal cells (MSCs) or platelet rich 
plasma (PRP). However, these therapies are often used clinically before rigorous testing has 
been undertaken, and so their efficacy is not known.  
ESWT involves applying high energy pressure pulses to a focused area and has been used 
to treat tendon injuries in the horse and human (Gerdesmeyer et al., 2003; Lin 2005). Shock 
waves generate pressure fluctuations within the tissue which are thought to initiate a 
healing response within the tendon by increasing the metabolic activity of the resident 
tenocyte population (Lin 2005). Clinical studies suggest that ESWT increases the rate of 
lesion healing in equine tendons as assessed ultrasonographically (McClure and 
Weinberger 2003) and may also have an analgesic effect (Dahlberg et al., 2006). However 
in a model using ESWT to treat collagenase-induced lesions in the SDFT it was found that 
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application of shock waves did not affect the ultrasonographic or histological parameters of 
tendon lesions compared to controls, but did result in increased neo-vascularisation (Kersh 
et al., 2006). Evaluation of the effects of ESWT on properties of normal tendon has found 
that ESWT results in increased GAG and protein synthesis in the short-term (3 h after 
treatment) (Bosch et al., 2007) however 6 weeks after treatment the matrix appears less 
organised compared to untreated tendons, and there was also increased gene expression for 
type I collagen (Bosch et al., 2009a), which is a feature of tendon injury (Riley 2008). 
These results suggest that EWST should be used with caution in the treatment of tendon 
injuries, as any beneficial effects are yet to be fully elucidated, and there may be 
detrimental effects to surrounding healthy tendon tissue. 
Another technique that has recently been developed to treat tendon injury is the injection of 
autologous mesenchymal stromal cells (MSCs) into the lesion. This treatment assumes that 
the resident tenocytes are incapable of repairing the tendon lesion and so uses bone marrow 
as a source of MSCs, which are isolated and expanded in culture and then injected into the 
injured tendon under ultrasonographic guidance (Smith and Webbon 2005). Clinical studies 
have found that horses treated with MSC injection had lower re-injury rates than those 
reported for horses treated using conventional methods (Smith 2008). Injection of MSCs 
into SDFT lesions in racehorses resulted in improved healing compared to controls treated 
conventionally as assessed by ultrasonography and successful return to racing in nine out of 
eleven cases (Pacini et al., 2007). Autologous MSC implantation has also been reported to 
result in morphology closer to that of uninjured tendons than controls treated with saline 
injection (Young et al., 2009a). Collagenase-induced lesions treated with MSCs had more 
normal histological parameters than the controls, but there was no difference in mechanical 
properties, gene expression levels, DNA and collagen content between MSC treated and 
control tendons (Schnabel et al., 2009). While this appears to be a promising treatment, 
further work needs to be undertaken to determine the precise effect of MSC injection on 
lesion healing, both in the short and long term.    
A treatment currently in use as an alternative to autologous MSC implantation is the 
injection of PRP into the site of injury. The reason for using PRP is that when activated, the 
platelets release several growth factors thought to enhance matrix repair by increasing 
tenocyte activity.  In vitro studies have found that SDFT tenocytes cultured in PRP-rich 
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media express higher levels of genes coding for collagen, without an increase in gene 
expression for matrix degrading enzymes (McCarrel and Fortier 2009; Schnabel et al., 
2007). Injection of PRP into experimentally induced lesions resulted in increased metabolic 
activity and increased organisation of repair tissue compared to controls (Bosch et al., 
2009b; Bosch et al., 2010).  
Although there have been significant advances in treatment of tendon injuries in recent 
years, there is as yet no treatment available that is able to restore the tendon to its previous 
levels of functionality so that re-injury does not occur. The mode of action of the majority 
of treatments currently in use for tendinopathy is to increase cell activity within the lesion, 
either by the implantation of additional cells or through the use of methods designed to 
increase metabolic activity of the cells resident within the tendon. The effects of injecting 
substances such as MSCs and PRP have yet to be fully determined, and although they 
appear to increase the rate of repair to some extent, long recovery periods are still required 
and it is not know if the level of repair achieved is any greater of that achieved when 
managing tendon injury conservatively. It is difficult to assess the repair process when little 
is known about tenocyte phenotype, activity and matrix turnover in healthy tendon; how 
these parameters differ between functionally distinct tendons and if they are affected by 
increasing age. 
1.12. Conclusions 
High strains experienced by the energy storing human Achilles tendon and equine SDFT 
undoubtedly contribute to the high incidence of injury to these tendons. The findings of 
epidemiological studies support this as the forelimbs, which carry 60% of the horse weight 
when standing and even more during locomotion, are more susceptible to overload injury, 
and activities which result in particularly high strains such as galloping and jumping at 
speed increase the risk of injury. However the presence of degenerative matrix changes and 
the increased incidence with increasing age in both humans and horses suggest that injury is 
not due to a simple mechanical overload. Furthermore some human and equine athletes 
compete at the highest level and never suffer from tendon injury. There is a large variation 
in the strength and stiffness of the SDFT between individual horses which does not 
correlate with body weight or age; it is not known at present whether this relates to injury 
susceptibility. The ability to turnover matrix components is likely to be important but as yet 
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it is not clear why the capacity to do this should be less in the injury prone SDFT that the 
rarely injured CDET; and further work is required to elucidate any differences in cell 
phenotype between the functionally distinct tendons. An improved understanding of matrix 
turnover and ageing processes in tendon will provide opportunities to modify management 
of athletes' training programmes to prevent injury and also to improve the current treatment 
options available for tendinopathies.
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CHAPTER TWO 
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2. Thesis Aims and Objectives 
2.1. General Hypothesis 
This thesis tests the hypothesis that tenocyte metabolism is programmed by the strains the 
cells experience in vivo meaning that functionally distinct high strain energy storing 
tendons have a lower rate of matrix turnover than low strain positional tendons and that this 
declines further with increasing age. 
2.2. Aims and Objectives 
The aim of this thesis is to test the hypothesis above by addressing the following objectives: 
1. To measure the age of extracellular matrix molecules in functionally distinct tendons in 
the equine forelimb and determine how this differs between tendons and changes with 
increasing horse age. 
2. To measure the ability of the tenocytes to synthesise structural components of the 
matrix and matrix degrading enzymes and determine if this differs between tendons and 
alters with increasing horse age. 
3. To quantify markers of extracellular matrix turnover at the protein level and determine 
if levels differ between tendons or with increasing horse age. 
4. To determine if tenocytes from functionally distinct tendons maintain their phenotype 
in vitro and if they are able to alter their phenotype if placed in a different strain 
environment from that which they experience in vivo. 
Experimental design 
General Methods (Chapter 3) 
Tendons from the equine forelimb were harvested from horses chosen with a wide age 
range (4 - 30 years). Four tendons were collected from the right forelimb of each horse and 
were separated into two groups according to their functions; the high strain energy storing 
tendons (superficial digital flexor tendon (SDFT) and suspensory ligament (SL)) and the 
low strain positional tendons (common digital extensor tendon (CDET) and deep digital 
flexor tendon (DDFT)). The mid-metacarpal region was harvested from each tendon and 
processed for analysis as described in subsequent chapters. 
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Objective 1: Matrix Age and Composition (Chapter 4) 
The work in this chapter tests the hypothesis that the matrix composition and age of the 
SDFT and SL would be similar as these tendons have a similar function in vivo, as would 
the composition and age of the CDET and DDFT. Furthermore, it was hypothesised that the 
accumulation of markers of matrix age would be more rapid in the SDFT and SL than in 
the CDET and DDFT, indicating an ‘older’ matrix in the high strain energy storing tendons 
compared to the low strain positional tendons. Matrix composition was assessed in the 
forelimb tendons by measuring the collagen, GAG, water and DNA content, and assessing 
levels of pyridinoline crosslinks. Molecular matrix age was determined by measuring the 
accumulation of the advanced glycation end product pentosidine and D-aspartic acid; these 
have been previously used as markers of matrix age as they accumulate over time in 
proteins with a low rate of turnover. To determine if the rate of turnover differed between 
the collagenous and non-collagenous matrix proteins, the matrix of the SDFT and CDET 
samples was separated into the collagenous and non-collagenous fraction and the half-life 
of the proteins in each fraction was estimated by measuring the accumulation of D-aspartic 
acid.  
Objective 2:  Potential for Matrix Synthesis and Degradation (Chapter 5) 
The work in this chapter tests the hypothesis that cells in the low strain positional tendons 
have a greater potential for synthesis of structural matrix proteins and degradative enzymes 
than their counterparts in the high strain energy storing tendons. It was further hypothesised 
that the potential for matrix protein production and matrix degradation would decrease with 
increasing horse age in all tendons, representing a decrease in overall cell activity. In order 
to assess the tenocytes’ ability to synthesise and degrade matrix components, mRNA was 
extracted from the tendon samples and the expression of genes coding for collagenous and 
non-collagenous matrix proteins and the enzymes that degrade these proteins was measured 
using real time reverse-transcription polymerase chain reaction (RT-PCR). To determine 
the potential for matrix degradation at the protein level zymography and a fluorometric 
assay were used to assess activity of specific matrix degrading enzymes in a semi-
quantitative manner in tissue from the SDFT and CDET. 
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Objective 3: Turnover of the Collagenous Matrix (Chapter 6) 
The work in this chapter tests the hypothesis that collagen turnover in high strain energy 
storing tendons is lower than that in low strain positional tendons and that the rate of 
collagen turnover decreases with increasing horse age in both tendon types. The rate of 
collagen turnover that occurs in the functionally distinct SDFT and CDET was assessed 
using several different techniques. The rate of collagen synthesis was determined by 
measuring the amount of the amino terminal pro-peptide of type I collagen (PINP) which is 
cleaved from the procollagen molecule during collagen synthesis. Collagen degradation 
was assessed by measuring the concentration of protein fragments produced when collagen 
undergoes enzymatic degradation; the cross-linked carboxy terminal telopeptide of type I 
collagen (ICTP) and the ¾ neoepitope (C1,2C) which are generated when collagen is 
cleaved by collagenases.  
Objective 4: Cell Phenotype Conditioning (Chapter 7) 
The work in this chapter tests the hypothesis that tendon cell phenotype is programmed by 
the in vivo strain environment. Specifically, it was hypothesised that tendon specific 
phenotype is due to the different in vivo cell environment and therefore culturing cells in 
monolayer in the absence of mechanical load and under the same conditions would result in 
significant alterations in cell phenotype and differences between SDFT and CDET 
tenocytes would be lost. Further, it was hypothesised that when exposed to strains they 
would not normally experience in vivo, the tenocytes will alter their phenotype; i.e. 
exposing tenocytes to low strains will cause them to exhibit a phenotype usually associated 
with cells from the CDET and vice versa. Initial experiments were carried out to determine 
the effect of culturing tenocytes from the SDFT and CDET in 2D and 3D culture systems 
on tenocyte phenotype. Tenocyte phenotype plasticity was assessed by loading medial 
accessory extensor tendons (MAET) in an in vitro system. MAETs were harvested from the 
medial border of the CDET and cyclically loaded at either low or high strains for a period 
of 20 hours. Cell phenotype was assessed by measuring the expression of genes coding for 
key matrix proteins and corresponding degradative enzymes and markers associated with a 
tenocyte phenotype using RT-PCR. 
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CHAPTER THREE 
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3. General Methods 
This chapter outlines the criteria for selecting horses for the study and protocols used for 
sample collection into RNAlater® and for snap freezing and processing snap frozen tendon 
tissue to a lyophilised ground state. The freeze dried tissue was used in the subsequent 
experimental chapters for biochemical analysis and the tissue collected into RNAlater® for 
gene expression studies.  
3.1. Horse Selection 
The distal region of forelimbs (dissected free at the level of the carpo-metacarpal joint) 
from skeletally mature horses (n = 32) aged between 4 and 30 (14.72 ± 1.39; median = 14) 
euthanased for reasons other than tendon injury were collected from a commercial equine 
abattoir (LJ Potter (SW) Ltd, Taunton, Somerset). Age was determined by examination of 
passports and confirmed by dental examination. To ensure horse age did not cluster at a 
particular value the entire age range was divided into ranges spanning either two or three 
years, and forelimbs from three horses were collected for each of these age ranges. Where 
possible breed and exercise history were recorded and any horses with a history of tendon 
injury were excluded from the study. 
3.2. Tendon Tissue Collection 
3.2.1. Samples for Biochemical and Gene Expression Analysis (Chapters 
4, 5 and 6) 
The superficial digital flexor tendon (SDFT), deep digital flexor tendon (DDFT), 
suspensory ligament (SL) and common digital extensor tendon (CDET) were harvested 
from the right forelimb of 30 horses on the same day as euthanasia. In 2 cases further 
examination in the laboratory revealed abnormalities in the right forelimb and so the 
tendons from the left forelimb were collected; one horse had sustained an injury to the skin 
superficial to the SDFT and the other had a small amount of fibrous tissue on the surface of 
the SL. Any tendons that had macroscopic evidence of degeneration, which is characterised 
by thickening or discolouration of the central core (Webbon 1977) were discarded.  The 
tendons were harvested according to a protocol to ensure samples were taken from a 
comparable region of tendon. The skin was removed from the level of the carpo-metacarpal 
joint to the proximal interphalangeal joint to expose the tendons (Figure 3-1). After the 
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tendons were dissected free from the limb any connective tissue was removed from their 
surface.   
 
Figure 3-1: Dorsal view of the equine forelimb with skin removed to expose the tendons. 
Before removal of the SDFT, the area where the communicating branch of the palmar nerve 
crosses the tendon was marked on the tendon (Figure 3-2). The communicating branch of 
the palmar nerve was used as an anatomical landmark to define the mid-metacarpal region 
of the tendon. A 0.5 cm section distal to the area marked was removed, the epitenon and 
peripheral tissue was dissected away and the remaining tendon tissue was placed in 
RNAlater® (Ambion, Applied Biosystems, Warrington, UK). A 2 cm section distal to this 
was removed and snap-frozen in hexane (Figure 3-2) cooled on dry ice.  
  
CDET 
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The DDFT was removed at the level of the metacarpo-phalangeal (MCP) joint. The 
distance between the insertion of the accessory ligament and the widest part of the distal 
end was measured and the half way point was marked. A section 1 cm either side of this 
mark was removed and snap-frozen. A 0.5 cm section was removed proximally, processed 
as described for the SDFT and placed in RNAlater® (Figure 3-3).   
 
Figure 3-2: Tissue collection from SDFT. A- The location of the communicating branch of the palmar 
nerve was marked in situ. B- The SDFT was removed at the level of the metacarpo-phalangeal joint.  C- 
The proximal section was placed in RNAlater and the distal section was snap frozen for matrix analysis. 
Communicating branch of palmar nerve 
A 
B 
C 
Proximal Distal 
0.5cm 2cm 
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The distal end of the SL was removed at the level of the MCP joint and the proximal end 
was removed as close to the origin as possible. The distance was measured from the 
proximal end to the point of bifurcation and the half way point was marked. Tissue was 
collected as for the DDFT (Figure 3-4).  
2cm 0.5cm 
Midpoint between insertion of accessory ligament and widest part of distal end 
C 
Proximal Distal 
Figure 3-3: Tissue collection from the DDFT. A- The location of the DDFT in situ. B- The DDFT was 
removed at the level of the metacarpo-phalangeal joint and the midpoint between the insertion of the 
accessory ligament and widest part of the distal end was marked on the tendon.  C- The proximal section 
was placed in RNAlater and the distal section was snap frozen for biochemical analysis. 
 
A 
B 
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Before the CDET was removed, the length of the third metacarpal bone was measured and 
half of this distance was marked on the tendon. Tissue was collected as for the DDFT but as 
the CDET has a much smaller cross sectional area than the other tendons a section was cut 
1.5 cm either side of the area marked and a section 1 cm in length was placed in 
RNAlater® (Figure 3-5).     
 
 
0.5cm 2cm 
Midpoint between origin on third metacarpus and bifurcation 
Proximal Distal 
C 
Figure 3-4: Tissue collection from the SL. A - The location of the SL in situ. B - The SL was removed at 
the level of the metacarpo-phalangeal joint and  as close to the origin on the third metacarpal as possible. 
The midpoint between the origin and the bifurcation was marked on the tendon.  C - The proximal section 
was placed in RNAlater and the distal section was snap frozen for biochemical analysis. 
 
A 
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The samples suspended in RNAlater® were stored at 4 °C overnight to allow thorough 
penetration of the tissue before being stored at -20 °C. The snap-frozen samples were 
individually wrapped in cling-film and tinfoil and stored at -80 °C. 
3.3. Tendon Tissue Preparation 
When required, the snap-frozen samples were thawed slightly so the epitenon and 
surrounding connective tissue could be removed. The remaining tendon tissue was 
chopped, accurately weighed to within 0.1 mg and re-frozen at -80 ºC. Tendon tissue 
samples were then freeze-dried overnight until a constant weight was reached. The 
lyophilised samples were reweighed and the water content was calculated and expressed as 
a percentage of the wet weight. The samples were stored at -80 ºC before being reduced to 
a fine powder by the use of a mikro-dismembrator (Sartorius, Germany) at 3000 rpm for 2 
minutes. The powdered samples were stored at -80 ºC until required for analysis. 
3.4. Reagents
Except where stated, all reagents used in the experiments described in the subsequent 
chapters of this thesis were obtained from Sigma-Aldrich Company Ltd., Dorset UK, and 
VWR International Ltd., Leicestershire, UK.
 
  
1cm 3cm 
Mid point between carpo-metacarpal joint and MCP joint 
B 
Proximal Distal 
Figure 3-5: Tissue collection from  the CDET. A - The midpoint betweed the carpo-metacarpal joint 
and the MCP joint was marked and CDET was removed at the level of the MCP. B - The proximal 
section was placed in RNAlater and the distal section was snap frozen for biochemical analysis. For the 
location of the CDET in situ, see Figure 3-1. 
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CHAPTER FOUR  
74 
 
4. Molecular Markers of Matrix Age Identify a Difference in 
Matrix Half-life between Functionally Distinct Tendons        
4.1. Introduction 
Little is known about the age of matrix molecules in living tendon and whether matrix age 
differs between tendons with physiologically distinct roles, and the effect this has on tendon 
mechanical properties. Tendons require high mechanical strength as they transfer force 
between muscle and bone and therefore must be able to resist high forces, which can reach 
up to 90 MPa in some tendons (Biewener 1998; Brown et al., 2003; Ker 2002). The ability 
to resist forces is provided mainly by collagen which makes up approximately 80% of the 
tendon dry weight. Tendons such as the human Achilles, and equine superficial digital 
flexor tendon (SDFT) and suspensory ligament (SL) also store and return energy during 
locomotion, increasing efficiency by as much as 36% during galloping exercise (Biewener 
1998). Energy storing tendons need to be more extensible under physiological loads than 
positional tendons such as the human anterior tibialis tendon and equine deep digital flexor 
tendon (DDFT) and common digital extensor tendon (CDET). Previous studies have 
identified a difference in the material properties between functionally distinct tendons; the 
SDFT is composed of less stiff material than the CDET (Batson et al., 2003). This is 
accompanied by differences in matrix composition; energy storing tendons have a greater 
proteoglycan content than positional tendons (Batson et al., 2003) which may allow energy 
storing tendons to be more extensible by allowing greater sliding movement between the 
collagen fibrils (Scott 2003).  
Tendon structure and mechanical properties must be maintained for efficient function, and 
this is achieved by balancing matrix synthesis and degradation. It was previously thought 
that, after maturity, the tenocytes resident within the tendon matrix became metabolically 
inactive such that the collagen comprising the matrix was not actively repaired and replaced 
during the course of a lifetime (Ballou and Thompson 1956; Neuberger et al., 1951).  
However,  it has recently been demonstrated that collagen in patella tendons is actively 
turned over (Miller et al., 2005), and acute exercise results in increased synthesis of 
collagen type I in Achilles tendons (Langberg et al., 1999; Langberg et al., 2001). Specific 
tendons such as the equine SDFT and human Achilles are prone to pathological changes 
and the incidence of tendon injury increases with increasing age in both horses and humans 
75 
 
(Jarvinen et al., 2005; Perkins et al., 2005), suggesting there is an imbalance in matrix 
synthesis and degradation in these tendons resulting from a decreased ability to renew the 
matrix.  
4.1.1. Matrix Composition 
The matrix composition of tendons in the equine forelimb has been assessed previously and 
changes occurring with age, as well as differences occurring between tendons have been 
identified (Batson et al., 2003; Birch et al., 1999a; Birch et al., 2002; Lin et al., 2005b). 
The mature SDFT has higher glycosaminoglycan (GAG) content, water content and 
cellularity than the CDET (Batson et al., 2003); these differences in composition result in 
differences in mechanical properties which are required for the efficient function of the 
SDFT and CDET. Differences in matrix composition have also been identified between the 
SDFT and DDFT (Birch et al., 1999a), although these are not as great as the differences 
found between the SDFT and the CDET. The DDFT has lower cellularity and percentage of 
type III collagen relative to type I, and higher GAG content and percentage of large 
diameter collagen fibrils than the SDFT. Differences in collagen crosslink profile have also 
been reported, with lower levels of hydroxlysyl-pyridinoline crosslinks in the DDFT than in 
the SDFT (Birch et al., 1999a). Matrix composition is also altered during injury, with 
increases in cellularity, type III collagen, GAG and water content as common features in 
SDFT degeneration (Birch et al., 1998). Similar changes have been reported in human 
tendinopathy; Achilles tendon lesions have a higher water content, and increased levels of 
denatured collagen (de Mos et al., 2007) than normal tendon samples. 
4.1.2. Matrix Age 
Molecular matrix age can be defined as the length of time a protein has been present in the 
matrix. This can be assessed in various tissues by measuring the age related accumulation 
of chemical modifications such as crosslinking and amino acid racemization that occur in 
tissues with a relatively low rate of metabolism. Matrix age gives an indication of the rate 
at which tenocytes are able to degrade damaged matrix and synthesise matrix components 
to repair any micro-damage, which is important to maintain tendon mechanical integrity 
and prevent the accumulation of micro-damage. 
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4.1.2.1. Crosslinks 
Crosslinks that occur between collagen molecules are formed by two different mechanisms; 
an enzymatic-controlled process that occurs during growth and development and a 
spontaneous non-enzymatic reaction between collagen molecules and sugars present in the 
tissue that occurs during ageing (see Chapter 1) (Bailey et al., 1998). In tendon, the 
pyridinolines are the major crosslinks that are formed by the action of the enzyme lysyl 
oxidase.  Some enzymatic and non-enzymatic crosslinks fluoresce naturally, so crosslink 
content can be estimated by measuring tissue fluorescence; previous work has shown that 
the SDFT has higher levels of tissue fluorescence than the CDET (Birch et al., 2008b), 
indicating greater matrix turnover in the CDET. This is surprising as it would be expected 
that there would be a higher rate of matrix turnover in the energy storing SDFT because it 
operates with a much lower safety margin than the CDET. However, previous work has 
also identified a difference in lysyl oxidase generated crosslink profile between the SDFT 
and CDET (Birch et al., 2006) which may account for the lower levels of tissue 
fluorescence recorded in the CDET.  
Accumulation of the glycated crosslink pentosidine has been used to assess matrix age and 
turnover in both human and equine tendon previously; pentosidine has been shown to 
increase linearly with subject age in human tendons that are rarely injured (Bank et al., 
1999). However, in the injury prone supraspinatus tendon pentosidine does not continue to 
accumulate in older aged individuals, and levels decrease in degenerated tendons (Bank et 
al., 1999). Pentosidine levels are also lower in degenerated Achilles tendons than in 
uninjured tendon (de Mos et al., 2007), suggesting that remodelling of the matrix occurs in 
tendon pathology in an attempt to repair the lesion. Assessment of the equine SDFT found 
that pentosidine increased with age in the sesamoidal region of mature tendon, but not in 
the mid-metacarpal region, where the majority of injuries occur (Lin et al., 2005b). 
However, pentosidine concentration in immature tendons was found to increase with age in 
both the sesamoidal and mid-metacarpal regions, and reached significantly higher levels in 
the mid-metacarpal region (Lin et al., 2005a). No previous studies have assessed matrix age 
in the functionally distinct tendons in the equine forelimb using accumulation of 
pentosidine as a probe. 
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4.1.2.2.  Amino Acid Racemization 
Another spontaneously occurring age related modification to the matrix is the racemization 
of amino acids. All amino acids are incorporated into proteins in the L-(levorotatory) form 
due to the stereo-specificity of enzymes required for protein synthesis (Shah et al., 1999), 
but over time they spontaneously convert to the D-(dextrorotatory) form. This is a very 
slow process in all amino acids, but occurs at a relatively rapid rate in aspartic acid (asp), 
and so the ratio of D to L-Asp in any tissue gives an indication of matrix age. Racemization 
results in a change in the optical conformation of the aspartic acid residue via the formation 
of a succinamide intermediate (McCudden and Kraus 2006). Both L-Asp and L-asparagine 
can be dehydrated to form L-succinamide, which then undergoes racemization and 
isomerisation to form D-Asp (McCudden and Kraus 2006) (Figure 4-1).   
 
Figure 4-1: Conversion of L-Asp and L-Asn to D-Asp via the formation of a succinamide intermediate and 
subsequent racemization and isomerisation. Adapted from McCudden and Kraus (2006). 
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Amino acid racemization was originally studied in an attempt to determine the presence of 
extraterrestrial life, based on the hypothesis that amino acids that had been synthesised 
biologically would have an excess of either D- or L- forms (Bada and McDonald 1996). 
Aspartic acid racemization has also been proposed as an alternative to radiocarbon dating 
(Bada et al., 1974) and as an age determinant in forensic science by comparison of the 
percent D-Asp in a sample of unknown age relative to that in a sample of known age 
(Ohtani and Yamamoto 1991). However, as the rate of racemization is dependent on the 
rate of protein turnover as well as subject age, only tissues that do not turnover over the 
course of a lifetime, such as dentin, can be used as a determinant of age. Recently, aspartic 
acid racemization has been used as a marker of matrix age in a variety of tissues and has 
been proposed as a biomarker of musculoskeletal diseases which are often characterised by 
alterations in protein turnover rates (McCudden and Kraus 2006).   
D-Asp has been shown to accumulate with age in collagen in various connective tissues, 
including bone (Pfeiffer et al., 1995), articular and intervertebral disc cartilage, and tendon 
in a similar manner to pentosidine (Maroudas et al., 1992; Riley et al., 2002; Sivan et al., 
2008; Verzijl et al., 2000b). Lower levels have been measured in degenerated intervertebral 
discs (Sivan et al., 2008) and tendons that are prone to pathological changes (Riley et al., 
2002) indicating an increased rate of protein turnover with disease. Proteoglycans are also 
susceptible to racemization; accumulation of D-Asp has been shown to occur in articular 
cartilage aggrecan (Maroudas et al., 1998) and intervertebral disc aggrecan (Sivan et al., 
2006b). D-Asp accumulation can be used to calculate protein half-life using the rate of D-
Asp accumulation in dentin (as turnover of collagen in dentin over the course of a lifetime 
is negligible) as the rate constant of racemization (Helfman and Bada 1976). 
4.1.3. Aims and Hypothesis 
The aims of this chapter were to define the matrix composition in functionally distinct 
tendons and to assess matrix age by measuring the accumulation of markers of matrix age. 
Based on previous findings, it was hypothesised that the matrix composition and age of the 
SDFT and SL would be similar as these tendons have a similar function in vivo, as would 
the composition and age of the CDET and DDFT. Furthermore, it was hypothesised that the 
accumulation of markers of matrix age would be more rapid in the SDFT and SL than in 
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the CDET and DDFT, indicating an ‘older’ matrix in the high strain energy storing tendons 
compared to the low strain positional tendons. 
4.2. Materials and Methods 
Lyophilised tendon tissue from the SDFT, DDFT, SL and CDET of 32 horses collected and 
processed as described in chapter 3 was used for these studies. 
4.2.1. Papain Digestion 
A small amount (20-40 mg) of powdered tissue was accurately weighed out and digested 
with papain, which breaks down matrix proteins and cell walls. Papain buffer (2 ml; papain 
(2 units/ml) in sterile phosphate buffered saline (PBS) plus 5 mM cysteine.HCl, 5 mM 
EDTA.Na2, pH 6.0) was added to each sample and the samples were digested for 24 hours 
at 60 °C (Birch et al., 1998). The samples were vortex mixed several times during digestion 
to ensure all tissue was solubilised. A sample containing no tissue was included with each 
batch to act as a blank for subsequent assays. 
4.2.2. Assessment of Matrix Composition 
4.2.2.1. Tendon DNA Content 
Immediately after papain digestion the DNA content of the tendons was measured using the 
bisbenzimidazole dye Hoechst 33258, which binds in the groove of the DNA double helix, 
and the method of Kim et al. (1988). Aliquots of papain digested tissue (150 µl) were 
diluted to 3 ml with dye buffer (0.1 µg/ml Hoechst 33258, 10 mM Tris-HCl, 1 mM 
EDTA.Na2, 0.1 mM NaCl, pH 7.4) and fluorescence was measured using a fluorometer 
(Perkin Elmer, LS-50B; excitation wavelength: 348 nm, emission wavelength 457 nm) in 
the presence and absence of the dye to account for background tissue fluorescence. DNA 
concentration was calculated by comparison to a standard curve constructed using calf 
thymus DNA standards from 0-0.5 µg/ml dye. The fluorescence of the papain buffer was 
taken into account by measuring fluorescence in the absence of tissue and subtracting this 
value from the fluorescence of the samples. DNA content was expressed as µg per mg dry 
weight tendon tissue. 
4.2.2.2. Tendon Collagen Content 
Collagen content was calculated by measuring the concentration of the imino acid 
hydroxyproline, which was assumed to make up 14% of collagen dry weight (Birch et al., 
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1998).  Aliquots (100 µl) of papain digested tissue were hydrolysed in 6 M hydrochloric 
acid (HCl), dried and re-dissolved in 10 ml deionised water. Hydroxyproline content was 
assessed using a method adapted from Bergman and Loxley (1963) and Bannister and 
Burns (1970) where hydroxyproline is oxidised by chloroamine T and coupled with 
dimethylaminobenzaldehyde (DMBA) which results in a coloured product which can be 
visualised at 550 nm using a spectrophotometer. Samples (1 ml) were mixed with 1 ml 
diluent (2 parts propan-2-ol to 1 part D.I. water), 1 ml of oxidant was added (0.42 g 
chloroamine T, 5 ml D.I. water, 25 ml stock buffer) and the samples were left to stand for 
20 minutes. Colour reagent (1 ml; 3 g DMBA, 4.5 ml 70% percholoric acid, 25 ml propan-
2-ol) was then added and the samples were left for 14 minutes before heating (70 ºC, 20 
minutes). Absorbance was read on a spectrophotometer (Shimadzu, UV-160A) after 
allowing the samples to cool for 10 minutes. Concentration was calculated by comparison 
to a standard curve prepared using L-hydroxyproline standards from 0-2.5 µg/ml (final 
concentration). The absorbance of the papain buffer was taken into account by measuring 
absorbance in the absence of tissue and subtracting this value from the samples. Collagen 
content was expressed as a percentage of dry weight tendon tissue. 
4.2.2.3. Tendon Glycosaminoglycan Content 
Sulphated glycosaminoglycan (GAG) content was measured in the papain digested tissue 
using dimethylmethylene blue dye (DMB), which binds sulphated GAGs and forms a 
complex that absorbs light at 525 nm (Farndale et al., 1986). Aliquots (100 µl) of papain 
digested tendon were mixed with 3 ml dye (1 l D.I. water containing 16 mg DMB, 3.04 g 
glycine, 2.37 g NaCl, 95 ml 0.1 M HCl). The absorbance of the resulting solution was 
measured using a spectrophotometer (Shimadzu, UV-160A) and GAG concentration was 
calculated by comparison to a standard curve prepared with bovine trachea chondroitin 
sulphate which was diluted in dye to give concentrations from 0-3.2 µg/ml (final 
concentration). The absorbance of the papain buffer was taken into account by measuring 
absorbance in the absence of tissue and subtracting this value from the samples. GAG 
concentration was expressed as µg per mg dry weight tissue. 
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4.2.3. Matrix Age 
4.2.3.1. High Performance Liquid Chromatography 
Tendon crosslink content and percent D-asp were measured using high performance liquid 
chromatography (HPLC). This technique is able to separate and quantify compounds with 
very similar chemical compositions. The equipment consists of mobile and stationary 
phases, and compounds are separated according to their affinity with these phases. The 
mobile phase is normally a mixture of organic and aqueous solutions, and the stationary 
phase is composed of silica or carbon and forms the lining of the column (Figure 4-2).  
 
Figure 4-2: Diagram showing HPLC setup. From www.waters.com. 
The sample is mixed with the mobile phase and is pumped through the column under high 
pressure (approximately 2000 psi). The rate at which the compounds present in the sample 
are eluted from the column depends on their affinity with the mobile and stationary phases; 
for example if the mobile phase is aqueous, hydrophilic compounds will be eluted from the 
column relatively rapidly whereas hydrophobic compounds will bind transiently to the 
column lining and will therefore take longer to travel through the column. The retention 
time of compounds can be altered by changing the mobile phases using a gradient program. 
Once separated, the concentration of various compounds can be determined by measuring 
their fluorescence at specific wavelengths using a fluorometer. The sample is exposed to a 
beam of light with a wavelength that causes the molecules in the compound to absorb 
photons, resulting in excitation of the molecules to a higher energy state. Once excited, the 
molecules then lose energy and return to their ground state, emitting photons in the process. 
82 
 
The excitation and emission wavelengths depend upon the structure of the molecules; 
therefore assessing fluorescence at different wavelengths enables the concentration of 
specific compounds within a sample to be determined. The fluorescence of each compound 
is plotted as a chromatogram and peak areas of unknown samples are compared to the peak 
area of a standard of known concentration. Some compounds, such as enzymatic and non-
enzymatic crosslinks fluoresce naturally due to their molecular structure, which consists of 
a number of planar aromatic rings. However other compounds, including aspartic acid 
residues have to be derivatized with a compound that fluoresces so they can be quantified.   
4.2.3.2.   Quantification of Pyridinoline and Pentosidine Crosslinks 
Hydroxylysyl-pyridinoline, lysyl-pyridinoline and pentosidine crosslinks were quantified 
using a single HPLC run. Approximately 15 mg powdered lyophilised tissue from the 
SDFT, DDFT, SL and CDET samples was hydrolysed in 3 ml 6 M HCl at 110 ºC for 24 h, 
dried and re-dissolved in 500 µl deionised water with 1% trifluoroacetic acid (TFA). The 
samples were filtered (0.2 µm filter) and 50 µl of sample was injected into the HPLC 
system (Series 200, PerkinElmer Life Sciences). The crosslinks were eluted using a 
Hypercarb column (150 × 4.6 mm, 7 µm internal diameter, Thermo Scientific) and a 
method adapted from Bailey et al. (1995). Separation of the crosslinks was achieved by 
using a 5 minute isocratic phase with 5% tetrahydrofuran (B) in deionised water (A), 
followed by a gradient from 5 to 20% B in 30 minutes, at a flow rate of 1 ml/min (Figure 
4-3). Methods were set up using TotalChrom™ (Version 6.2.1, PerkinElmer). Mobile 
phases A and B both contained 0.5% TFA (v/v). Fluorescence was detected using a 
fluorometer (PerkinElmer). From 0-20 minutes the excitation wavelength was 295 nm and 
the emission wavelength was 405 nm; this was to detect the pyridinoline crosslinks. From 
20-35 minutes the excitation wavelength was 335 nm and the emission wavelength was 385 
nm; this was to detect pentosidine. To prevent column contamination, the column was 
washed with 70% B for 5 minutes after each sample had been separated.  
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Figure 4-3: Screenshot showing gradient program set up in TotalChrom™. The blue line represents the 
percentage of mobile phase A and the red line represents the percentage of mobile phase B. The total run 
time, including the column wash, was 54 minutes.  
Pentosidine concentration was calculated by measuring the fluorescence of known 
concentrations of pentosidine (12.5 pmoles in 50 µl injection volume) (kindly provided by 
Mr Nick Avery). Pyridinoline concentration was calculated using a commercially available 
standard (Metra Pyd/Dpd HPLC Calibrator, Quidel Inc, USA supplied by Technoclone Ltd, 
Surrey, UK) containing a mixture of lysyl-pyridinoline (348.5 pmoles) and hydroxylysyl-
pyridinoline (722.5 pmoles) in an injection volume of 50 µl. Pyridoxamine (200 pmoles) 
was used as an external standard to detect any changes in run-to-run retention time. 
Hydroxylysyl-pyridinoline standards eluted in 2 peaks, corresponding to 2 isomers, at 6.4 
and 7 minutes and lysyl-pyridinoline standards eluted in 2 peaks at 10 and 11.2 minutes 
(Figure 4-4). Pentosidine standards eluted at 34.0 minutes (Figure 4-5).  
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Figure 4-4: Chromatogram showing retention time of HP and LP standard solution.  
    
 
Standards were diluted serially in D.I. water containing 1% TFA to determine if the 
fluorometric response was linear in the expected range of crosslinks concentration in the 
samples. The fluorometric response of the pyridinoline standards was found to increase 
linearly with standard concentration for both HP and LP (Figure 4-6) and for pentosidine 
(Figure 4-7). 
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Figure 4-6: Amount of HP and LP standard solution (pmoles injected onto column) plotted against 
fluorometric response (peak area). The fluorometric response of both HP and LP standards showed an 
excellent correlation with the concentration injected (r=0.99). 
 
 
Figure 4-7: Amount of pentosidine standard (pmoles injected onto column) plotted against fluorometric 
response (peak area). There is a very strong correlation between pentosidine concentration and peak area 
(r=0.99). 
Sample concentration was calculated by comparing the sample peak area for each crosslink 
with that of the appropriate standard. Peak area was calculated automatically using 
TotalChrom™ software (Figure 4-8). 
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Figure 4-8: Screenshot showing crosslink peak area as determined by TotalChrom™ software. 
Variation in the fluorometric response of the system was accounted for by measuring the 
fluorescence of the pentosidine standard at the beginning, middle and end of each batch of 
samples, and correcting for any change in fluorescence. Crosslink concentration was 
expressed as mM/M collagen, assuming the molecular weight of collagen to be 300 000. 
Collagen content was assessed in diluted (500 fold) aliquots (100 µl) of the hydrolysed 
tissue for approximately half the tendon samples using the method described above. 
However, pentosidine concentration did not differ when calculated using the collagen 
content of the papain digested samples or that of the crosslink hydrolysates and there was a 
strong correlation (r=0.99) between the two calculations of pentosidine concentration 
(Figure 4-9), so pentosidine concentration was calculated using the collagen content of the 
papain digested tissue for the remainder of the samples. 
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Figure 4-9: Graph showing pentosidine concentration calculated using collagen content of hydrolysed or 
papain digested tissue (r=0.99) 
4.2.3.3.  Measurement of Aspartate Racemization 
The percent of L- and D-Aspartate was also measured in tissue from the tendons in the 
equine forelimb using HPLC. Aliquots (100 µl) of papain digested tissue were hydrolysed 
in 1 ml 6 M HCl at 110 ºC for 24 h, dried and re-dissolved in 10 ml 0.1 M HCl. Aspartic 
acid racemers do not fluoresce naturally and so the samples were derivatized with o-
phthaldialdehyde-N-acetyl-L-cysteine (OPA-NAC) solution according to Yekkala et al. 
(2007). OPA-NAC reagent was prepared by dissolving 5.5 mg OPA in 420 µl methanol 
before adding 13.4 mg NAC. The volume was made up to 10 ml by the addition of 0.4 M 
sodium borate buffer adjusted to pH 9.4 with 1 M sodium hydroxide. Standards and 
samples (100 µl) were mixed with 200 µl OPA-NAC and allowed to stand for 5 minutes. 
The reaction was quenched by the addition of 200 µl of 0.3 M sodium phosphate buffer (pH 
7.50), and the mixture was left for 5 minutes before 50 µl was injected into the HPLC 
system. Derivatization was performed by an autosampler (PerkinElmer) to ensure that the 
timings of the derivatization and quenching reactions did not change between samples.   
The column used to achieve the separation was a Nova-Pak C8 column (150 × 3.9 mm, 4 
µm particle size, Waters), as it has been shown to have special selectivity for the 
derivatized racemers of aspartic acid (Yekkala et al., 2007). Separation was achieved using 
a gradient program according to Yekkala et al. (2007). Mobile phase A was 10% methanol 
and 90% 30 mM sodium phosphate buffer (pH 7.5), mobile phase B was 90% methanol and 
y = 1.022x
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10% 30 mM sodium phosphate buffer (pH 7.5). A gradient program was run as follows; 0-8 
min 0-100%B, 8-13 min 100% B, 13-15 min 100-0% B and 15-35 min 0% B (Figure 4-10). 
Fluorescence was measured at an excitation wavelength of 337 nm and an emission 
wavelength of 442 nm. 
 
Figure 4-10: Screenshot showing gradient set up for separation of D- and L-Asp using TotalChrom™ 
software. The blue line represents mobile phase A and the red line represents mobile phase B. 
Percentage of D- and L-Asp was calculated by expressing the peak area of D-Asp in each 
sample as a percentage of the peak area of L-Asp and correcting for the difference in 
fluorescence. Peak areas were measured using TotalChrom™ software (Figure 4-11). 
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Figure 4-11: Screenshot showing D- and L-Asp peak area as determined by TotalChrom™. 
To assess the validity of the HPLC technique (Yekkala et al., 2007) in our laboratory, the 
following tests were carried out before the samples were analysed: 
1. To ensure D- and L-Asp could be separated from each other and from other amino 
acids, a mixture containing 1 nmoles of D-and L-Asp (Sigma), and 1.25 nmoles of other 
amino acids (Thermo Scientific) in a 50 µl injection volume was injected into the 
HPLC system (Series 200, Perkin-Elmer) and separated according to the method 
outlined above. 
D-Asp eluted at 5.3 minutes and L-Asp eluted at 6.7 minutes; both peaks showed clear 
separation from the other amino acids which eluted after 9 minutes (Figure 4-12). 
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Figure 4-12: Trace showing separation of D-Asp (retention time 5.3 min) and L-Asp (retention time 6.7 min) 
from other amino acids (after 9 min). Also note the difference in fluorescent response between the D- and L-
Asp peaks. 
2. To account for any D- or L-Asp present in the buffer or derivatization reagents 0.1 M 
HCl was derivatized and D- and L-Asp were measured. 
System peaks eluted with the D- and L-Asp derivatives (equivalent to 0.52 pmoles D-
Asp and 6.82 pmoles L-Asp) and so the areas of these peaks were subtracted from the 
areas of the D- and L-Asp peaks before the ratio of D- to L-Asp was calculated. 
3. Specific fluorescence of D- and L-Asp was calculated by injecting equal amounts (250 
pmoles) of D- and L-Asp and determining the difference in peak area.  
When equal amounts of D- and L-Asp were injected, the ratio of D:L-Asp peak area 
was 1:1.29. This difference in specific fluorescence was corrected for by multiplying 
the percentage of D-Asp by 1.29. 
4. The precision of the measurement of the fluorescent response was determined by 
calculating the percent relative standard deviation (RSD) of the peak ratio of D- and L-
Asp from 6 measurements where 900 pmoles L-Asp and 100 pmoles D-Asp were 
injected into the HPLC system.  
The RSD was 0.69%, indicating low variability between runs. 
5. The fluorescent response of increasing amounts of D-Asp was measured while L-Asp 
was kept constant at 900 pmoles to determine if the change in measured ratio of D- to 
L-Asp was linear from 0.1-11% (the expected range of D-Asp concentration in the 
samples). 
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Fluorescent response was found to be linear with increasing concentration of D-Asp 
(Figure 4-13). 
 
Figure 4-13: Ratio of D-Asp injected plotted against ratio of D-Asp measured (r=0.99). 
6. To determine the smallest amount of D-Asp that could be detected in the presence of a 
large amount of L-Asp concentrations of D-Asp from 0.5 to 50 pmoles were injected 
while L-Asp was kept constant at 900 pmoles. 
The smallest amount of D-Asp that could be detected was 1 pmole and the smallest 
amount that could be quantified accurately in the presence of 900 pmoles L-Asp was 5 
pmoles (0.56%) (Figure 4-14). This value is lower than the percentage of D-Asp 
recorded in all the samples before correction. 
 
Figure 4-14: Trace with scale adjusted to show the smallest amount of D-Asp (5 pmoles) that could be 
quantified accurately in the presence of a greater than 100 fold excess of L-Asp (900 pmoles). 
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7.  Heating is known to cause racemization, so this was accounted for by hydrolysing a 
known amount of L-Asp and measuring the amount of racemization that occurred 
during the hydrolysis step.  
Hydrolysis caused an average of 2.64% L-Asp to convert to D-Asp, once the system 
peaks had been subtracted so this percentage was subtracted from the % D-Asp values 
calculated for the samples. 
8. To account for any D- or L-Asp present in the papain or guanidine hydrochloride 
(GuHCl) buffers a blank (buffer minus tissue) was included for each tissue treatment 
and D- and L-Asp content was measured. 
Small amounts of D- and L-Asp were detected in the papain and GuHCl extraction 
buffers, and so the corresponding peak area was subtracted from the D- and L-peak area 
for each sample before the ratio of D- to L-Asp was calculated. 
 
Separation of Matrix Components 
Aspartic acid is present in all proteins; it is not specific to collagen, and so to determine the 
age of the collagenous and non-collagenous matrix components these components were 
separated by GuHCl extraction before the percentage of D-Asp present was determined by 
HPLC. Approximately 20 mg powdered SDFT and CDET was suspended in 2 ml 4 M 
GuHCl (pH 5.8) with 0.1 M sodium acetate plus protease inhibitors (10 mM 6-
aminohexanoic acid, 5 mM benzamidine-HCl, 1 mM phenylmethyl-sulfonyl fluoride, 10 
mM EDTA and 5 mM N-ethylmaleimide). The extraction was carried out for 24 hours at 4 
°C with agitation, the samples were then centrifuged (4500 g for 5 minutes) and the 
supernatant was removed. The collagenous pellets were washed extensively in D.I. water to 
remove the GuHCl and freeze dried and stored at -80 ºC. The supernatant was also stored at 
-80 ºC until required. 
To ensure the GuHCl extraction successfully separated the collagenous and non-
collagenous matrix, the GAG and collagen content of the pellet and supernatant from a 
small number of samples (n = 5) was assessed using the methods described above; GuHCl 
extraction successfully separated SDFT and CDET samples into collagenous and non-
collagenous matrix components.  The collagenous pellet contained 87% of the collagen 
93 
 
content of the whole matrix and 13% of the GAG content of the matrix. After filtration, the 
supernatant contained 75% of the total GAG content and 1% of the total collagen content of 
the matrix. 
The collagenous pellet remaining after GuHCl extraction was papain digested and 100 µl of 
papain digest was hydrolysed and the aspartate racemization was measured using the 
methods described above. GuHCl was removed from the supernatant, which contained the 
proteoglycan components of the matrix, using centrifugal filter units (Microcon YM-3, 
3000 molecular weight cut-off, Millipore) according to the manufacturer’s instructions. 
Aliquots (20 µl) of the remaining sample were hydrolysed, dried and re-dissolved in 1 ml 
0.1 M HCl before aspartate racemization was measured as described. Due to time 
constraints, aspartate racemization in the collagenous and non-collagenous matrix 
components was assessed in the SDFT and CDET, and not in the DDFT or SL. 
Half-life Calculations 
The accumulation of D-Asp in any tissue depends on the intrinsic rate constant of 
racemization, i.e. the amount of racemization that occurs when no tissue is turned over (ki), 
and the protein turnover (kT).  As the amount of D-Asp formed in vivo is very small (D/L < 
0.15), racemization is approximated as irreversible.  The rate of accumulation of D-Asp 
over time can therefore be expressed as in Equation 1. 
Equation 1: d(CAsp(D)/(D+L))/dt = ki CAsp(L)/(D+L) -  kT CAsp(D)/(D+L) 
where CAsp is the concentration of aspartic acid in the protein.  Assuming CAsp is constant 
over time and that D/(D+L) < 0.1 (Maroudas et al., 1998), which it is in vivo, D/(D+L) ≈ 
D/L and L/(D+L) ≈ 1, Equation 1 simplifies to Equation 2. 
Equation 2: d(D/L)/dt = ki - kT(D/L) 
To calculate protein turnover, this equation can be rearranged into Equation 3. 
Equation 3: kT = (ki – (d(D/L)/dt))/(D/L) 
The accumulation rate (d(D/L)dt) in Equation 3 was approximated by fitting a linear curve 
to the measured data for the ratio D/L in each matrix component of tendon as a function of 
time.  
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The rate constant of racemization (ki) is taken as the rate of accumulation of D-Asp in 
dentin; collagen in dentin is the most stable during the human lifetime and so negligible 
collagen turnover occurs in this tissue.  The accumulation rate of D-Asp in dentin is 7.87 x 
10
-4
/year (Helfman and Bada 1976).  However, the rate of racemization is temperature 
dependent; if it is assumed that the average temperature of dentin is 33 °C based on tooth 
surface temperature (Fanibunda 1986) and the average temperature of tendon is 37 °C 
(Wilson and Goodship 1994), then the value of ki can be corrected for difference in 
temperature using Equation 4 (Bada 1984). 
Equation 4: ki(T) = ki(310) x exp( - ((Ea/R) x (310 – T)/(T x 310))) 
where T is temperature in Kelvin, Ea is the activation energy (33.4 x 10
3
 as calculated by 
Bada et al. (1973)) and R is the gas constant (1.987). Using this equation, ki at 37 °C was 
calculated to be 1.604 x 10
-3
/year.  This value for ki was used to calculate kT for the whole 
matrix and the collagenous component of the matrix.  Previous work has found that non-
collagenous proteins have a higher intrinsic rate of racemization; the ki value was 
calculated to be 1.873 x 10
-3
/year in articular cartilage aggrecan (Maroudas et al., 1992).  
Intra-articular temperature is comparable to that of dentin (Becher et al., 2008) and so when 
the difference in temperature between articular cartilage and tendon is accounted for using 
Equation 4 the ki value for non-collagenous protein is 3.73 x 10
-3
/year. 
The rate of protein turnover was then used to calculate protein half-life (t1/2) using Equation 
5. 
Equation 5: t1/2 = ln(2)/kT 
4.2.3.4 . Tissue Fluorescence 
Tissue fluorescence was measured as part of the DNA assay to account for any 
fluorescence that did not result from the DNA-binding dye. Tissue fluorescence is non-
specific but has been shown previously to correlate with horse age and to be lower in the 
CDET than the SDFT (Birch et al., 2008b). Tissue fluorescence is expressed as arbitrary 
units/mg collagen. 
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4.2.4. Statistical Analysis 
Statistical significance was assessed using a linear mixed effects model (SPlus, Version 16, 
Insightful) with horse as a grouping factor to determine the effect of tendon type and 
increasing age on each variable measured. All data were found to be normally distributed 
when analysed using a Kolmongorov-Smirnoff test (Minitab, Version 15) and so 
correlation analysis was performed for each variable using Pearson’s product moment 
correlation (SPSS, Version 14). Data are displayed as mean ± SEM. 
4.3. Results 
The concentration of matrix components and markers of matrix age are shown in Table 4-1 
and the correlations of these components with increasing horse age are shown in Table 4-2. 
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 SDFT DDFT SL CDET 
Water (%) 64.91±0.29
 
63.60±0.26***
 
67.76±0.23***
 
58.78±0.20***
 
Collagen (%) 75.81±1.45
 
76.90±2.06 65.11±1.62**
 
80.38±1.26* 
GAG (µg/mg) 10.40±0.86
 
11.86±0.71
 
13.30±0.94*
 
1.83±0.12***
 
DNA (µg/mg) 0.54±0.02
 
0.35±0.02***
 
0.69±0.03***
 
0.39±0.02***
 
Tissue Fl. (Arb. Units/mg) 58.22±3.43
 
55.51±2.77
 
52.98±2.67*
 
38.33±1.69***
 
Pentosidine (mM/M) 13.83±1.69 18.01±2.25* 17.33±2.06*** 14.80±2.14 
OH-lys Pyr (mM/M) 737.84±45.18 584.79±31.01*** 598.67±40.98* 70.11±4.53*** 
Lys Pyr (mM/M) 101.51±19.11 90.72±16.87 100.23±17.13 84.33±16.33 
D/L-Asp × 100 (total) 1.12±0.12 1.59±0.17* 1.16±0.15 1.18±0.12 
D/L-Asp × 100 (collagen) 5.64±0.52 - - 4.31±0.42** 
D/L-Asp × 100 (non-coll.) 0.88±0.25 - - 1.58±0.26** 
Half-life (whole matrix) 7.85±0.82 11.94±1.31*** 8.14±1.08 8.02±0.84 
Half-life (collagen) 197.53±18.23 - - 34.03±3.39*** 
Half-life (non-coll.) 2.18±0.41 - - 3.51±0.51* 
 
Table 4-1: Concentration of matrix components and markers of matrix age in equine forelimb tendons. Data are displayed as Mean ± SEM, 
n = 32; *Indicates significant difference from SDFT: *p<0.05; **p<0.005; ***p<0.001 
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 SDFT DDFT SL CDET 
Water (%) 0.403(0.022) NS NS 0.366(0.039) 
Collagen (%) NS NS NS NS 
GAG (µg/mg) NS NS NS -0.643(<0.001) 
DNA (µg/mg) NS NS NS NS 
Tissue Fl. (Arb. Units/mg) 0.883(<0.001) 0.873(<0.001) 0.785(<0.001) 0.820(<0.001) 
Pentosidine (mM/M) 0.847(<0.001) 0.882(<0.001) 0.849(<0.001) 0.893(<0.001) 
OH-lys Pyr (mM/M) NS NS NS NS 
Lys Pyr (mM/M) 0.390(0.027) NS NS 0.481(0.005) 
D/L-Asp × 100 (total) 0.694(<0.001) 0.567(0.001) 0.522(0.002) 0.637(<0.001) 
D/L-Asp × 100 (collagen) 0.376(0.034) - - NS 
D/L-Asp × 100 (non-coll.) NS - - 0.465(0.008) 
Half-life (whole matrix) 0.687(<0.001) 0.568(0.001) 0.525(0.002) 0.643(<0.001) 
Half-life (collagen) 0.376(0.034) - - NS 
Half-life (non-coll.) NS - - 0.458(0.008) 
 
Table 4-2: Correlation coefficient (r) of concentration of matrix components and markers of matrix age with increasing horse age (n = 32); 
p-value is shown in brackets; NS = not significant. 
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4.3.1. Matrix Composition 
4.3.1.1.  Water Content 
Water content was similar to previously reported values (Batson et al., 2003; Birch et al., 
1998)  and was significantly different (p<0.001) between the four tendons (Figure 4-15). 
The SL had the highest percentage water, followed by the SDFT, then the DDFT. The 
CDET had the lowest water content. Water content was not correlated with age in any 
tendon. 
 
Figure 4-15: Tendon water content (mean ± SEM). n = 32 * indicates significant difference relative to the 
SDFT. 
4.3.1.2.  DNA Content 
DNA content of SL was higher (p<0.001) than in the other tendons, and DNA content was 
higher (p<0.001) in the SDFT than in the DDFT and CDET (Figure 4-16), indicating that 
the SL and SDFT have a higher cellularity than DDFT and CDET.  DNA content was not 
correlated with age in any of the tendons. 
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Figure 4-16: DNA content of SDFT, DDFT, SL & CDET (mean ± SEM). n = 32. * Denotes significant 
difference relative to the SDFT 
4.3.1.3.  Sulphated Glycosaminoglycan Content 
The GAG content was significantly lower (p<0.001) in the CDET than in the other tendons.  
GAG content was significantly higher (p=0.001) in the SL than in the SDFT and decreased 
significantly (r=-0.643. p<0.001) with age in the CDET (Figure 4-17), but showed no 
relationship with age in the other tendons. 
 
Figure 4-17: Tendon GAG content (mean ± SEM) n = 32 (A). *Indicates significant difference relative to the 
SDFT. Scatterplot showing decreased GAG content (B) in the CDET with increasing age (r=-0.643). 
4.3.1.4.  Collagen Content 
The collagen content of the SL was significantly lower (p<0.001) than in the other tendons 
and was significantly higher (p≤0.029) in the CDET than in the SDFT (Figure 4-18).  
Collagen content was not correlated with age in any tendon. 
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Figure 4-18: Tendon collagen content (mean  ± SEM) n = 32. * indicates significant difference relative to the 
SDFT.  
4.3.2. Matrix Age 
4.3.2.1.  Tissue Fluorescence 
In agreement with previous findings (Birch et al., 2008b), tissue fluorescence of the CDET 
was lower (p<0.001) than in the other tendons (Figure 4-19).  Tissue fluorescence increased 
significantly (p<0.001) with age in all tendons (Figure 4-20). 
 
 
Figure 4-19: Tendon tissue fluorescence (mean ± SEM). n = 32 * indicates difference relative to the SDFT. 
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Figure 4-20: Tissue fluorescence of the SDFT & CDET (A), and DDFT & SL (B) as a function of horse age. 
Tissue fluorescence increased linearly with horse age in all tendons (SDFT, r=0.88, p<0.001; DDFT, r=0.87, 
p<0.001; SL, r=0.79, p<0.001; CDET, r=0.82, p<0.001). 
4.3.2.2. Pentosidine and Pyridinoline Crosslinks 
Pentosidine and pyridinoline crosslinks were detected in all tendon samples, a typical 
chromatogram showing separation of crosslinks in an SDFT sample is shown in Figure 
4-21. The DDFT and SL had similar crosslink profiles to the SDFT, whereas the CDET 
exhibited a distinct crosslink profile (Figure 4-22). 
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Figure 4-21: Typical chromatogram showing separation of hydroxylysyl-pyridinoline (HP) lysyl-pyridinoline 
(LP) and pentosidine crosslinks from a sample of hydrolysed SDFT. 
 
Figure 4-22: Chromatogram showing separation of hydroxylysyl-pyridinoline (HP) lysyl-pyridinoline (LP) 
and pentosidine in the CDET. Note the difference in crosslink profile when compared to that of the SDFT 
shown in Figure 4-21. 
HP crosslinks were present at significantly higher concentrations in the SDFT than in the 
other tendons (p≤0.0017), with levels approximately 10-fold lower in the CDET (Figure 
4-23). HP concentration did not change significantly with increasing horse age. 
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Figure 4-23: Tendon HP content (mean ± SEM) n = 32. * indicates significant difference relative to SDFT. 
LP crosslinks were present at lower levels than HP in all tendons. In contrast, LP crosslink 
concentration was not significantly different between tendon types, and increased 
significantly with horse age in the SDFT and CDET (p≤0.027) (Figure 4-24). 
 
Figure 4-24: Concentration of lysyl-pyridinoline in the SDFT and CDET as a function of horse age. LP 
concentration increased significantly with horse age in the SDFT (r=0.39, p=0.03) and CDET (r=0.48, 
p=0.005). 
Pentosidine content was significantly higher (p≤0.003) in the DDFT and SL than in the 
SDFT and CDET (Figure 4-25).  Pentosidine concentration increased significantly 
(p<0.001) with age in all tendons (Figure 4-26). 
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Figure 4-25: Tendon pentosidine content (mean ± SEM) n = 32. * indicates significant difference relative to 
the SDFT. 
 
Figure 4-26: Pentosidine content of SDFT, DDFT, SL & CDET as a function of horse age. Pentosidine 
content increased significantly with horse age in all tendons (SDFT, r=0.85, p<0.001; DDFT, r=0.88 p<0.001; 
SL, r=0.85, p<0.001; CDET r=0.89, p<0.001). 
4.3.2.3. Matrix Half-life 
The accumulation rates of D-Asp used to calculate matrix half-life are shown in Table 4-3. 
 Fraction  Accumulation rate of D-Asp (×10
-4
/year) 
 SDFT DDFT SL CDET 
Whole Tendon 5.87 6.82 6.16 5.82 
Collagenous 14.06 - - 7.27 
Non-Collagenous 2.57 - - 6.58 
Table 4-3: Accumulation rates of D-Asp per year in the SDFT and CDET ((d(D/L)dt) in Equation 1). 
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Whole Matrix 
Percent D-aspartate was significantly higher (p≤0.037) in the DDFT than in the other 
tendons.  As with pentosidine, the percentage of D-aspartate increased significantly 
(p<0.001) with age in all tendons (Figure 4-27).  
 
Figure 4-27: Percent D-aspartate in SDFT & CDET (A), and DDFT & SL (B) as a function of horse age. 
Percent D-Asp increased linearly with horse age in all tendons (SDFT, r=0.69, p<0.001; DDFT, r=0.57, 
p=0.001; SL, r=0.52, p=0.002; CDET, r=0.64, p<0.001). 
Correspondingly, matrix half-life was greater in the DDFT than in the other tendons 
(p≤0.0001) (Figure 4-28) and increased significantly with horse age in all tendons (Figure 
4-29). 
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Figure 4-28: Whole matrix half-life (mean ± SEM) n = 32. * indicates significant difference relative to the 
SDFT. 
 
Figure 4-29: Whole tendon half-life in the SDFT & CDET (A) and DDFT & SL (B) as a function of horse 
age. The half-life of the whole matrix increased significantly with horse age in all tendons (SDFT, r=0.69, 
p<0.001; DDFT, r=0.57, p=0.001; SL, r=0.53, p=0.002; CDET, r=0.64, p<0.001). 
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Percent D-Asp showed a good correlation with pentosidine concentration in all tendons 
(p≤0.005) (Figure 4-30). 
 
 
Figure 4-30: Correlation of pentosidine with % D-Asp in the SDFT & CDET (A), and DDFT & SL (B). 
Pentosidine concentration was significantly positively correlated with D-Asp in all tendons (SDFT, r=0.65, 
p<0.0001; DDFT, r=0.52, p=0.002; SL, r=0.49, p=0.005; CDET, r=0.63, p<0.0001). 
Half-life of Collagenous Matrix Components 
After separation of the matrix into collagenous and non-collagenous fractions, collagen 
half-life was significantly (p<0.001) higher in the SDFT (197.53 (±18.23) years) than the 
CDET (34.03 (±3.39) years) (Figure 4-31) and increased significantly with age in the SDFT 
(p=0.03) but not in the CDET (Figure 4-32). 
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Figure 4-31: Half-life of matrix components in the SDFT and CDET (mean ± SEM) n = 32. * indicates a 
significant difference relative to the SDFT. Data are displayed on a Log10 scale. 
 
Figure 4-32: Half-life of the collagenous matrix of the SDFT and CDET as a function of horse age. Collagen 
half-life increased significantly with age in the SDFT (r=0.38, p=0.03) but not in the CDET. 
Half-life of Non-collagenous Matrix Components 
The half-life of the non-collagenous component was considerably lower than that of the 
collagen component for both tendon types. As with collagen, the non-collagenous proteins 
showed a significant difference in half-life within the matrix but in this case the SDFT 
(2.18 (±0.41) years) showed a lower residence time than the CDET (3.51 (±0.51) years) 
(p=0.04) (Figure 4-31). Non-collagenous matrix half-life increased significantly with age in 
the CDET (p=0.008) but not in the SDFT (Figure 4-33). 
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Figure 4-33: Half-life of the non-collagenous matrix proteins in the SDFT and CDET as a function of horse 
age. Non-collagenous matrix half-life increased significantly with age in the CDET (r=0.46, p=0.008) but was 
not correlated with age in the SDFT. 
4.4. Discussion 
The results of this work confirm that there is considerable variation in the matrix 
composition between the different tendon types. Furthermore the results show that the rate 
of turnover differs between tendon types and changes with horse age. It is widely accepted 
that tendon pathology is a degenerative condition resulting in an accumulation of micro-
damage and decreased mechanical competence however the nature and progression of the 
micro-damage is not clear. Matrix age and corresponding rate of turnover gives an 
indication of the ability of the tenocytes to maintain the matrix and is therefore of particular 
relevance to the accumulation of micro-damage to collagenous and non-collagenous matrix 
components with ageing in injury prone tendons such as the SDFT. A logical assumption 
would be that high strain tendons which work with low safety margins such as the SDFT 
would require a greater capacity to repair micro-damage and have a matrix which appears 
relatively younger than low strain tendons such as the CDET. However, previous work 
based on the measurement of tissue fluorescence suggested that the opposite scenario was 
true (Birch et al., 2008b) and so this chapter tested the hypothesis that the matrix of high 
strain energy storing tendons would be ‘older’ than the matrix of low strain positional 
tendons. 
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4.4.1. Age of Tendon Matrix when Assessed as a Whole 
Small amounts of D-Asp and pentosidine indicate relatively rapid protein turnover and 
short residence time (Stabler et al., 2009), while higher levels of D-Asp and pentosidine 
indicate that protein turnover is slower. Our results show that both D-Asp and pentosidine 
accumulate with age in the tendons in the equine forelimb, suggesting a relatively low rate 
of protein turnover in all tendons assessed. No previous studies have calculated protein 
half-life in tendon using aspartate racemization however the D/L ratios have been measured 
in human supraspinatus and biceps tendon tissue and the levels recorded (approximately 
1%) were similar to those obtained in this study (Riley et al., 2002) without separation into 
collagen and non-collagenous components. Levels of pentosidine are also similar to those 
reported previously in human tendon (Bank et al., 1999). In contrast to previous work (Lin 
et al., 2005b), a significant increase was identified in pentosidine concentration with horse 
age in the mid-metacarpal region of the SDFT. The levels reported in this chapter are 
approximately 15 fold higher than those reported by Lin et al. (2005b); it is possible that 
the detection method used here is more sensitive than that used previously and was able to 
detect small changes in tendon pentosidine content with increasing age.  
However, when the matrix was studied as a whole, no differences in matrix age were 
identified between the functionally distinct SDFT and CDET; this is surprising as previous 
results suggest a lower rate of matrix turnover in the injury prone SDFT than in the 
positional CDET, based on measurements of tissue fluorescence (Birch et al., 2008b). In 
agreement with previous results, a difference in tissue fluorescence between tendons was 
also identified. However, both enzymatic and lysyl oxidase crosslinks fluoresce naturally, 
and so a difference in crosslink profile could also account for the lower levels of 
fluorescence in the CDET. Indeed, levels of hydroxylysyl-pyridinoline were significantly 
lower in the CDET. The CDET has been shown previously to contain a significant number 
of histidinohydroxylysinonorleucine crosslinks which are not present in the SDFT (Birch et 
al., 2006) and do not fluoresce naturally so are not detected by the methods used in this 
thesis. Contrary to the hypothesis, this study was not able to group the DDFT or SL with 
either the SDFT or CDET based on matrix composition or whole matrix age. No difference 
was identified in matrix age in the SL compared to the SDFT or CDET but composition of 
this tendon was significantly different from that of the SDFT. The half-life data and 
pentosidine levels presented in this chapter indicate that the rate of matrix turnover in the 
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DDFT is lower than in the other tendons; this tendon is not thought to act as an energy 
store, and is not exposed to high strains (Platt et al., 1994) and so a low rate of turnover 
may not be detrimental to its function, which is thought to be mainly to flex the distal 
phalangeal joint during late swing (Butcher et al., 2009).  
4.4.2. Age of Collagenous and Non-Collagenous Matrix Proteins 
Separation of the matrix of the functionally distinct SDFT and CDET into its collagenous 
and non-collagenous components reveals a difference in protein half-life that is not evident 
when the matrix is assessed as a whole. The results presented in this chapter suggest a half-
life of 198 and 34 years for the SDFT and CDET collagenous matrix respectively and 2.2 
and 3.5 years respectively for the non-collagenous matrix proteins. These results support 
the original hypothesis, showing that the age of the collagenous matrix is greater in the high 
strain energy storing SDFT than in the low strain positional CDET. The relatively low rate 
of turnover of the collagenous matrix in the injury prone SDFT may predispose this tendon 
to microdamage accumulation. In contrast, it appears that microdamage in the CDET would 
be repaired relatively rapidly due to the greater rate of collagen turnover in this tendon. 
However, turnover of the non-collagenous matrix proteins appears to occur more rapidly in 
the SDFT than in the CDET. 
Collagen half-life has been calculated in other tissues; Sivan et al. (2008) reported a half-
life of 95 to 215 years in intervertebral disc collagen depending on donor age whereas 
Verzijl et al. (2000b) reported 117 years in articular cartilage. Non-collagenous protein 
half-life has also been calculated in other tissues, with values of 3 to 25 years reported for 
aggrecan fractions in articular cartilage (Maroudas et al., 1998), and 6 to 26 years for 
intervertebral disc aggrecan (Sivan et al., 2006b). The half-life of collagenous and non-
collagenous matrix components calculated in these studies are in the same region as the 
values reported here. It would be of value to assess the half-life of the collagenous and non-
collagenous proteins in the DDFT and SL to determine if either tendon shows similarities 
to the SDFT or CDET in terms of matrix age.  
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4.4.3. Factors Affecting Half-life Calculations and the Rate of Pentosidine 
Accumulation 
The half-life value of almost 200 years for the collagenous component of the SDFT 
reported in this chapter suggests that only 0.25% of the collagen is renewed each year. 
Therefore, in biological terms, turnover is insignificant and the collagen is essentially inert. 
The absolute values however reported in this chapter and by others rely on assumptions 
made in the calculations, as the accumulation of D-Asp is affected by several factors, 
including temperature, pH and protein structure (McCudden and Kraus 2006); increasing 
temperature by 4 °C causes the rate constant of racemization to double. The calculations 
were based on a tendon temperature of 37 ºC and assumed that the pH in dentin and tendon 
were not significantly different. Tendons in the equine forelimb are likely to be exposed to 
a wide range of temperatures; during exercise the SDFT has been shown to experience 
temperatures as high as 45 °C (Wilson and Goodship 1994), and this temperature variation 
may alter the rate constant of racemization. The difference in the calculated half-life is 
significant; for example a 1 °C increase would change the half-life of the collagenous 
matrix in the SDFT from 198 years to 77 years while an increase to 45 °C would decrease 
the half-life to 8 years (Figure 4-34). However the half-life of the majority of tendon 
collagen is likely to be closer to the higher values calculated. Regardless of absolute values, 
the data presented in this chapter show a clear difference between tendon types in relation 
to collagen and non-collagenous matrix turnover which were not appreciated when the 
whole tissue was analysed. The half-life of the collagenous matrix in the SDFT is 
approximately five times greater than in the CDET supporting the hypothesis.  
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Figure 4-34: Effect of temperature on predicted average collagen half-life in the SDFT. An exponential 
equation was found to give the best fit (r=0.99). 
The rate at which pentosidine accumulates is also affected by several factors, including the 
availability of sugars in the matrix, protein structure and temperature. Tendon blood supply 
is generally poor, especially in the core region, and therefore accumulation of AGEs may 
be limited by low levels of sugars within tendon. Glycation has been shown to occur at 
much lower levels in collagen fibrils than in monomeric collagen in vitro (Slatter et al., 
2008). It is not clear why pentosidine levels are similar between the SDFT and CDET when 
measurement of D-Asp in the collagenous and non-collagenous matrix components showed 
clear differences between these functionally distinct tendons; this is an area which requires 
further investigation. 
Differences in matrix age may not have been apparent when the age of the entire matrix 
was assessed as neither pentosidine nor D-Asp are specific to collagen; pentosidine has also 
been shown to accumulate with age in aggrecan from cartilage (Pokharna and Pottenger 
1997; Verzijl et al., 2001) and intervertebral discs (Sivan et al., 2006b). However, 
proteoglycans are present at low levels within tendon and are turned over more rapidly than 
the collagenous matrix; therefore the levels of pentosidine within the non-collagenous 
matrix are likely to be very low. D-Aspartate also accumulates with age in non-collagenous 
proteins in dentin (Masters 1983) and in cartilage aggrecan (Maroudas et al., 1998; Sivan et 
al., 2006b). The rate constant of D-Asp accumulation is approximately 2.5 fold greater for 
aggrecan than for collagen (Maroudas et al., 1992), therefore although proteoglycan content 
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in tendon is relatively low, the proteoglycans present may contain a disproportionately high 
number of D-Asp residues.  
4.4.4. Why are Matrix Proteins Turned Over at Different Rates in the 
SDFT and CDET? 
A lower rate of collagen turnover in the high strain SDFT compared to the low strain CDET 
appears counterintuitive, and there are several possible explanations for this. The difference 
may reflect a compromise of the synthetic ability of tenocytes within the SDFT due to 
physiochemical factors such as nutrient availability, oxygen tension or increased 
temperature. However, other investigators have suggested that collagenous structures which 
require very high mechanical strength are protected from re-modelling which may weaken 
the structure (Laurent 1987). In a comparable manner, the collagenous matrix in the SDFT 
may not be turned over in an attempt to preserve its structural integrity and keep it within 
the narrow range of strength and stiffness required for optimal energy storage. 
Alternatively, differences in the way that the tendons are loaded during high speed 
locomotion may result in a predisposition to collagen damage over proteoglycan damage in 
the CDET. This possibility is supported by the lower half-life of the non-collagenous 
component of the SDFT compared to the CDET and previous work of others showing a 
high rate of proteoglycan turnover in flexor tendon (Rees et al., 2000). The viscoelastic 
behaviour of tendon is complex and depends on the rate of deformation. Studies in rat tail 
tendon have shown that at small strain rates the response is dominated by the elastic 
component whereas at high strain rates the response is dominated by viscosity which is 
largely provided by the proteoglycan matrix (Puxkandl et al., 2002). In addition to higher 
strains, the SDFT is loaded during the stance phase of gallop and is subjected to a faster 
rate of loading than the CDET. Further, proteoglycans within tendon matrix are thought to 
contribute towards strain transfer between collagen fibrils (Scott 2003). The SDFT is 
exposed to strains up to six times greater than the CDET and so if proteoglycans do play a 
role in strain transfer, the proteoglycans in the matrix of the SDFT are more likely to be 
damaged, and therefore require repair, than those in the CDET. Assessment of matrix 
composition showed that the SDFT has a GAG content approximately six fold greater than 
the GAG content of the CDET. In addition, the GAG content in the CDET (but not the 
SDFT) decreased significantly with increasing horse age, providing further evidence to 
suggest proteoglycans have a more important role in energy storing tendons. Therefore 
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turnover of the non-collagenous matrix is greater in the SDFT than in the low strain CDET 
as damage is more likely to occur to proteoglycans in this tendon due to the high strains it 
experiences. 
Although this work separates collagen and non-collagenous components of the matrix there 
may, in addition, be pools of collagen which differ in their turnover rate. The extraction 
technique used does not retain all of the collagen in the insoluble fraction; a small amount 
of soluble collagen (less than 13%) is extracted from the matrix which is likely to represent 
a more labile pool of collagen. However the insoluble collagen does also appear to be 
slowly replaced giving support to other studies which have detected collagen synthesis and 
degradation in tendon (Langberg et al., 1999; Langberg et al., 2001; Miller et al., 2005) but 
are not able to distinguish between pools of collagen that are turned over at different rates.  
4.4.5. Effect of Age Related Modifications on Tendon Mechanical 
Properties 
Age related modifications to tendon collagen, as identified in this chapter, are of biological 
significance as they are likely to change the mechanical behaviour of the tendon. Glycation 
of collagen is likely to have a much more significant effect on mechanical properties than 
aspartic acid racemization. Although the accumulation of D-aspartic acid is a useful marker 
of tissue age, it is present in very low concentrations within the matrix and therefore it is 
unlikely to alter tendon mechanical properties significantly. Extensive glycation may 
however alter tendon mechanical properties; in vitro studies have shown that glycation of 
rabbit Achilles tendon increases the stiffness and strength of the tendon (Reddy et al., 2002) 
and it is well documented that AGEs are strongly associated with diabetic complications 
(Monnier et al., 2008) such as stiffening of collagenous tissues. However previous work 
has not found an increase in tendon stiffness with increasing horse age (Birch 2007); the 
reasons for this are yet to be determined. 
4.4.6. Spread of Data 
The data presented in this chapter show a degree of variation between individuals, even 
once age has been accounted for; especially in the case of percent D-Asp and pentosidine. It 
is possible that low values could be an early sign of tendon degeneration, however all 
tendons included in the study appeared macroscopically normal. Increased water content is 
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indicative of early tendon injury; none of the tendons in this study exhibited a particularly 
high percentage of water. Furthermore, tendons that had high or low percent D-Asp or 
pentosidine had water contents that were in the middle of the range reported, suggesting 
that the tendons analysed in this study were not injured. In addition, previous studies have 
reported considerable variations in tendon strength and stiffness between individual horses 
that is not correlated with horse weight or exercise history (Birch 2007), it would be of 
value to determine if there is any correlation between tendon mechanical properties and the 
markers of matrix age studied in this chapter. 
In this chapter a difference has been identified in the turnover of the collagenous and non-
collagenous matrix components in functionally distinct tendons in the equine forelimb. The 
collagenous matrix in the high strain energy storing SDFT is turned over at a much slower 
rate than in the low strain positional CDET; while this may protect the tendon under normal 
circumstances, if micro-damage does occur it is more likely to accumulate in the SDFT. 
Furthermore, increased half-life of collagen in aged SDFTs may be a factor that contributes 
to the increased incidence of injury with ageing in this tendon. In contrast, turnover of the 
non-collagenous matrix occurs more rapidly in the SDFT than in the CDET, supporting the 
hypothesis that proteoglycans contribute significantly to force transfer at high strain levels 
and rates. The long half-life of the collagen molecules in the SDFT also results in age 
related modifications such as racemization and glycation, which may further alter tendon 
mechanical properties. The high strains the SDFT experiences combined with the low rate 
of collagenous matrix turnover and associated alteration in mechanical properties with 
increasing horse age would suggest that gross failure of this tendon would be unavoidable. 
However, many horses compete at the highest level and never suffer from a tendon injury. 
The data presented in this chapter show considerable variation between horses and previous 
studies have also found a wide variation in material properties of tendons from different 
horses which are not related to horse size or exercise history (Birch 2007) indicating that 
some individuals may be more at risk of tendon damage than others. The low rate of 
collagen turnover in the high strain SDFT may result from lower cell activity in terms of 
collagen metabolism and may have important implications for matrix renewal and repair. 
The increased collagen half-life in the SDFT in older horses suggests that cell activity may 
decline further with ageing. It is therefore important to assess cell activity in these 
functionally distinct tendons to determine if this is the case. 
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4.5. Conclusions 
 Matrix composition differs between functionally distinct tendons in the equine 
forelimb. 
 The prioritisation of collagenous and non-collagenous matrix protein turnover differs 
between the functionally distinct SDFT and CDET.  
 Collagenous matrix proteins are metabolised more rapidly in the low strain positional 
CDET than in the high strain energy storing SDFT. 
 Turnover of non-collagenous matrix proteins occurs more rapidly in the SDFT than in 
the CDET. 
 Ageing results in an increase in the half-life of collagen in the SDFT and an increase in 
the half-life of non-collagenous protein in the CDET. 
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5. Potential for Matrix Synthesis and Degradation Differs 
between Functionally Distinct Tendons 
5.1. Introduction 
The composition of tendon matrix is governed by the cellular component of tendon and the 
rate of matrix turnover is determined by cell activity. The variation in matrix composition 
between the different tendon types suggests that there is a difference in the pattern of gene 
expression by the resident tenocytes. In addition, the age of matrix components differs 
between the high strain energy storing superficial digital flexor tendon (SDFT) and low 
strain common digital extensor tendon (CDET) in the equine forelimb, as shown by the 
data presented in the previous chapter of this thesis, suggesting different levels of gene 
expression activity between the cells in these functionally distinct tendons.  
Despite a greater cellularity in the SDFT than the CDET, the collagen appears to be older in 
this tendon suggesting that cells in the SDFT are less active than their counterparts in the 
CDET in terms of collagen synthesis and degradation. Correspondingly, previous work has 
shown that cells from the CDET express higher levels of genes coding for collagen type I 
and III, and collagen degrading enzymes than cells in the SDFT (Birch et al., 2008b). In 
contrast, non-collagenous matrix half-life is greater in the CDET than in the SDFT, 
suggesting that turnover of the non-collagenous matrix proteins occurs more rapidly in the 
SDFT than in the CDET. Differences in the turnover of the collagenous and non-
collagenous matrix proteins between functionally distinct tendons are likely to be due to 
differences in the way in which these tendons are loaded; the SDFT experiences greater 
strain levels and rates than the CDET. It has been shown that at high strain rates the 
response is dominated by viscosity, which is provided mainly by the proteoglycanous 
components of the matrix, rather than elasticity, which is provided mainly by the 
collagenous component of the matrix (Puxkandl et al., 2002). It would therefore be logical 
to expect cells in the SDFT to produce more message for non-collagenous matrix proteins; 
however previous work has not identified a difference in expression of the non-collagenous 
proteins decorin and collagen oligomeric matrix protein (COMP) between the SDFT and 
CDET (Birch et al., 2008b). The potential for matrix synthesis and degradation has not 
been investigated previously in the other tendons in the equine forelimb; the suspensory 
ligament (SL) acts as an energy store in a similar manner to the SDFT and is thought to 
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experience relatively high strains. In contrast, the deep digital flexor tendon (DDFT), like 
the CDET, is mainly positional in function; acting to stabilise the metacarpophalangeal 
joint during extension of the forelimb (Butcher et al., 2007) rather than playing a role in 
energy storage and is not subjected to high strains. 
It is well documented that cells are able to alter their phenotype according to the amount of 
deformation they experience (Ingber 1997), cells are thought to have a pre-set sensitivity to 
deformation such that if strain-induced signals are above or below a certain level, termed 
the ‘mechanostat set-point’, the cells will remodel the matrix accordingly (Frost 1987). It 
would appear that a certain level of mechanical load is required to maintain normal 
tenocyte phenotype and function; stress deprivation causes increased expression of the 
collagenase matrix metalloproteinase-13 (MMP-13) and a loss of cell-matrix interactions 
(Arnoczky et al., 2008b). High strains also result in perturbations to tenocyte phenotype, 
causing increased expression of MMP-1 and -3 (Archambault et al., 2002; Sun et al., 2008; 
Tsuzaki et al., 2003). Differences in the amounts and rates of strain experienced by 
tenocytes within the forelimb tendons is therefore likely to be an important determinant of 
gene expression and cell phenotype in functionally distinct tendons. 
It is also possible that ageing has an effect on cell phenotype; collagenous matrix half-life 
was found to increase with horse age in the SDFT (see chapter 4), suggesting a decrease in 
collagen turnover in aged tendons. Further, it has previously been suggested that overall 
cell activity within tendon declines with ageing (Smith et al., 2002a). This may have 
important consequences in terms of initiation and progression of tendon degeneration. 
Epidemiological studies have established that the incidence of tendinopathy is increased in 
aged individuals (Clayton and Court-Brown 2008; Kasashima et al., 2004). However, 
previous work was not able to identify any alterations in collagen gene expression with 
increasing age (Birch et al., 2008b). Further work is therefore required to identify the 
underlying causes of age related tendinopathy, which is characterised by a gradual decrease 
in mechanical integrity caused by accumulation of micro-damage to the extracellular matrix 
rather than an acute overstrain injury (Riley 2008). Micro-damage accumulation indicates 
that there is an inability of the cells to degrade and repair areas of damaged matrix. It is 
possible that overall gene expression decreases with increasing age, such that cells in aged 
tendons are less able to repair the matrix when micro-damage occurs and therefore overuse 
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injuries and clinically detectable degeneration are more likely to develop. The SDFT is 
injured far more frequently than the CDET (Ely et al., 2004; Ely et al., 2009); this tendon 
may be further predisposed to micro-damage accumulation due to its relatively low cell 
activity in terms of collagen turnover.  
Tendinopathy, both in humans and horses, is associated with alterations in the expression of 
specific genes. Several studies have reported increased expression of degradative enzymes, 
including MMPs -1, -9, -13 and -23, and ADAM-12 in tendon lesions (de Mos et al., 2007; 
Jones et al., 2006; Karousou et al., 2008; Nomura et al., 2007). Increased collagen gene 
expression has also been reported in chronic Achilles tendinopathy (de Mos et al., 2007; 
Ireland et al., 2001) and experimentally induced lesions in the SDFT showed increased 
collagen type I and III expression during healing (Dahlgren et al., 2005). However, there 
appears to be a decrease in the synthesis of enzymes that degrade the non-collagenous 
matrix components; studies have found that expression of MMP-3 and -10 decreases in 
Achilles tendinopathy (Ireland et al., 2001; Jones et al., 2006). Although the changes in 
gene expression that occur in tendon rupture and tendinopathy have been documented, 
there are little data available regarding differences in gene expression between tendons with 
specific functions. Further, it has not been established if any changes in gene expression 
occur with normal ageing in tendons that do not exhibit pathological changes.  
5.1.1. Synthesis of Matrix Proteins 
5.1.1.1. Transcription 
In all tissues the synthesis of specific proteins is tightly controlled and occurs in several 
stages. When a protein is required, it is not synthesised directly from the DNA template, 
instead the DNA sequence is transcribed into messenger RNA (mRNA), and this is used as 
a template for protein synthesis. The DNA double helix is unwound by the enzyme helicase 
so a single nucleotide chain can be copied. The RNA polymerase enzyme binds to the DNA 
template; the binding sites are determined by promoters which are sequences located 
upstream to the start site for transcription and are recognised by transcription factors. RNA 
polymerase reads the DNA strand in the 3' to 5' direction, and transcribes a single strand of 
mRNA in the opposite direction. Synthesis of mRNA is terminated when the RNA 
polymerase encounters a stop codon (Stryer et al., 1995).The mRNA then migrates from 
the nucleus into the cytoplasm, where it binds to ribosomes and is used as a template for 
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peptide synthesis in a process known as translation. By quantifying the amount of mRNA it 
is therefore possible to determine which genes are being expressed by cells in a specific 
tissue at a specific time. However, the amount of mRNA produced is very small, and so for 
quantification it needs to be amplified. Amplification of mRNA can be achieved using real 
time reverse transcriptase polymerase chain reaction (RT-PCR), which results in large 
enough copy numbers to enable accurate quantification of small amounts of mRNA.  
RT-PCR 
The first stage in the RT-PCR reaction is the reverse transcription of the mRNA to 
complementary DNA (cDNA); this step is required as RNA is not able to act as a template 
for polymerisation (Bustin 2000). This reaction is catalysed in vitro by a reverse 
transcriptase enzyme such as Moloney murine leukaemia virus reverse transcriptase 
(MMLV-RT) which synthesises cDNA from the mRNA strands using oligo-nucleotides. 
Once cDNA has been synthesised, it can then be amplified by PCR; the cDNA is incubated 
with a DNA polymerase and primer sequences that have been designed specifically for the 
genes of interest, plus a fluorescent dye such as SYBR® green, which does not fluoresce in 
solution, but does when bound to double stranded DNA. Therefore the increase in 
fluorescence over a certain number of heating cycles can be used to monitor the amount of 
DNA, and therefore corresponding mRNA, present in a sample (Bustin 2000). A PCR cycle 
consists of three stages; first the samples are heated to 95 °C for 15 seconds to separate the 
cDNA strands. The samples are then cooled to 54 °C to allow the gene specific primers to 
anneal to the cDNA strands. The solution is then heated to 72 °C, which allows the DNA 
polymerase to synthesise new DNA strands. Primer annealing is required for the DNA 
polymerase to be able to bind to the DNA strands, meaning that only cDNA coding for the 
gene of interest is amplified. The samples are then heated to 95 °C again to separate the 
newly synthesised DNA strands and allow further cDNA synthesis; repeating this for 20 
cycles results in a million-fold amplification (Stryer et al., 1995). 
5.1.1.2. Translation 
Translation of mRNA into proteins occurs in the rough endoplasmic reticulum; like 
transcription this process is subject to a high level of control and occurs in three stages. 
However, translation is much more complex than transcription and is mediated by more 
than one hundred molecules, including transfer RNAs, enzymes, protein factors and 
ribosomes (Stryer et al., 1995). The first step in mRNA translation is initiation, which is 
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precisely coordinated and involves several eukaryotic initiation factors which form the 43S 
pre-initiation complex on the mRNA sequence that is undergoing translation. This complex 
joins with the 60S ribosomal subunit at the AUG start codon which results in the formation 
of the 80S initiation complex. Once this has occurred, elongation, which is mediated by the 
80S ribosome, can begin. Elongation of the polypeptide chain requires the participation of 
translation elongation factors, which supply the ribosome with appropriate amino acids and 
translocate the ribosome along the mRNA. Termination of translation occurs when a stop 
codon is encountered; this final step is mediated by the eukaryotic release factor, which 
dissociates the ribosome from the mRNA and releases the ribosomal subunits (Tavernarakis 
2008).  
Protein synthesis can therefore be controlled both at the transcriptional and translation 
levels by targeting a variety of molecules required for these processes. At the 
transcriptional level, gene expression is controlled predominantly by the activity of 
transcription factors and microRNAs (Hobert 2008). Transcription factors are required for 
the initiation of transcription and their activity can be regulated by post translational 
modifications, including phosphorylation, and they can either positively or negatively 
regulate gene expression. In contrast, MicroRNAs generally modulate gene expression by 
repression. MicroRNAs are RNA sequences 19 to 25 nucleotides long which bind to the 
target mRNA sequence and therefore down-regulate expression of a specific gene (Pillai et 
al., 2007). MicroRNAs are often partially complementary to many mRNA sequences and 
therefore one microRNA can target up to hundreds of genes (Chen et al., 2009). Translation 
is mainly controlled at the initiation stage; phosphorylation of specific eukaryotic initiation 
factors decreases their ability to form the pre-initiation complex, a step which is essential 
for successful translation (Tavernarakis 2008). 
Further control is achieved after protein synthesis by post-translational modifications; for 
example matrix degrading enzymes are synthesised as inactive pro-enzymes, in order to 
activate the enzyme the pro-peptide must be cleaved by other proteases present within the 
matrix (Suzuki et al., 1990). Active matrix degrading enzymes can be inhibited by tissue 
inhibitors of metalloproteinases (TIMPs), which bind to the enzyme active site (Nagase et 
al., 2006). The potential for matrix degradation can therefore be assessed at the protein 
level by measuring the concentration of specific MMPs present within the matrix; active 
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MMPs have a lower molecular weight than pro-MMPs, which allows separation and 
quantification of both pro- and active enzymes. 
5.1.2. Aim and Hypothesis 
The aim of this chapter was to assess the potential for matrix synthesis and degradation in 
functionally distinct equine tendon and to determine if this alters with ageing. This was 
achieved by measuring the expression at the transcriptional level of key matrix proteins and 
corresponding degradative enzymes using real time RT-PCR. Protein synthesis at the 
translational level was assessed by measuring the pro- and active forms of enzymes that are 
able to degrade specific components of the matrix. It is not possible to directly measure 
newly synthesised collagen and non-collagenous protein levels in tendon tissue against a 
background of long-lived matrix proteins. It was hypothesised that cell activity is 
programmed by the in vivo strain environment such that cells in low strain positional 
tendons (DDFT and CDET) will exhibit a greater capacity to turnover the collagenous 
matrix whereas cells in high strain energy storing tendons (SDFT and SL) will show a 
greater potential for non-collagenous matrix turnover. Furthermore, it was hypothesised 
that overall cell activity will decrease with increasing horse age in all tendons. 
5.2. Materials and Methods 
Lyophilised tendon tissue from the SDFT, DDFT, SL and CDET of 32 horses collected and 
processed as described in chapter 3 was used for the protein experiments outlined below 
and RNA was extracted from the tendon tissue stored in RNAlater® (see Chapter 3). 
5.2.1. Measurement of Gene Expression 
5.2.1.1. RNA extraction 
Approximately 200 mg of tissue was finely chopped and frozen in liquid nitrogen before 
being powdered using a mikro-dismembrator (Braun Biotech International, Melsungen, 
Germany). The dismembrator equipment was cooled in liquid nitrogen immediately before 
use to ensure the tissue remained frozen during powdering. Each sample was shaken for 2 
minutes at 2000 rpm. If the tendon had not been reduced to a powder it was re-frozen in 
liquid nitrogen and the process was repeated. The dismembrator equipment was washed 
with a disinfectant (Virkon, 1% solution) between samples to ensure no contamination 
occurred.  The powdered tissue was placed in TRI reagent® solution (Ambion, Applied 
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Biosystems, Warrington, UK) at a concentration of approximately 100 mg/ml. TRI 
reagent® contains phenol and guanidine thiocyanate, which inhibit RNase activity. This 
was left to stand at room temperature for up to 1 hour before being stored at -80 °C, where 
it is stable for up to 1 month. 
RNA extraction was achieved by using RNeasy mini kits (Qiagen Ltd., Crawley, UK). The 
samples stored in TRI reagent® were allowed to thaw completely, vortex mixed and 
centrifuged at 12 000 g for 10 minutes at 4 °C.  The supernatant was removed into a clean 
tube and the remaining tissue was discarded. Chloroform (200 µl) was added to each tube 
and they were vortex mixed thoroughly before being left at room temperature for 10 
minutes.  The samples were then centrifuged at 12 000 g for 15 minutes at 4 °C. This 
separates the sample into 3 phases; the upper aqueous phase which contains the RNA, the 
interphase which contains the DNA and the organic phase which contains the proteins. Up 
to 375 µl of the aqueous phase was removed to a clean tube, and an equal amount of 70% 
ethanol was added (made up with 0.1% diethylpyrocarbonate treated (DEPC) water). Up to 
700 µl of each sample was transferred to an RNeasy spin column in a collection tube and 
centrifuged at 8000 g for 15 seconds. This causes any RNA longer than 200 bases to bind 
to the column membrane, while contaminants are washed away. Any remaining DNA was 
removed by the inclusion of an on-column DNA digestion step using RNase-free DNase. 
The RNA was extracted according to the manufacturer’s instructions (RNeasy mini 
handbook, Qiagen) and was eluted in 50 µl RNase free water and stored at -80 °C.  RNA 
concentration was measured using a nano-drop® spectrophotometer (ND 3300, NanoDrop 
Technologies, Wilmington, USA).  The spectrophotometer was cleaned before use and 
zeroed with RNase free water. 1 µl of RNA containing water was placed on the 
spectrophotometer, and RNA concentration was measured in ng/µl.          
5.2.1.2. Reverse Transcription to cDNA 
Reverse transcriptase was used to transcribe the RNA to cDNA. 1-2 µg RNA from each 
sample was made up to 11 µl with 0.1% DPEC water and 1 µl Oligo-dT primer was added 
to each sample to give a final volume of 12 µl. The samples were vortex mixed and 
centrifuged briefly before heating for 5 minutes at 70 °C and then immediately placed on 
ice. A master mix was made up containing 5 µl 5x reverse transcriptase buffer, 1.25 µl of 
dATP, dCTP, dTTP and dGTP (all 10 mM), 0.63 µl RNase inhibitor, 1 µl M-MLV reverse 
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transcriptase and 1.38 µl dH2O per sample. Master mix (13 µl) was added to each sample 
and they were vortex mixed and centrifuged briefly. The samples were heated for 60 
minutes at 42 °C, then for a further 5 minutes at 95 °C. They were placed on ice before 
being stored at -20 °C. 
5.2.1.3. Identification of Endogenous Control Genes 
The most stably expressed genes were identified from a panel of eight potential endogenous 
control genes. The expression levels of gylceraldehyde 3-phosphate dehydrogenase 
(GapDH), 18S, TATA-box binding protein (TBP), succinate dehydrogenase A (SDHA), 
hypoxanthine phosphoribosyltransferase-1 (HPRT1), HIRA interacting protein-5 (HIRP5), 
mitochondrial ribosomal protein S7 (MRPS7) and β-actin (ACTB) were determined in the 
SDFT, DDFT, SL and CDET from 4 horses. To ensure the reference genes selected did not 
alter significantly with increasing age the tendon samples used to assess stability were 
selected from horses aged 4 to 24. This panel of genes was selected as they have been 
identified as some of the most stably expressed genes in a variety of tissues from different 
species (Ayers et al., 2007; Bogaert et al., 2006; Maccoux et al., 2007; Taylor et al., 2009). 
The two genes that had the least variation between samples were identified using GeNorm 
(Vandesompele et al., 2002). GeNorm is available from 
www.medgen.ugent.be/~jvdesomp/geNorm and is a collection of macros for Microsoft 
Excel that determines the two most stably expressed genes. This method is based on the 
principle that the ratio of two ideal control genes should be equal in all samples, regardless 
of cell type or experimental conditions, so any variation in this ratio means the genes are 
not constantly expressed. A gene stability measure (M) is generated by calculating the 
pairwise variation of each gene with other control gene and excluding the gene with the 
highest M value in a stepwise manner, until the two most stably expressed genes with the 
lowest M values remain (Vandesompele et al., 2002). HIRP5 and MRPS7 were found to be 
the most stably expressed genes in equine tendon from the panel of 8 genes assessed 
(Figure 5-1).  
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Figure 5-1: Graph showing expression stability values for control genes measured. 
The pairwise variation between two sequential normalisation factors (V) is calculated to 
indicate how many control genes it is necessary to include to ensure the data is normalised 
accurately. Large V values indicate that the addition of another control gene has a 
significant effect and so should be included. Vandesompele et al. (2002) suggest that at 
least three internal control genes are used for normalisation, and propose a cut-off value for 
V of 0.15, below which there is no need to include any additional control genes. The 
variation between using two and using three control genes is 0.007 in equine tendon (Figure 
5-2), so two control genes were used as the inclusion of another gene would have little 
effect on normalisation. A limited amount of cDNA was available for some samples and so 
using fewer control genes allowed the mRNA expression of more genes of interest to be 
quantified. HIRP5 and MRPS7 were used as endogenous control genes for all samples. As 
previous data were normalised to GapDH (Birch et al., 2008b), expression of GapDH was 
measured alongside the reference genes to determine if normalising the data to GapDH had 
a significant effect on gene expression levels calculated. Expression levels of Col12A1, 
MMP-9, MMP-10, ADAM-12 and ADAMTS-2 were calculated relative to GapDH 
expression in approximately half the tendon samples and compared to the expression levels 
calculated when using MRPS7 and HIRP5 as reference genes. 
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Figure 5-2: Determination of the optimal number of control genes by calculating the pairwise variation 
between sequential normalisation factors. Each bar represents the effect of including an additional control 
gene. These data show that the inclusion of additional control genes has little effect on the stability of the 
control genes. 
5.2.1.4. Primer design 
Equine specific primers were designed using programs available online. The horse genome 
has now been sequenced and is available through Ensembl 
(www.ensembl.org/Equus_caballus/index.html). The gene of interest (e.g. TIMP-4) was 
searched for in Ensembl and the transcript sequence for the equine gene was obtained 
(Figure 5-3).   
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Figure 5-3: Transcript sequence for equine TIMP-4 obtained from Ensembl.  The alternating text colour 
indicates different exons. 
Homologous sequences in other sequences were identified using a basic local alignment 
search tool (BLAST, www.ncbi.nlm.nih.gov/blast/Blast.cgi). The alignment between 
equine and human sequences was determined using ClustalW2 
(www.ebi.ac.uk/Tools/clustalw2) (Figure 5-4). 
 
Figure 5-4: Alignment of human and equine sequences for TIMP-4.  The stars indicate areas of sequence 
homology. 
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Information regarding intron size and location was obtained from Ensembl (Figure 5-5). To 
prevent amplification of any contaminating genomic DNA, primers were designed so that 
the sequence they amplified was intron spanning. If possible, the primers were designed 
around large introns close to the 3’ end of the sequence where there was good alignment 
between human and equine sequences as this further reduces the chance of amplifying 
genomic DNA and increases the efficiency of the amplification. 
 
Figure 5-5: Intron information for equine TIMP-4. 
Exon boundaries were marked with square brackets and the relevant portion of the 
sequence was copied to a primer design program (www.roche-applied-
science.com/sis/rtpcr/upl; http://frodo.wi.mit.edu) (Figure 5-6). Primers were chosen 
according to the optimum properties outlined by Bustin et al. (2000). Ideally,  primers 
should be 15-20 bases long, have a G/C content between 20 and 70%, the melting 
temperature (Tm) should not differ more than 2 °C between the forward and reverse 
primers and the maximum and minimum Tm should be 58 °C and 60 °C respectively. All 
primers used met these criteria. Forward and reverse primer sequences were ordered from 
Eurogentec (Seraing, Belgium). 
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Figure 5-6: Primers for equine TIMP-4 designed by Roche’s assay design centre. 
For some genes, searching for the equine sequence in Ensembl did not produce any results 
(ADAM-8, ADAM-12, ADAMTS-3, ADAMTS-8, ADAMTS-12, MMP-7, MMP-10, 
MMP-19, MMP-25, TIMP-4) so the BLAST was used to identify sequences homologous to 
the human gene. If no corresponding equine sequences were found, the BLAST program 
from Ensembl was used to display regions of the equine genome that are homologous to the 
human gene sequence (www.ensembl.org/Equus_caballus/blastview) (Figure 5-7). 
 
Figure 5-7: Alignment of equine sequences with human MMP-7 
The alignment of the sequence with the greatest homology was checked against the human 
gene sequence using ClustalW2, and if the alignment was sufficient primers were designed 
from the equine sequence. Forward and reverse primer sequences are shown in Table 5-1.   
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Gene Primer Sequence 
 Forward Reverse 
18S
*
 GGCGTCCCCCAACTTCTTA GGGCATCACAGACCTGTTATTG 
ACTB
α
 CCAGCACGATGAAGATCAAG GTGGACAATGAGGCCAGAAT 
ADAM-12 AGTTCGCCTCAGCGAGTG GGAGGGTTTGGCTTACGG 
ADAM-17 CGCATTCTCAAGTCTCCACA TGAAAAGATGTGCTAGGCAGAC 
ADAMTS-2 CCTATCCAGAAGACCTCGTCA CAGCACAGCTTGTTGTAGCC 
Aggrecan
§
 GAGGAGCAGGAGTTTGTCAACA CCCTTCGATGGTCCTGTCAT 
Biglycan
*
 TGAAGCTCAACTACCTGCGAATC AGATGGAGTTCATTCAGGGTCTCT 
Col 1A2
*
 GCACATGCCGTGACTTGAGA CATCCATAGTGCATCCTTGATTAGG 
Col 3A1
*
 ACGCAAGGCCGTGAGACTA TGATCAGGACCACCAACATCA 
Col 5A1
*
 TCCTTCAAAGTGTACTGCAACTTCA GATTCTGGCCCCCTCAGACT 
Col 12A1 GCGAGAGGGGTATTGGATCT CTGGTGGACCTGTTCTGGAT 
COMP
*
 GGTGCGGCTGCTATGGAA CCAGCTCAGGGCCCTCAT 
Decorin
*
 CATCCAGGTTGTCTACCTTCATAACA CCAGGTGGGCAGAAGTCATT 
Fibromodulin
*
 CAACCAGCTGCAGAAGATCC GCAGAAGCTGCTGATGGAG 
GapDH
*
 GCATCGTGGAGGGACTCA GCCACATCTTCCCAGAGG 
HIRP5
*
 TTGCATCTGGCTTACCCTTAG CCACAACTTCATCATCTTCTTCA 
HPRT1
α
 GGCAAAACAATGCAAACCTT CAAGGGCATATCCTACGACAA 
Lumican
*
 GTGTCAAGACAGTAAGGATTCAAAGC CAATGCCAAGAGGAAAGTAAACG 
MMP-1
§
 GGTGAAGGAAGGTCAAGTTCTGAT AGTCTTCTACTTTGGAAAAGAGCTTCTC 
MMP-3
§
 TCTTGCCGGTCAGCTTCATATAT CCTATGGAAGGTGACTCCATGTG 
MMP-9
‡
 TTGGACATGCACGACGTCTT AAGCGGTCCTGGGAGAAGTAA 
MMP-10 CCTGATGTCGGTCACTTCAC GCATCTCTTGGCAAATCCTG 
MMP-13
§
 CTGGAGCTGGGCACCTACTG ATTTGCCTGAGTCATTATGAACAAGAT 
MMP-23
*
 GGCGGCATCCACTTTGAC CATACGTCTTCTTCCAGCTGTA 
MRPS7
*
 CCGTGATCAGTAAATTCACCAACA TCATGAGGGATCTGGCCAAT 
Scleraxis
*
 TCTGCCTCAGCAACCAGAGA TCCGAATCGCCGTCTTTC 
SDHA
λ
 ACAGAGGAATGGTCTGGAATACTGA GTGAGCACCACGTGACTCCTT 
TBP
*
 TGCTGCTGTAATCATGAGGGTAA TCCCGTGCACACCATTTTC 
Tenascin
*
 GGGCGGCCTGGAAATG CAGGCTCTAACTCCTGGATGATG 
TIMP-3 CTGCAACTTCGTGGAGAGGT GGCAGGTAGTAGCAGGATTTGA 
TIMP-4 CCTTTTTGCAGAGAGAAAGTCTG GCAGTGTGTAGCAGGTGGTG 
Table 5-1: Forward and reverse primer sequences. Primers were designed by C.T. Thorpe, except where 
indicated: 
*
Designed by S.E. Taylor; 
‡
Designed by E.D. Barr; 
§
Designed by P.D. Clegg 
α
From: Bogaert et al. 
(2006); 
λ
Designed by E. Humphrey. 
Primer validation 
Primer stocks were made up for each gene of interest by combining forward and reverse 
primers to give a concentration of 3 µM in 0.1% DEPC water. Complementary DNA was 
pooled from several samples to give a final volume of 100 µl, which is sufficient to validate 
8 primers in a 96 well plate format. The cDNA was diluted 10-fold 5 times from an original 
1 in 9 dilution. A master mix was made up for each gene containing 12.5 µl SYBR® green 
PCR master mix (Applied Biosystems), 2.5 µl primer stock and 5 µl dH2O per well. 
SYBR® green PCR master mix contains SYBR Green 1 Dye, AmpliTaq Gold® DNA 
Polymerase, dNTPs with dUTP, Passive Reference 1, and optimized buffer components. A 
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96 well plate was made up according to the layout in Table 5-2, with 5 µl of the pooled 
cDNA solution in each well. All measurements were made in duplicate.   
 1 2 3 4 5 6 7 8 9 10 11 12 
A 10000 10000 1000 1000 100 100 10 10 1 1 dH2O dH2O 
B 10000 10000 1000 1000 100 100 10 10 1 1 dH2O dH2O 
C 10000 10000 1000 1000 100 100 10 10 1 1 dH2O dH2O 
D 10000 10000 1000 1000 100 100 10 10 1 1 dH2O dH2O 
E 10000 10000 1000 1000 100 100 10 10 1 1 dH2O dH2O 
F 10000 10000 1000 1000 100 100 10 10 1 1 dH2O dH2O 
G 10000 10000 1000 1000 100 100 10 10 1 1 dH2O dH2O 
H 10000 10000 1000 1000 100 100 10 10 1 1 dH2O dH2O 
Table 5-2: Plate layout for primer validation.  A to H are the primers that were validated (Plate 1: ADAM-8, -
12 and -17; ADAMTS-2, -3, -8 and -12; Col-12A1. Plate 2: Col -14A1; MMP-2, -7, -10, -19, and -25; and 
TIMP-3 and -4).  Each concentration of cDNA was measured in duplicate.   
Ct values for each cDNA concentration were determined by RT-PCR. An absolute 
quantification followed by a dissociation curve was performed using an ABI 7300 HT 
system (Applied Biosystems). The cycling conditions were 10 min. polymerase activation 
at 95 ºC followed by 40 cycles at 95 ºC for 15 sec. and 60 ºC for 60 sec.  The Ct values for 
each gene were plotted against the log of the relative concentration of cDNA.  If there was 
only 1 peak in the dissociation curve (Figure 5-8) and the gradient of the line describing the 
relationship between concentration and Ct values was -3.32 ± 0.2 (Figure 5-9), the primer 
was specific for the gene and had good amplification efficiency and therefore could be used 
to measure expression levels accurately. More than one peak in the dissociation curve 
indicates the primer is not gene specific. If these criteria were not met, the primers were re-
designed. 
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Figure 5-8: Dissociation curves showing primer specificity (A) and a primer that is not specific for a 
particular gene (B). 
 
Figure 5-9: Ct values for Collagen XII primers plotted against the log of cDNA concentration.  The gradient 
of the line is -3.34, which shows good amplification efficiency. 
5.2.1.5. PCR 
Gene expression levels were determined for each sample using an ABI 7900 HT fast real 
time PCR system in a 384 well plate format (Applied Biosystems). Plates were made up 
with 4.6 µl cDNA, 5 µl SYBR® master mix, 0.3 µl primers (9.1 mM) and 0.1 µl dH2O per 
well. Primer sequences used are shown in Table 5-1. These genes were selected as they are 
either key tendon matrix proteins or their expression has been shown to be altered in 
tendons with evidence of pathology (Jones et al., 2006). Scleraxis and tenascin expression 
was also measured as these genes have been proposed as markers of tendon phenotype 
A B 
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(Murchison et al., 2007; Taylor et al., 2009). Expression of COMP, tenascin and scleraxis 
were also assessed in a sample of equine skin and cartilage. All samples were measured in 
triplicate. The cycling conditions were 10 min. polymerase activation at 95 ºC followed by 
40 cycles at 95 ºC for 15 sec. and 60 ºC for 60 sec.; this was followed by a dissociation step 
which determines if cDNA sequences for any genes other than the gene of interest are 
being amplified. If there was more than one peak in the dissociation curve the results for 
the well in question were discarded. The maximum acceptable Ct value was set at 40 
cycles, and samples that had Ct values higher than this were re-measured; high Ct values 
will result in less precise results as the original mRNA concentration is very small. 
   
Figure 5-10: Amplification plot showing acceptable (A) and unacceptable (B) Ct values. 
5.2.1.6. Calculation of mRNA Expression Ratios 
Any wells that contained products with 2 peaks in the dissociation curve were omitted from 
the calculations. Ct values for each well were generated by the 7900 SDS software (version 
2.2, Applied Biosystems). The geometric mean of the Ct values was calculated for the 
endogenous control genes and for each gene measured. The geometric mean was used 
rather than the arithmetic mean as it is less affected by outlying values (Vandesompele et 
al., 2002).  The relative differences in gene expression were calculated using the 2
-ΔCt
 
method (Livak and Schmittgen 2001). The Ct values for the endogenous control genes were 
subtracted from the Ct values for the genes of interest for each sample, and the data were 
converted to ratios using the equation 2
-ΔCt
. This expresses the data as a ratio of the control 
genes and indicates gene expression per cell. In addition the data were multiplied by the 
DNA concentration of each sample (measured in chapter 4) to show overall gene 
A B 
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expression per mg of tissue. As collagen type I and decorin are the most abundant 
collagenous and non-collagenous proteins present in tendon, the ratio of Col1A2 to decorin 
expression was calculated for all samples analysed. 
5.2.2. MMP Protein Levels 
5.2.2.1. Fluorogenic MMP Assay 
A fluorogenic assay was used to assess protein levels of pro- and active forms of MMP-13 
in the SDFT and CDET (Birch et al., 2008b).  Lyophilised tendon tissue (30 mg) was 
suspended in 1.2 ml extraction buffer (50 mM HEPES, 200 mM NaCl, 1 mM CaCl2, 0.01% 
BRIJ-35, pH 7.3) and incubated at 22 °C for 60 min. in a water bath. The samples were 
vortex mixed several times during incubation to ensure maximal MMP extraction. Samples 
were centrifuged at 16 000 g for 5 min. and the supernatant was removed and stored at -80 
°C. Aliquots (40 µl) of each sample including a blank (extraction buffer minus tissue) were 
pipetted into a 96 well fluorometer plate in duplicate. 50 μl of assay buffer (50 mM 
HEPES, 200 mM NaCl, 1 mM CaCl2, 0.01% BRIJ-35, pH 7.3) containing 20 mM 4-
aminophenylmercuric acetate (APMA) were added to each well. Plates were incubated at 
37 °C for 1 h to allow the APMA to activate the latent enzyme. Fluorescence was also 
measured without the addition of APMA to determine the amount of active MMP-13 in the 
samples. A quenched fluorescence substrate for MMP-13 (Calbiochem) was added to each 
well to give a final concentration of 0.1 mM. This substrate is cleaved preferentially by 
MMP-13 and is less efficient as a substrate for MMP-1 or MMP-8. Plates were incubated at 
37 °C and fluorescence measured after 2 h on a fluorescence reader (Bio-tek Instruments 
Inc. FLX800 microplate reader) with excitation and emission wavelengths of 325 nm and 
393 nm respectively. Duplicate sample readings were averaged and the blank reading 
subtracted. Activity was expressed as relative fluorescence units per mg tissue. 
5.2.2.2. Zymography 
Zymography was used to assess MMP protein levels in the SDFT and CDET samples in a 
semi-quantitative manner. Proteins within each sample were separated using sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE); the SDS denatures the 
proteins and gives them a negative charge. The samples are then loaded onto a 
polyacrylamide gel and a current is passed through the gel, separating the proteins out 
according to their molecular weight. Gels are co-polymerised with a protein that can be 
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digested by the MMPs. After electrophoresis, gels are incubated at 37 ºC to allow the 
MMPs to digest the protein; SDS also activates latent MMPs without the removal of the 
propeptide, allowing the concentration of pro- and active MMPs to be determined. After 
incubation the gels are stained in order to visualise the areas that have been digested. 
Sample Preparation 
Lyophilised tendon tissue from the SDFT and CDET was incubated in 2x non-reducing 
sample buffer (approximately 15 mg tissue in 600 µl; 125 mM Tris, 2% SDS, 10% 
glycerol, 0.01% bromophenol blue at pH 6.8) at 22 ˚C for 30 min. The samples were 
centrifuged (16 000 g, 2 min.) and the supernatant was removed and stored at -80 °C. 
Preparation of MMP-9 Standard 
An MMP-9 standard was prepared using neutrophil cells from equine blood (collected from 
an equine abattoir). A density gradient was created using 70% and 85% Percoll™ (GE 
Healthcare, Amersham, UK) in 10x Hanks Balanced Salt Solution (HBSS, Gibco, Paisley, 
UK) and whole blood (12 ml) was added to the top. After centrifugation (1200 g, 20 min., 
20 °C) the neutrophil containing lower middle and upper middle layers were removed to a 
clean tube and washed in HBSS (1X). The tube was centrifuged (800 g, 8 min, 20 °C) and 
the supernatant removed, leaving a pellet of neutrophil cells suspended in a small amount 
of supernatant, of which 3 µl was diluted in 3 ml sample buffer. 
Gelatin Zymography 
Gelatin zymography was used to assess the pro and active forms of the gelatinases (MMP-2 
and -9) in the SDFT and CDET samples. For electrophoresis, 8% acrylamide separating 
gels containing bovine gelatin type B (1 mg/ml) were used with a 4% stacking gel. Initial 
experiments were carried out to determine the range in which the MMP-9 standard 
concentration was linear by measuring the area of digestion bands produced by serially 
diluting the MMP-9 standard in sample buffer (Figure 5-11). Area of digestion bands 
increased linearly with increasing concentration up to an area of 8000 units (Figure 5-12); 
all sample digestion bands had areas smaller than this.   
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Figure 5-11: Gelatin zymogram showing digestion bands of serially diluted MMP-9 standards prepared from 
equine neutrophil cells. 
 
Figure 5-12: Area of digestion bands increased linearly with MMP-9 concentration up to a band area of 8000 
(r=0.98).  
Sample supernatant (15 µl) was loaded onto the gel, along with the prepared MMP-9 
standard (10 µl) and a molecular weight marker (10 µl; Precision Plus Standards, Biorad 
Laboratories Ltd., Hemel Hempstead, UK). After loading, electrophoresis was performed at 
20 mA constant current per gel for 1.5 hours. Gels were washed in 100 ml 2.5% Triton X-
100 solution for 1 hour using a shaker. Gels were subsequently rinsed in incubation buffer 
(50 mM Tris, 0.2% Sodium Azide, 5 mM Calcium chloride, pH 7.6) and then incubated in 
100 ml incubation buffer (as above) at 37 °C for 40 hours. Gels were rinsed in D.I. H2O and 
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stained for 30 min in 100 ml stain solution (0.5% Coomassie Blue R250, 30% methanol, 
10% acetic acid). After staining, the gels were de-stained in 200 ml de-stain solution (10% 
methanol, 5% acetic acid) for 20 hours in order to visualise the areas where the gelatin had 
been enzymatically digested. Gels were placed on a light box and photographed from a 
predefined distance using a Nikon Coolpix camera (5700) set at the highest resolution. 
Images were analysed using Scions β 4.0.2 image analysis software (Scion Corporation, 
Maryland, USA) (Figure 5-13). Comparison to the molecular weight marker indicated that 
pro-MMP-9 had a molecular weight of approximately 100 kDa and active MMP-9 had a 
molecular weight of approximately 90 kDa. Pro-MMP-2 had a molecular weight of 
approximately 70 kDa and the active form of the enzyme had a molecular weight of 
approximately 65 kDa. Digestion bands were expressed per mg of tissue and relative to the 
MMP-9 standard to allow comparison between gels. 
 
Figure 5-13: Semi-quantification of MMPs extracted from tendon tissue. A – Gelatin zymogram showing 
standards and pro- and active forms of MMP-2 and -9 in SDFT and CDET samples from three different 
horses. B – Rectangles mark standard and sample lanes. C – Resulting lane plot from B; the area of each 
digestion band is calculated and expressed relative to the standards for each gel. 
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Casein Zymography 
Casein zymography was used to assess MMP-3 concentration at the protein level in the 
SDFT and CDET. Sample supernatant (20 µl) was loaded onto 10% separating gels 
containing β-casein (1 mg/ml) using a 4% stacking gel. A molecular weight marker (10 µl) 
was included on each gel. The MMP-9 standard prepared from neutrophils was also run 
alongside the samples on each gel to act as a negative control. Electrophoresis, gel staining 
and destaining, and image analysis was performed as for gelatin zymography. To allow 
comparison of samples separated on different gels, an SDFT sample with a relatively high 
concentration of MMP-3 was identified and run on every gel, and the activity of MMP-3 in 
all other samples were expressed relative to this sample (Figure 5-14). Comparison with the 
molecular weight marker gave an approximate molecular weight of 50 kDa for pro-MMP-3 
and 45 kDa for the active form of the enzyme. 
 
Figure 5-14: Casein zymogram showing pro and active forms of MMP-3 in SDFT and CDET samples from 
three horses. Areas of digestion bands were quantified as for gelatin zymography (see Figure 5-13). 
5.2.3. Statistical Analysis 
Data were analysed using linear mixed effects in SPlus (Version 6.1, Insightful). Results 
were grouped by horse number to account for individual variation and the effects of age 
and tendon type on mRNA and protein levels were determined. The distribution of the data 
were tested in Minitab (Version 15) using a Kolmongorov-Smirnoff test for normality. The 
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gene expression data did not follow the normal distribution and so these data were log10 
transformed and re-tested for normality. However, the transformed data did not follow the 
normal distribution and so the un-transformed data were used for statistical analysis. 
Correlation analysis was performed in SPSS (Version 14) using parametric (Pearson’s 
product moment correlation) or non-parametric (Spearman’s rank correlation) tests 
depending on whether the data followed the normal distribution. Statistical significance was 
set at p<0.05. All data are displayed as mean ± SEM. 
5.3. Results 
5.3.1. Primer Design and Validation 
Equine specific primers had not been designed previously for several genes that have been 
implicated in tendon injury (Jones et al., 2006) and so primers were designed for ADAM-8, 
-12 and -17; ADAMTS-2, -3, -8 and -12; Col-12A1 and -14A1; MMP-2, -7, -10, -19, -23 
and -25; and TIMP-3 and -4. From these, primers for ADAM-12 and -17, ADAMTS-2; 
Col-12A1; MMP-10 and -23; and TIMP-3 and -4 met the criteria for specificity and 
efficient amplification and so the other primers were not used to quantify gene expression 
in the tendon samples. Average gene expression per cell and per tissue weight is shown in 
Table 5-3.
 1
4
2
 
 SDFT DDFT SL CDET 
 Per cell Per mg tissue Per cell Per mg tissue Per cell Per mg tissue Per cell Per mg tissue 
Col1A2 34.93±7.23 19.42±4.30 61.40±10.94 17.99±2.83 29.58±4.81 20.96±4.19 78.46±13.83** 30.88±6.12 
Col3A1 18.56±3.93 10.72±2.75 29.57±10.72 8.28±2.59 19.06±4.41 14.65±4.24 14.95±3.16 6.04±1.46 
Col5A1 1.49±0.40 0.84±0.22 1.95±0.72 0.58±0.18 0.69±0.15 0.51±0.13* 0.64±0.12 0.27±0.06** 
Col12A1 9.51±1.38 5.20±0.79 15.08±3.50 6.26±2.09 15.52±4.30 9.61±2.27 15.64±2.59 6.00±1.07 
Aggrecan 5.55±1.81 3.07±0.96 12.80±2.91** 3.57±0.70 3.95±0.80 2.70±0.47 0.21±0.03* 0.08±0.02*** 
Biglycan 63.27±13.76 35.84±8.44 78.36±16.11 23.49±4.77 75.65±30.15 55.44±23.19 25.00±4.60** 9.35±1.87*** 
Decorin 1343.42±302.85 780.99±198.98 793.59±67.81 245.38±20.64*** 763.11±75.97 527.61±57.03 483.48±53.23*** 190.83±25.68*** 
Fibromodulin  32.80±6.68 18.53±3.90 42.33±10.25 12.46±2.76* 13.28±2.19* 8.83±1.42*** 19.89±3.58 7.99±1.58*** 
Lumican 48.50±7.45 27.62±5.30 73.09±10.48* 22.20±3.13 58.21±8.48 41.10±7.35* 13.06±1.57*** 5.19±0.70*** 
MMP-1 0.03±0.01 0.01±0.01 0.08±0.05 0.04±0.02 0.01±<0.01 0.01±<0.01 0.14±0.03* 0.05±0.01* 
MMP-3 3.52±0.83aa 1.89±0.45aa 4.03±1.20 1.14±0.29* 0.70±0.28** 0.57±0.27*** 1.39±0.30*aa 0.52±0.12***aa 
MMP-9 0.43±0.20 0.23±0.11 0.66±0.19 0.23±0.08 0.84±0.30 0.58±0.21 2.34±0.59*** 0.99±0.28* 
MMP-10 17.46±4.48 8.61±2.09 14.46±3.98 4.42±1.01* 2.23±0.77*** 1.50±0.51*** 7.39±1.71** 2.76±0.63*** 
MMP-13 0.16±0.12 0.07±0.05 0.13±0.05 0.05±0.03 0.03±0.01 0.02±0.01 0.72±0.13*** 0.27±0.05*** 
MMP-23 0.03±0.01 0.02±0.01 0.05±0.03 0.02±0.01 0.03±0.01 0.02±0.01 0.08±0.03 0.04±0.02 
TIMP-3 55.08±9.29 31.01±6.19 64.20±10.90 20.34±3.57* 48.69±9.46 33.79±8.52 36.36±5.78* 14.62±2.71** 
TIMP-4 0.53±0.15 0.27±0.07 0.54±0.09 0.19±0.05 0.64±0.13 0.46±0.10 0.88±0.24 0.35±0.0 
ADAM-12 0.05±0.01 0.03±0.01 0.10±.0.03 0.03±0.01 0.03±0.01 0.02±0.01 0.05±0.02 0.02±0.01 
ADAM-17 1.21±0.22 0.65±0.13 1.13±0.21 0.35±0.07* 0.90±0.18 0.63±0.14 1.66±0.32 0.71±0.16 
ADAMTS-2 1.22±0.27 0.64±0.12 1.45±0.37*** 0.48±0.13 0.63±0.15 0.44±0.12 1.22±0.40 0.46±0.15 
Tenascin 1.86±0.49 1.07±0.29 6.31±1.84*** 1.83±0.53* 1.15±0.30 0.85±0.23 1.24±0.28** 0.53±0.13 
Scleraxis 3.79±0.99 2.35±0.64 2.05±0.41* 0.61±0.10*** 2.51±0.53 1.77±0.37 1.48±0.22 0.60±0.10*** 
COMP 2674.33±570.18 1516.06±320.36 2171.91±365.16 647.99±96.65** 2111.21±335.53 1463.28±251.1 1495.1±282.1** 577.50±109.10*** 
Table 5-3: Relative gene expression in equine forelimb tendons per cell and per tissue weight (corrected for DNA content) (mean ± SEM) n = 32. * Indicates significant 
difference relative to SDFT. *** p>0.001; ** p>0.005; * p>0.05. 
a
 indicates significant correlation with age. 
aaa
 p>0.001; 
aa
 p>0.005; 
a
 p>0.05. 
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5.3.2. Collagen Gene Expression 
The genes coding for the various collagens found in tendon were expressed in all tendon 
samples. As expected, Col1A2 was the most highly expressed of all the collagens in all 
tendons; expression levels of Col1A2 were on average twofold greater than expression of 
Col3A1 and fourfold greater than Col12A1 (Figure 5-15). Col5A1 was expressed at the 
lowest levels in all tendons, expression levels were approximately 20 fold less than 
expression of Col1A2 (Figure 5-15). Expression of Col1A2 was significantly higher in the 
CDET than in the SDFT per cell (p=0.002) (Figure 5-16), but due to a lower cellularity in 
the CDET there was no significant difference per tissue weight (p=0.053).  Expression of 
Col3A1 and Col12A1 did not differ between tendons, but expression of Col5A1 was 
significantly lower in the CDET (p=0.001) and in the SL (p=0.049) per tissue weight than 
in the SDFT (Figure 5-15). Collagen gene expression was not correlated with horse age in 
any tendon. 
 
Figure 5-15: Relative expression of genes coding for collagen in equine tendon corrected for tendon DNA 
content (mean ± SEM) n = 32. *indicates significant difference to the SDFT. Data are displayed on a Log10 
scale. 
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Figure 5-16: Relative expression of COL1A2 per cell (mean ± SEM) n = 32. * Indicates significant 
difference relative to the SDFT. 
5.3.3. Proteoglycan Gene Expression 
Expression of decorin was greater than expression of other proteoglycans in all tendons 
(Figure 5-17). Expression of the proteoglycans aggrecan and biglycan was significantly 
higher in the SDFT than in the CDET per tissue weight (p≤0.0004). Expression of decorin 
was greater in the SDFT than in the DDFT and CDET (p<0.0001), and fibromodulin 
expression was greater in the SDFT than in the other tendons (p≤0.03). Lumican expression 
was significantly greater in the SDFT than in the CDET (p=0.0002), and significantly 
greater in the SL when compared to the SDFT (p=0.02). Proteoglycan gene expression was 
not correlated with horse age in any tendon. 
 
Figure 5-17: Relative expression of genes coding for proteoglycans in tendon corrected for DNA content 
(mean ± SEM) n = 32. * Indicates significant difference compared to SDFT. Data are plotted on a Log10 scale. 
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5.3.4. Ratio of Collagen Type I to Decorin Expression 
The ratio of Col1A2 to decorin expression was calculated for each tendon; this ratio was 
significantly greater in the DDFT and CDET than in the SDFT (p≤0.017) (Figure 5-18). 
The ratio did not alter with increasing horse age in any tendon. 
  
Figure 5-18: Ratio of Col1A2 to decorin expression in the forelimb tendons (mean ± SEM) n = 32. * 
Indicates significant difference relative to the SDFT.  
5.3.5. Matrix Degrading Enzyme Gene Expression 
Collagenase gene expression (MMP-1 and -13) was significantly higher in the CDET than 
in the SDFT both per cell (p≤0.0049) and per tissue weight (p≤0.0281) (Figure 5-19), and 
was not correlated with horse age in any tendon. Gelatinase expression (MMP-9) was also 
significantly higher in the CDET per cell (p=0.0009) and per tissue weight (p=0.0124) 
when compared to the SDFT (Figure 5-19) and showed no significant correlation with 
horse age in any tendon. 
*
*
0
0.05
0.1
0.15
0.2
0.25
SDFT DDFT SL CDET
R
e
la
ti
ve
 G
e
n
e
 E
p
re
ss
io
n
146 
 
 
Figure 5-19: Relative gene expression of collagenases (MMP-1 & -13) and gelatinase (MMP-9) in equine 
tendon corrected for tendon DNA content (mean ± SEM) n = 32. * Indicates significant difference relative to 
SDFT. Data are plotted on a Log10 scale. 
Stromelysin gene expression (MMP-3 and -10) was significantly higher in the SDFT than 
in the other tendons per tissue weight (p≤0.03) (Figure 5-20). There was no difference in 
MMP-23 expression between tendons. 
 
Figure 5-20:  Relative gene expression of stromelysins (MMP-3 & -10) and MMP-23 corrected for tendon 
DNA content (mean ± SEM) n = 32. * Indicates significant difference relative to the SDFT. Data are plotted 
on a Log10 scale. 
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MMP-10 expression increased significantly with horse age in the SDFT and CDET 
(p≤0.005) (Figure 5-21), whereas MMP-3 showed a trend towards increased expression 
with horse age in the SDFT (r=0.3) but this was not significant (p=0.06). 
 
Figure 5-21: MMP-10 gene expression in the SDFT and CDET as a function of horse age. MMP-10 
increased significantly with age in both the SDFT (n=32, r=0.531, p=0.003) and in the CDET (n=32, r=0.496, 
p=0.005). 
ADAM-17 was expressed at significantly lower levels in the DDFT than in the SDFT 
(p=0.04); and expression of ADAM-12 and ADAMTS-2 did not differ between tendons 
(Figure 5-22). Expression of these enzymes did not show a correlation with age in any 
tendon. 
 
Figure 5-22: Gene expression of ADAM-12 & -17, and ADAMTS-2 in equine tendon corrected for DNA 
content (mean ± SEM) n = 32. * Indicates significant difference relative to the SDFT. 
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TIMP-3 expression was significantly higher in the SDFT than in the DDFT and CDET 
(p≤0.04) (Figure 5-23), and TIMP-4 expression did not differ between tendons.  TIMP-3 & 
-4 expression was not correlated with horse age in any tendon.    
 
 
Figure 5-23: TIMP-3 and -4 expression in equine tendons (mean ± SEM) n = 32. * Indicates significant 
difference relative to the SDFT. Data are displayed on a Log10 scale. 
5.3.6. Expression of Other Genes Associated with Tendon Matrix 
COMP was the most highly expressed gene in all tendons, and was expressed at greater 
levels in the SDFT and SL than in the DDFT and CDET (p≤0.002) (Figure 5-24). COMP 
expression did not change with horse age in any tendon. 
 
Figure 5-24: COMP expression in equine tendon corrected for tendon DNA content (mean ± SEM) n = 32. * 
Indicates significant difference relative to the SDFT. 
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Scleraxis also showed greater expression in the SDFT than in the DDFT and CDET 
(p=0.0009) and was significantly positively correlated with Col1A2 expression in all 
tendons (r≥0.55, p<0.0001). Tenascin expression did not differ between tendons (Figure 
5-25). Expression of scleraxis and tenascin was not correlated with horse age in any of the 
tendons. 
 
Figure 5-25: Expression of scleraxis and tenascin in equine tendon corrected for DNA content (mean ± SEM) 
n = 32. * Indicates difference relative to the SDFT. 
Expression of COMP was approximately 20 000 times lower in equine skin than in tendon, 
and scleraxis expression was 20 times less. Expression of tenascin was also lower in skin 
than in tendon (approximately 3 times lower). 
5.3.7. Comparison of Reference Genes 
There was no significant difference in expression ratio between different tendons of any of 
the genes when calculated relative to GapDH or MRPS7 and HIRP5 (Figure 5-26), 
although absolute values did differ as GapDH is expressed at overall greater levels than 
MRPS7 and HIRP5 (approximately 30 fold greater expression of GapDH).  
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Figure 5-26: A - Expression of MMP-10 normalised to GapDH expression; B - MMP-10 expression 
normalised to expression levels of MRPS7 and HIRP5. Note the almost identical expression profiles when 
using different endogenous control genes. 
5.3.8. MMP Protein Levels 
Levels of the collagenase MMP-13 were assessed in the SDFT and CDET using a 
fluorogenic assay; MMP-13 protein levels are shown in Table 5-4. MMP-13 was detected 
only in the active form in both the SDFT and CDET, and was present at greater 
concentrations in the CDET relative to the SDFT (p=0.001) (Figure 5-27). MMP-13 
concentration was not affected by increasing horse age in either tendon. There was no 
correlation between MMP-13 mRNA levels and MMP-13 protein concentration. 
 SDFT CDET 
Pro-MMP-13 (RFU/mg tissue) 0 0 
Active MMP-13 (RFU/mg tissue) 45.46±5.66 65.80±4.62
*** 
Table 5-4: MMP-13 protein levels in the SDFT and CDET (mean ± SEM) n = 32. * Indicates significant 
difference relative to the SDFT. *** p<0.001. RFU; Relative fluorescence units. 
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Figure 5-27: Concentration of active MMP-13 in the SDFT and CDET (mean ± SEM) n = 32. * Indicates 
significant difference relative to the SDFT. 
The gelatinases MMP-2 and -9 were detected in all tendon samples; protein levels are 
shown in Table 5-5. MMP-9 was present entirely in the active form whereas MMP-2 was 
detected mainly in the latent form, although small amounts of the active form were also 
present in most tendon samples (Figure 5-28). MMP-2 (both the pro and active forms) and 
MMP-9 were detected in higher concentrations in the SDFT than in the CDET (p≤0.006). 
Neither MMP-2 nor -9 were correlated with age in either tendon. There was also no 
correlation between MMP-9 mRNA and protein levels. 
 SDFT CDET 
Pro-MMP-2 (Units/mg) 6.53±0.32 5.46±0.38
* 
Active MMP-2 (Units/mg) 1.13±0.13 0.35±0.064
*** 
Pro-MMP-9 (Units/mg) 0 0 
Active MMP-9 (Units/mg) 0.43±0.066 0.13±0.033
*** 
Table 5-5: Protein levels of MMP-2 and -9 in the SDFT and CDET (mean ± SEM) n = 32. * Indicates 
significant difference relative to the SDFT. * p<0.05; ** p<0.005; *** p<0.001. 
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Figure 5-28: Concentration of the gelatinases MMP-2 and -9 in the SDFT and CDET (mean ± SEM) n = 32. 
* Indicates significant difference relative to the SDFT. 
Casein zymography showed that MMP-3 was present mainly in the latent form with small 
amounts of active enzyme present in some tendon samples. MMP-3 levels are shown in 
Table 5-6. Both the pro and active forms were present in higher concentrations in the SDFT 
than in the CDET (p≤0.04) (Figure 5-29).  
 SDFT CDET 
Pro-MMP-3 (Units/mg) 5.17±0.57 3.34±0.54
* 
Active MMP-3 (Units/mg) 0.93±0.23 0.11±0.093
*** 
Table 5-6: MMP-3 protein levels in the SDFT and CDET (mean ± SEM) n = 32. * Indicates significant 
difference relative to the SDFT. * p<0.05; **p<0.005; ***p<0.001.  
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Figure 5-29: Concentration of MMP-3 in the SDFT and CDET (mean ± SEM) n = 32. * Indicates a 
significant difference relative to the SDFT. 
Pro MMP-3 concentration increased significantly with age in the SDFT (p<0.0001) but was 
not correlated with age in the CDET. Active MMP-3 concentration was not significantly 
associated with age in the CDET but showed a significant increase with age in the SDFT 
(p=0.02) (Figure 5-30). Correspondingly, total MMP-3 concentration was significantly 
greater in the SDFT than in the CDET (p=0.003) and showed a significant positive 
correlation with age in the SDFT (p<0.0001) but not in the CDET (Figure 5-31). 
 
Figure 5-30: Concentration of active MMP-3 as a function of horse age in the SDFT and CDET. Active 
MMP-3 concentration increased significantly with age in the SDFT (p<0.0001, r=0.6) and was not correlated 
with age in the CDET. 
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Figure 5-31: Total MMP-3 concentration in the SDFT and CDET as a function of horse age. Total MMP-3 
concentration was significantly greater in the SDFT than in the CDET (p=0.003) and increased significantly 
with age in the SDFT (p<0.0001, r=0.8) but showed no relationship with age in the CDET.  
Total and active MMP-3 protein levels showed a weak but significant positive correlation 
with MMP-3 mRNA levels in the SDFT (p≤0.04) but not in the CDET (Figure 5-32). 
 
Figure 5-32: Total MMP-3 protein levels plotted against MMP-3 mRNA levels. Total protein increased 
concomitantly with MMP-3 mRNA levels in the SDFT (p=0.04, r=0.4) but there was no relationship between 
MMP-3 protein and mRNA levels in the CDET. 
It was not possible to determine which of the MMPs assessed at the protein level were 
present in the highest concentration as the measured activities were relative not absolute 
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activities which allowed comparison between tendon samples but not between different 
MMPs.  
5.4. Discussion 
As hypothesised, the results of this work show a different pattern of gene expression by 
cells from the functionally distinct tendons in the equine forelimb. In addition, differences 
in the levels of matrix degrading enzymes at both the gene and protein level support the 
earlier work and indicate a difference in the rate of turnover between the different tendons. 
However, few alterations in the expression levels of any gene were identified with 
increasing horse age. 
5.4.1. Normalising Gene Expression 
Normalising gene expression has inherent problems, usually relating to the selection of 
appropriate control genes. Many studies select reference genes without determining if their 
expression is constant. This may generate misleading results as the expression of control 
genes may alter with disease, between tissues or with increasing age. Appropriate control 
genes can be selected by determining which genes are most stably expressed in the tissue or 
condition of interest (Maccoux et al., 2007; Vandesompele et al., 2002). GeNorm was used 
to identify the two most stably expressed control genes in mature equine tendon (MRPS7 
and HIRP5); all data were expressed relative to these genes to account for differences in 
starting amount of mRNA. As previous work (Birch et al., 2008b) has normalised data to 
GapDH, in some samples data were also normalised to this gene. This did not result in 
significant alterations in expression levels suggesting that GapDH is also suitable as a 
reference gene in equine tendon. To ensure reference genes did not show altered expression 
with age cDNA from horses aged 4, 11, 12 and 24 were used to assess the candidate 
reference genes. MRPS7 and HIRP5 have been found to be the most stably expressed genes 
in several tissues and disease states (Clements et al., 2009; Maccoux et al., 2007). HIRP5 
interacts with HIRA proteins, which bind to histones in the nucleus and are involved in 
DNA packaging (Lorain et al., 2001). MRPS7 is involved in protein synthesis within the 
mitochondria and it is thought to be a factor that initiates mitochondrial translation (Cavdar 
et al., 1999). MRPS have been used previously as reference genes as their expression does 
not alter significantly with age or disease (Maccoux et al., 2007; Szabo et al., 2004).  
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5.4.2. Differences in Potential for Matrix Turnover between Tendons   
The gene expression data show that cell phenotype differs between functionally distinct 
tendons; per cell more message for collagen type I production is expressed in the CDET 
tenocytes than by SDFT cells. This supports previous findings (Birch et al., 2008b) and the 
data presented in chapter 4, which indicates an ‘older’ collagenous matrix in the SDFT than 
in the CDET. The capacity to synthesise collagen depends on tendon cell number in 
addition to the amount of collagen synthesised per cell. Collagen content is similar between 
the SDFT and CDET but cellularity is significantly greater in the SDFT (see chapter 4). 
When this is taken into account, the difference in the potential for collagen type I synthesis 
is no longer significant between the SDFT and the CDET, although there is a trend towards 
greater expression in the CDET (p=0.053). However, the significantly higher expression of 
collagenases (MMP-1 and -13) in the CDET relative to the SDFT suggests the cells in the 
CDET are more able to degrade collagen. This is supported by the higher concentration of 
MMP-13 at the protein level in the CDET than in the SDFT. Expression of Col1A2 was 
only two to fourfold greater than Col3A1 and Col12A1 expression in all tendons; however 
the heterotrimeric nature of type I collagen means that expression of Col1A2 accounts for 
one third of the total collagen type I gene expression. In contrast, both collagen type III and 
XII are homotrimers and therefore are only coded for by a single gene; when this is taken 
into account levels of collagen type I expression are approximately twelve times greater 
than collagen type III and XII expression. This reflects the percentage of these minor 
collagens present within tendon. 
The pattern of gene expression in the DDFT and SL suggests that the cells from these 
tendons exhibit phenotypes that are intermediate between the SDFT and the CDET. This is 
likely to be related to the functions of these tendons and the strains they experience during 
galloping exercise. The strain experienced by the SL during high speed locomotion has not 
been assessed, but it can be assumed that it is not exposed to the extremely high strains 
experienced by the SDFT; although overstrain injury does occur to the SL the incidence of 
injury is approximately 13 fold greater in the SDFT in racehorses (Ely et al., 2004). In a 
similar manner, although the DDFT and CDET do not act as energy stores, the DDFT is 
likely to experience higher strains than the CDET as it situated on the palmar aspect of the 
forelimb and will therefore undergo deformation when the metacarpophalangeal joint is 
hyper-extended during stance phase. This provides further evidence to suggest that gene 
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expression in the equine forelimb tendons is regulated by the amount of strain each tendon 
experiences in vivo. However, it is not known if this phenotype is pre-set or if the cells are 
able to alter their phenotype according to the strains they experience. 
The matrix half-life data (chapter 4) show that in both energy storing and positional tendons 
the non-collagenous matrix proteins are turned over more rapidly than the collagenous 
fraction of the matrix. This is supported by the gene expression data which show greater 
expression of genes coding for the predominant proteoglycans in tendon than those that 
code for collagen. Furthermore, non-collagenous matrix half-life in the SDFT is lower than 
in the CDET, in support of this the gene expression data show the potential for 
proteoglycan synthesis and degradation is greatest in the SDFT. This would be expected as 
the levels of proteoglycan as determined from sulphated GAG content are higher in the 
SDFT than the CDET (see chapter 4). The greater potential for proteoglycan degradation is 
also apparent at the protein level, with higher levels of the stromelysin MMP-3 in the SDFT 
than in the CDET. This is likely to be of functional significance; proteoglycans are thought 
to be involved in strain transfer between collagen fibrils (Scott 2003), and so may be at 
higher risk of damage in the high strain SDFT than in the low strain CDET, especially as it 
has been shown that they play a greater role in strain transfer at higher strains (Puxkandl et 
al., 2002).  
5.4.3. Function of Proteoglycans in Functionally Distinct Tendons  
It is well established that the small leucine rich proteoglycans (SLRPs) are involved in the 
regulation of collagen fibril formation (Banos et al., 2008), but more recently it has been 
proposed they contribute significantly to the transfer of strain between collagen fibrils in 
mature tendon (Scott 2003). In agreement with previous studies (Ilic et al., 2005; Rees et 
al., 2000; Vogel and Meyers 1999), decorin was the most abundantly expressed SLRP in all 
tendons. Decorin is likely to have several functions within tendon; it inhibits the lateral 
fusion of fibrils, resulting in the formation of thinner fibrils (Birk et al., 1995). Fibril mass 
average diameter is lower in the SDFT than in the CDET (Birch 2007); fibril size may 
impact on strain transfer between fibrils as fibrils with a smaller diameter have a greater 
relative surface area and therefore be able to form a greater number of intermolecular 
crosslinks. The decorin binding site on type I collagen molecules is close to the 
predominant intermolecular cross-linking site (Keene et al., 2000), therefore the greater 
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levels of decorin in the SDFT may influence enzymatic crosslink formation. Decorin has 
also been implicated directly in the transfer of strain between collagen fibrils by interacting 
with other decorin molecules bound to adjacent collagen fibrils via its GAG side chain 
(Gupta et al., 2010; Scott 2003). However, the precise mechanism of strain transfer is 
unclear and proteoglycan removal results in conflicting data; one study showed that 
proteoglycan removal did not have a significant effect on tendon mechanical properties 
(Fessel and Snedeker 2009), whereas others have found a decrease in tendon strain in 
certain tendon regions (Rigozzi et al., 2009). This suggests that tendon response to strain is 
complex and heterogeneous throughout the tendon. Proteoglycans are proposed to provide 
the viscous properties to tendon, which is viscoelastic in nature. Fibre sliding, which is 
thought to be controlled by collagen-proteoglycan interactions, has been shown to be the 
major mechanism of tendon extension at high strains (Screen et al., 2004). In support of 
this, tendons from decorin-null mice have decreased strain rate sensitivity (Robinson et al., 
2004b) and increased rate of strain relaxation (Elliott et al., 2003). Therefore proteoglycans 
may play a more important role in the high strain SDFT, than in low strain tendons such as 
the CDET. 
The second most abundant SLRP in tendon, biglycan also regulates fibrillogenesis; it is 
similar in structure and thought to have complementary functions to decorin (Banos et al., 
2008; Zhang et al., 2005), suggesting that biglycan may also be involved in regulating 
lateral fusion of fibrils. Lumican and fibromodulin are able to regulate fibrillogenesis by 
inhibiting fibril fusion (Hedbom and Heinegard 1989) but it is not known if they have 
additional functions in mature tendon. Aggrecan is found at relatively low concentrations in 
the tensile region of tendon; in this study aggrecan expression was significantly greater in 
the SDFT than in the CDET. One of the main functions of aggrecan is to attract water into 
the matrix (Benjamin and Ralphs 1998); this may account for the higher water content in 
the SDFT (see chapter 4). It is well established that the SLRPs regulate collagen 
fibrillogenesis during embryogenesis and development. However, the half-life data 
presented in chapter 4 indicate that collagen turnover in tendon occurs relatively slowly, 
especially in the high strain SDFT, and therefore the rate of fibrillogenesis in mature tendon 
is likely to be low. The main function of proteoglycan in mature tendon may therefore be to 
transfer strain between fibrils. The data show that the potential for proteoglycan turnover is 
greater in the high strain energy storing SDFT than in the low strain positional CDET. This 
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supports the conclusions drawn in chapter 4 suggesting that proteoglycans in the SDFT are 
more likely to be damaged and require repair due to the levels and rates of strain the SDFT 
experiences.  
5.4.4. Regulation of Matrix Turnover in Functionally Distinct Tendons 
In order to be able to respond appropriately to mechanical and chemical signals the rate of 
tendon matrix turnover is tightly controlled by the tenocytes. Control of protein synthesis, 
including synthesis of degradative enzymes occurs at the transcriptional, translational and 
post-translational levels (see chapter 1); therefore it cannot be assumed that if mRNA is 
expressed for a protein that protein will necessarily be synthesised and correctly modified 
to have a functional role in the matrix. Collagen type I is synthesised from two mRNA 
sequences to form procollagen chains, which undergo hydroxylation and folding to form a 
triple helix (Bellamy and Bornstein 1971). The N- and C-terminal pro-peptides are then 
removed before it is incorporated into fibrils (Birk et al., 1995; Kadler et al., 1996). It is 
likely that in tendon some of the mRNA coding for collagen never undergoes translation, in 
addition some pro-collagen molecules may be degraded instead of being incorporated into 
the matrix. It is therefore important to assess synthesis of proteins within tendon at as many 
of these levels as possible in order to determine the rate of matrix turnover accurately.  
As well as depending on the successful transcription, translation and activation of specific 
enzymes, matrix degradation is further limited by the hierarchical structure of tendon and 
the presence of enzyme inhibitors. The enzymes assessed in this chapter show there are 
differences between the mRNA and protein levels, and the pro- and active forms that are 
specific to each enzyme. There was no correlation between the mRNA and protein levels of 
the gelatinase MMP-9 and the collagenase MMP-13, while there was a weak correlation 
between mRNA and protein levels of the stromelysin MMP-3 in the SDFT but not in the 
CDET. Although MMP-9 mRNA levels were greater in the CDET than in the SDFT, 
protein levels of MMP-9 were greater in the SDFT. MMP-2 and -9 are able to degrade 
denatured collagen and so the higher levels of these enzymes in the SDFT suggest a greater 
potential for degradation of damaged collagen in this tendon. At the protein level MMP-13 
and MMP-9 were only detected in the active form, suggesting they are activated shortly 
after synthesis. MMP-2 and -3 were present mainly in the latent form, with small amounts 
of active enzyme in the matrix. ProMMP-2 can only be activated by membrane bound 
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MMPs (Visse and Nagase 2003). Cell density is relatively low in the CDET, this may 
therefore explain the lower levels of active MMP-2 in this tendon. These data give an 
indication of the complexity of the regulation of matrix degrading enzyme activity within 
tendon and also suggest that control of enzyme activation is specific to each MMP, 
allowing the degradation of different fractions of the matrix to be tightly controlled. 
Although MMP-1 and -13 are the main collagen degrading enzymes, the stromelysin 
MMP-3 is likely to play an important role in tendon matrix degradation; as well as 
degrading a variety of matrix proteins, it is also involved in the activation of collagenases 
and gelatinases (Olson et al., 2000; Suzuki et al., 1990) and is thought to assist in collagen 
degradation (Sweeney et al., 2008). Levels of collagenases were significantly higher in the 
CDET than in the SDFT, but mRNA and protein levels of MMP-3 were greater in the 
SDFT, which may result in comparable rates of collagen degradation between these 
tendons. TIMP-3, the predominant enzyme inhibitor in tendon, was expressed at higher 
levels in the energy storing SDFT and SL suggesting that there is an overall greater enzyme 
activity in the positional CDET and DDFT. Collagen may be further protected from 
collagenases by the SLRPs, which bind to the surface of the fibrils. Coating type I collagen 
fibrils with decorin, fibromodulin or lumican decreases collagenase degradation when 
compared to uncoated fibrils (Geng et al., 2006). The higher proteoglycan content in the 
SDFT may therefore protect collagen within this tendon from degradation. 
The role of other degradative enzymes within tendon matrix is less clear. The main function 
of ADAMTS-2 is cleavage of the amino pro-peptides of type I collagen during synthesis 
(Colige et al., 1997) so levels of this enzyme may be more associated with synthesis than 
degradation. ADAMTS-2 expression is increased in tendinopathy (Jones et al., 2006); this 
may therefore reflect increases in collagen synthesis in an attempt to repair matrix damage. 
There was no difference in ADAMTS-2 levels between functionally distinct tendons; 
however it has been shown that ADAMTS-14 functions as the main type I procollagen N-
propeptidase in tendon (Colige et al., 2002). ADAM-12 is able to cleave a variety of matrix 
components (Roy et al., 2004) and is also involved in cell attachment and migration 
(Thodeti et al., 2003). ADAM-12 expression is up-regulated in tendinopathy (Jones et al., 
2006), possibly reflecting an overall increase in matrix turnover in an attempt to repair the 
lesion. MMP-23 has also been implicated in tendinopathy; expression increases in painful 
Achilles tendons (Jones et al., 2006). MMP-23 is a transmembrane protein (Pei et al., 
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2000); its substrate specificity is yet to be determined but it is upregulated during 
endochondral bone formation (Clancy et al., 2003). Up-regulation of this gene in 
tendinopathy may therefore be an indication of alterations in tenocyte cell phenotype. 
Expression of genes associated with tendinopathy in the human were not significantly 
different between tendons and did not alter with increasing age. This suggests that 
processes involved in ageing are different from those that result in tendinopathy. 
5.4.5. Expression of Other Proteins in Tendon 
COMP had the greatest levels of expression of all genes in all tendons. This glycoprotein 
has been proposed to act as a catalyst in collagen fibrillogenesis (Halasz et al., 2007; 
Sodersten et al., 2005). The concentration of COMP is correlated with tendon mechanical 
properties (Smith et al., 2002b) and so this protein may also play a role in strain transfer 
between fibrils (Smith et al., 1997). However, COMP-null mice do not exhibit a tendon 
phenotype (Svensson et al., 2002) and so this glycoprotein may not be as critical to tendon 
function as previously thought. COMP expression was greater in the high strain SDFT and 
SL than in the low strain DDFT and CDET, suggesting expression may be modulated by 
mechanical load. Tenascin-C and scleraxis were expressed at lower levels than COMP in 
all tendons; these genes are often used as markers of tendon phenotype, but their functions 
in mature tendon are yet to be determined.    
5.4.5.1. Markers of Tendon Phenotype in Functionally Distinct Tendon 
Several genes have been proposed as markers of tenocyte phenotype, including tenascin-C 
and scleraxis (Murchison et al., 2007; Taylor et al., 2009), but no individual gene has been 
identified that is only expressed by tenocytes. The results in this chapter are similar to those 
reported previously (Taylor et al., 2009), with greater expression of scleraxis than tenascin-
C. Comparison of expression in equine tendon to expression of tenascin-C and scleraxis in 
skin and cartilage samples confirm the cells in the tendons studied exhibit a tendon 
phenotype. Transfection experiments have shown that over-expression of scleraxis results 
in a 200% increase in Col1A1 expression (Lejard et al., 2007). Correspondingly, the data 
presented in this chapter show a correlation between expression of scleraxis and Col1A2 in 
all tendons. Scleraxis expression was significantly lower in the low strain CDET and DDFT 
than in the high strain SDFT; it is well established that expression of this gene is modulated 
by mechanical load (Eliasson et al., 2009; Farng et al., 2008; Kuo and Tuan 2008).  
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The data presented in this chapter has also identified a difference in cell phenotype between 
functionally distinct tendons which is most obvious between the SDFT and CDET. Cells in 
the SDFT can be characterised by greater expression of proteoglycans and enzymes that 
degrade them, whereas cells in the CDET express greater levels of genes coding for 
collagen type I (per cell) and collagenases. Therefore the ratio of collagen type I to decorin 
expression could be used to differentiate between cells from functionally distinct tendons. 
This ratio is on average fourfold greater in the low strain positional CDET than in the high 
strain energy storing SDFT (Figure 5-18), suggesting that turnover of proteoglycans is 
more critical to maintain tendon function than turnover of the collagenous matrix in energy 
storing tendons and supporting the data presented in chapter 4. This ratio would be of use to 
determine if cell phenotype alters with the progression of tendinopathy, and also in in vitro 
systems to compare the phenotype of cultured cells to that of cells in native tendon tissue.  
5.4.6. Effect of Age on Cell Phenotype 
In contrast to the hypothesis tested, gene expression is not altered with increasing horse 
age; the only gene that showed a significant relationship with horse age was MMP-10, 
expression of which increased with ageing in both the SDFT and CDET. Changes in gene 
expression that occur during tendon development and maturation and with tendinopathy 
have been determined previously, but there is little information available regarding 
alterations in gene expression that occur with normal ageing. There was also no alteration 
in the concentrations of the assayed MMPs at the protein level with increasing age, with the 
exception of MMP-3, which increased with ageing in the SDFT. These data indicate that 
there is no decrease in the ability of aged cells to turnover the matrix components at least 
with respect to transcription of matrix macromolecules and synthesis of matrix degrading 
enzymes. This suggests that the increased incidence of tendinopathy with ageing may not 
be a cell mediated problem. Although the data presented in this chapter do not identify a 
decrease in the synthesis of degradative enzymes with increasing age, it is possible that the 
synthesis of structural matrix proteins decreases with ageing; studies have identified a 
decrease in overall protein synthesis rates in aged individuals (Tavernarakis 2008). 
Alternatively, age related modifications to the matrix may increase the resistance of both 
the collagenous and non-collagenous matrix to degradation; it has been shown that glycated 
type VI collagen is significantly more resistant to degradation by MMPs in vitro than non-
glycated collagen (Mott et al., 1997). Furthermore, pentosidine levels have been associated 
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with decreased proteoglycan synthesis, suggesting that AGEs may inhibit protein synthesis 
(DeGroot et al., 1999). This chapter assessed the potential for matrix synthesis and 
degradation; the rate of collagen protein synthesis and matrix collagen degradation can be 
further assessed by measuring molecular markers of collagen synthesis and degradation. 
5.5. Conclusions 
 Cell phenotype differs between the functionally distinct SDFT and CDET and this 
corresponds to the differences in matrix protein half-life identified in chapter 4.  
 Cells in the CDET have a greater potential to synthesise and degrade collagenous 
matrix components than those in the SDFT.  
 Cells in the SDFT show a greater potential for non-collagenous matrix turnover than 
their counterparts in the CDET.  
 These differences are also evident at the protein level, with greater concentrations of 
collagen degrading enzymes in the CDET and higher levels of proteoglycan degrading 
enzymes in the SDFT.  
 The ability of cells to synthesise matrix components and degradative enzymes does not 
alter with increasing age.  
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6. Markers of Collagen Turnover Indicate an Accumulation of 
Partially Degraded Collagen within Energy Storing Tendons   
6.1. Introduction 
Although gene expression data, as measured in the previous chapter, gives an indication of 
protein synthesis it does not provide conclusive evidence that the protein is present within 
the matrix. Likewise, the presence of matrix degrading enzymes does not show that these 
enzymes are actively degrading the matrix. In fact, the data presented in the previous 
chapters show disparity; the half-life of the collagenous matrix increases with age in the 
superificial digital flexor tendon (SDFT), indicating a reduced rate of collagen turnover in 
aged energy storing tendons. However, the data presented in chapter 5 show that there is no 
overall decrease in the genes expressed by tenocytes with increasing horse age in either the 
SDFT or the common digital extensor tendon (CDET) and there also does not appear to be 
any alteration in the ability of cells to degrade the matrix with increasing age in equine 
tendon, based on measurement of MMP protein levels. The incidence of tendon injury 
increases with age in both horses and humans (Clayton and Court-Brown 2008; Kannus et 
al., 1989; Kasashima et al., 2004) and this has previously been attributed to a decrease in 
cell activity in aged tendons (Smith et al., 2002a) although the data presented in this thesis 
do not support this. 
This may be because the rate of degradation of damaged collagen within the matrix and 
subsequent repair that occurs within tendon is not only dependant on the ability of 
tenocytes to synthesise pro-collagen molecules and synthesise and activate degradative 
enzymes; it also depends on how resistant the matrix is to degradation. Intact triple helical 
collagen is much more resistant to degradation than collagen monomers in solution (Slatter 
et al., 2008). In tendon, neighbouring collagen molecules are cross-linked to one another 
and packed tightly together to form fibrils, and only the molecules on the surface of the 
fibrils are available for degradation as the collagenases are unable to access the collagen 
molecules located in the centre of the fibrils. Furthermore, in order for collagenases to be 
able to degrade intact triple helical collagen the C-terminal telopeptide must be unwound 
(Chung et al., 2004; Perumal et al., 2008). This action cannot be performed by the 
collagenases; the stromelysin MMP-3 is thought to play a key role in this process (Sweeney 
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et al., 2008), and so collagen degradation depends on the presence of several MMPs with 
different substrate specificity. 
The rate of degradation of matrix collagen can be assessed further by using the 
concentration of protein fragments generated when triple helical collagen is degraded as 
markers of degradation. In a similar manner, the concentration of pro-collagen with tendon 
matrix can be used as a marker of collagen synthesis. 
6.1.1. Collagen Synthesis 
Collagen is synthesised as procollagen molecules (see chapter 1), with non-triple helical 
amino- and carboxy- pro-peptide regions (Figure 6-1). During synthesis, the pro-peptide 
regions are removed by proteolytic enzymes (Colige et al., 2002). The cleaved collagen 
molecules are then able to assemble into fibrils, which are incorporated into the tendon 
matrix. As such, collagen molecules within the tendon matrix that have not had the N- and 
C- terminal pro-peptides removed are newly synthesised and so measurement of the 
concentration of pro-collagen peptides within the matrix can be used as markers of the rate 
of collagen synthesis at the level of translation.  
Collagen synthesis was first quantified in this manner by Taubman et al. (1974) by 
measuring the concentration of the C-terminal peptide (PICP) using a competitive radio 
immunoassay (RIA). PICP is now a well established marker of collagen synthesis and has 
been used to identify changes in collagen synthesis in a variety of disease states, including 
investigating the pathogenesis of osteoporosis (Parfitt et al., 1987) and the identification of 
bone metastases (Klepzig et al., 2009). More recently changes in levels of collagen pro-
peptides have been used to assess the effect of exercise on the rate of collagen synthesis, 
both in humans (Karlsson et al., 2003a; Karlsson et al., 2003b) and horses (Billinghurst et 
al., 2003; Price et al., 1995b). While most of these studies have focused on changes in bone 
or cartilage metabolism, concentration of collagen pro-peptides has also been used to assess 
alterations in tendon turnover with exercise or disease. Levels of serum PICP have been 
shown to be elevated in horses with tendinopathy, and have also been shown to decrease 
with increasing horse age, representing an overall decrease in collagen synthesis (Jackson 
et al., 2003). However, this study measured changes in serum levels of PICP and so may 
not reflect the specific changes that occur in tendon tissue with increasing age. Localisation 
of pro-collagen molecules within tendon matrix has also been achieved using 
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immunohistochemistry (Halper et al., 2005; Young et al., 2009b). However, no previous 
studies have measured the total concentration of pro-collagen molecules extracted from 
equine tendon tissue ex vivo. 
 
Figure 6-1: Representation of the type I pro-collagen molecule showing the N- and C- terminal propeptides, 
which are removed during processing and the C-terminal region where pyridinolines crosslink the molecule to 
adjacent molecules. Adapted from Urena and De Vernejoul (1999). 
6.1.2. Collagen Degradation 
Intact triple helical collagen can only be degraded by the collagenases (MMP-1, -8 and -13) 
(Lauer-Fields et al., 2000; Visse and Nagase 2003), which cleave the triple helix into ¼ and 
¾ fragments (Figure 6-2). This exposes new ends of the collagen molecule (neoepitopes) 
which can be measured using antibodies specific to the end sequences. Therefore the 
concentration of the ¼ and ¾ fragments within the matrix can be measured and used as 
indicators of the rate of collagen degradation. The concentration of the ¾ fragment (C1,2C 
neoepitope) has been measured to assess collagen degradation rates in lung disease 
(Armstrong et al., 1999) and both equine and human osteoarthritic cartilage (Billinghurst et 
al., 1997; Billinghurst et al., 2004; Frisbie et al., 2008), but has not been used previously to 
assess collagen degradation in tendon tissue.  
(PINP) 
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Figure 6-2: Schematic showing the collagenase cleavage site on type I collagen molecules, which results in 
the generation of ¼ and ¾ fragments. Adapted from Chung et al. (2004).  
Another marker of collagen degradation is the cross-linked C-terminal telopeptide of type I 
collagen (ICTP). ICTP consists of a trivalent collagen cross-link which connects three 
polypeptide chains (Figure 6-1); two are α1 chains from one collagen molecule while the 
third is derived from either an α1 or an α2 chain from the helical region of an adjacent 
molecule (Risteli et al., 1993). Therefore any ICTP present in the matrix must have been 
generated when collagen molecules that had been incorporated into fibrils were degraded; 
mature inter-molecular crosslinks would not be present between newly synthesised collagen 
molecules and so ICTP would not be produced when they were degraded. The 
concentration of ICTP has been used widely as a marker of collagen degradation; serum 
levels of ICTP are often used to assess bone degradation in a variety of disease states, 
including rheumatoid arthritis (Hakala et al., 1993) and myelomas (Elomaa et al., 1992). 
Collagen degradation in tendon has also been assessed by measuring the concentration of 
ICTP in peritendinous tissue of the Achilles tendon (Christensen et al., 2008; Langberg et 
al., 1999; Langberg et al., 2001). ICTP has also been used to study bone and tendon 
turnover in horses; several studies have used serum levels of ICTP to assess changes in 
collagen degradation with increasing age or injury (Jackson et al., 2003; Lepage et al., 
1998; Price et al., 1995a; Price et al., 2001). However, measurement of serum levels of 
ICTP will only give an indication of general collagen turnover and is not specific to a 
particular tissue. ICTP has also been used previously as a marker of the rate of collagen 
degradation in equine tendon (Birch et al., 2008b); this study reported that levels of 
extracted ICTP were lower in the SDFT than in the CDET. 
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6.1.3. Aims and Hypothesis 
The aims of this chapter were to assess collagen synthesis at the protein level and actual 
degradation of the matrix in the functionally distinct SDFT and CDET from horses with a 
wide age range. Collagen synthesis was assessed by measuring pro-collagen levels in a 
semi-quantitative manner using Western blotting. Matrix collagen degradation was assessed 
by measuring the concentration of protein fragments that are generated when type I 
collagen is cleaved by collagenases; the concentrations of ICTP and the C1,2C neoepitope 
were measured using commercially available enzyme linked immunosorbent assay 
(ELISA) and RIA. It was hypothesised that the rate of collagen synthesis and degradation 
in the high strain energy storing SDFT would be lower than that in the low strain positional 
CDET and that collagen turnover would decrease with increasing horse age in the SDFT. 
6.2. Materials and methods 
Lyophilised tendon tissue from the SDFT and CDET of 32 horses collected and processed 
as described in chapter 3 was used for the following studies. 
6.2.1. Markers of Collagen Synthesis 
6.2.1.1. PINP 
Collagen synthesis was assessed at the protein level in the SDFT and CDET from 14 horses 
selected from the sample group based on age range (6 – 30 years) by measuring the 
concentration of pro-collagen that could be extracted from the matrix. Pro-collagen was 
detected using an antibody for the N-terminal propeptide of type-I collagen (PINP) using 
Western blotting. Initial work found that the more commonly used commercially available 
EIAs for PICP (Takara procollagen Type I C-peptide EIA, Takara Bio Inc., Japan; 
MicroVue CICP EIA kit, Quidel) did not show cross reactivity with equine collagen. 
Previous work has shown that an antibody for PINP raised against ovine protein (SP1.D8, 
Developmental Studies Hybridoma Bank, The University of Iowa, Department of 
Biological Sciences, Iowa, UK) shows good cross reactivity with the horse (Young et al., 
2009b) and so this antibody was used to assess collagen synthesis in equine tendon. Protein 
was precipitated from Guanidine-HCl (GuHCl) extracts (see chapter 4) (Birch et al., 
2008b); 900 μl of 95% ethanol in 50 mM sodium acetate at pH 7.4 was added to a 100 μl 
aliquot of the supernatant from the GuHCl extraction. Protein was precipitated overnight at 
-20 °C, and the supernatant was removed following centrifugation (16 000 g for 25 min). 
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The pellet was air dried and re-dissolved in 100 μl of 50 mM sodium acetate, pH 7.4 and 
precipitated again. The remaining samples were reconstituted in 100 µl 2x reducing buffer 
(10% mecaptoethanol in 125 mM Tris, 2% SDS, 10% glycerol, pH 6.8) and heated at 60 ºC 
for 5 min. before loading 20 µl of each sample onto the gels. Proteins were separated by 
SDS-PAGE on a 5% acrylamide gel with a 4% stacking gel; a molecular weight standard 
(10 µl; Precision Plus Standards, Biorad Laboratories Ltd., Hemel Hempstead, UK) was 
run alongside the samples on each gel. Proteins were separated by applying a constant 
current of 20 mA per gel to the gels for 55 min.  
Initial work was preformed to confirm the position of the collagen α1 and α2 chains when 
proteins were separated by electrophoresis, pepsin digested type I collagen purified from 
equine and rat tail tendon was heated at 90 ºC for 5 minutes and separated by SDS-PAGE. 
Gels were stained with Coomassie Blue R-250 stain solution for 1 hour, and destained in 
de-stain solution for 2 hours. Collagen α1(I) and α2(I) chains had a molecular weight of 
approximately 130 kDa and 120 kDa respectively (Figure 6-3). These values are similar to 
those reported in the literature for pepsin extracted equine collagen (Falini et al., 2004). 
 
Figure 6-3: Gel stained with Coomassie Blue R-250 showing molecular weight marker and position of 
collagen α1 and α2 chains. 
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After electrophoresis, gels were incubated in transfer buffer (10% 10 x running buffer, 20% 
methanol, 70% deionised water) and proteins were transferred to PVDF membranes 
(Amersham Hybond-P, GE Healthcare, Amersham, UK) by blotting for 75 min at 100 V. 
Membranes were stored overnight in transfer buffer. Membranes were then washed in Tris 
buffered saline (0.05 M, pH 8) with 0.1% Tween 20 (TBS-T) containing 4% skimmed milk 
powder for 1 hour at room temperature on an orbital shaker. Membranes were rinsed in 2 
changes TBS-T and then incubated in ovine PINP antibody raised in mouse (SP1.D8, 
diluted 1 in 1000 in TBS-T) for 2 hours at room temperature with shaking. Membranes 
were rinsed in 2 changes of TBS-T, then washed for 15 min. in TBS-T, followed by three 5 
min. washes in TBS-T. Membranes were incubated in an enhanced chemi-luminescent 
(ECL) peroxidase labelled anti-mouse secondary antibody (GE Healthcare, diluted 1 in 10 
000 in TBS-T) for 2 hours at room temperature with shaking. After washing as described 
above blots were developed with Amersham ECL Plus™ Western blotting detection 
reagents according to the manufacturer’s instructions (GE Healthcare). Membranes were 
then placed in an x-ray film cassette with autoradiography film (Hyperfilm, Amersham 
Biosciences). Exposure time was varied from 10 minutes to 18 hours to determine the best 
exposure time; the time that resulted in the best contrast was 10 minutes. Resulting x-ray 
films were developed and the x-rays were photographed on a lightbox using a Nikon 
Coolpix camera (5700, high resolution) set at a defined distance from the lightbox. Band 
areas were quantified using Scion Image (Version 4.0.3.2, Scion Corporation, Maryland, 
USA). To allow comparison between blots, a CDET sample was selected and included on 
each gel, and levels of pro-collagen were expressed relative to this CDET sample and per 
tissue weight. Comparison to the molecular weight marker showed four bands with 
molecular weights ranging from approximately 155 kDa to 200 kDa (Figure 6-4). These 
bands are likely to represent pro-collagen α1(I) and α2(I) chains either with both the N- and 
C-terminal propeptides still attached, or with just the N-terminal propeptide attached. The 
molecular weight of the collagen α1(I) chain is 139 kDa (Urtasun et al., 2009), the C-
terminal pro-peptide has a molecular weight of 35 kDa (Pedersen and Bonde 1994) and the 
N-terminal pro-peptide has a molecular weight of 27 kDa (Jensen et al., 1998). The 
collagen α2(I) chain is slightly smaller, with a molecular weight of 130 kDa (Urtasun et al., 
2009), PICP on the α2(I) chain has a molecular weight of 33 kDa (Pedersen and Bonde 
1994) and PINP has a molecular weight of 20 kDa. Therefore the band at 200 kDa 
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represents the procollagen α1(I) chain with PICP and PINP attached and the band at 190 
kDa represents the procollagen α2(I) chain with PICP and PINP attached. The bands at 165 
kDa and 155 kDa correspond to the α1(I) and α2(I) chains with PINP, but not PICP 
attached. The band corresponding to the pro-collagen α2 chain with both PICP and PINP 
attached (190 kDa) was the clearest band in the majority of samples and so the area of this 
band was measured to assess the rate of collagen synthesis in the SDFT and CDET. 
    
Figure 6-4: X-ray showing bands of protein corresponding to PINP concentration in the SDFT and CDET 
from 3 horses.  
To ensure the PINP antibody did not recognise mature collagen molecules that no longer 
contained an N-terminal pro-peptide region, rat tail tendon and equine collagen were 
separated by SDS-PAGE and probed using the SP1.D8 antibody. Development of the 
subsequent blot did not result in the visualisation of any bands (Figure 6-5). 
MW 
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Figure 6-5: X-ray confirming that the SP1.D8 antibody does not recognise mature collagen molecules. 
6.2.2. Markers of Collagen Degradation 
6.2.2.1. ICTP 
The concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) 
was assessed in the SDFT and CDET using a commercially available competitive RIA 
(Orion Diagnostica, distributed in the UK by Oxford Biosystems, Oxford, UK). A known 
amount of 
125
I-labelled ICTP competes with an unknown amount of unlabelled ICTP for 
antibody binding sites. Although designed for use with human serum, it has been 
demonstrated previously that this RIA shows good cross-reactivity with the horse (Price et 
al., 1995a). Protein was precipitated from GuHCl extracts as described above. The 
remaining pellet was re-dissolved in 1 ml of dilution buffer (0.8% SDS, 140 mM sodium 
chloride, 8 mM disodium hydrogen phosphate, 2.7 mM potassium chloride, 1.5 mM 
potassium dihydrogen phosphate, 3.1 mM sodium azide, pH 7.4). Previous work has 
validated this RIA for use with samples that have undergone GuHCl extraction (Birch et 
al., 2008b); there was a very strong correlation between diluted GuHCl extracted samples 
and ICTP reference standards (Thorpe et al., 2010). Preliminary work was carried out to 
determine the dilution factors required, to measure the concentration in trypsin digested 
samples and to determine the effect of different dilution buffers. The RIA was performed in 
duplicate according to the manufacturer’s instructions and a blank containing dilution 
buffer with no tissue was included to account for any difference in absorbance due to the 
dilution buffer used. Radioactivity was measured using a gamma counter and the standards 
CDET 
standard 
Rat tail tendon 
collagen 
Equine tendon 
collagen 
α1 pro-collagen chain 
α2 pro-collagen chain 
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provided were used to construct a calibration curve, from which sample ICTP concentration 
was determined. Concentration of ICTP was expressed as ng per mg dry weight tissue. 
As expected, the concentration of ICTP was approximately 400 times greater in the trypsin 
digested samples, and was similar between the SDFT and CDET, reflecting a similar 
overall collagen content. Reconstituting the GuHCl extracted pellets in PBS was found to 
result in incomplete dissolution of the pellets and low readings, and so pellets were 
redissolved in the buffer used in the previous study (Birch et al., 2008b). It was determined 
that dissolving samples from the SDFT in 1 ml dilution buffer resulted in readings that 
were within the range of the standard curve whereas samples from the CDET had to be 
further diluted 10 fold to bring them within range of the standard curve.  
6.2.2.2. Neoepitopes of Type I Collagen 
The ¾ fragment generated when intact type I collagen is cleaved by collagenases was 
extracted from the matrix by collagen denaturation using heat followed by trypsin 
digestion, and concentration was measured in the SDFT and CDET samples using a 
commercially available ELISA kit (IBEX Technologies Inc., Montreal, Canada), using an 
antibody which recognises an 8 amino acid sequence at the C-terminal cleavage site 
(Billinghurst et al., 1997). Approximately 30 mg lyophilised powdered tissue from the 
SDFT and CDET was accurately weighed out and suspended in 0.75 ml 3-(N-Tris 
(hydroxymethyl) methylamino)-2-hydroxypropanesulfonic acid (TAPSO) buffer (100 mM 
TAPSO, 10 mM CaCl, pH 8.2). The samples were heated at 90 °C for 35 minutes and then 
cooled to 37 °C before 0.4 ml trypsin solution (10 000 units/ml TAPSO buffer) was added. 
The samples were incubated for 20 hours at 37 °C with shaking. After 20 hours, trypsin 
activity was inhibited with 20 µl N-p-tosyl-L-lysin chloromethyl ketone (18.2 mg in 1 ml 
TAPSO buffer). A blank containing no tissue was included with the samples and was used 
to dilute the standards to account for any difference in absorbance caused by differences in 
buffer composition. The ELISA was performed in duplicate according to the 
manufacturer’s instructions and the resulting absorbance was measured at 450 nm using a 
plate reader (BioRad 3550 microplate reader). Previous studies (Billinghurst et al., 1997) 
have used chymotrypsin to extract the peptide from the matrix so preliminary work was 
carried out to determine the effects of using trypsin instead of chymotrypsin, and 
denaturing the collagen prior to enzymatic digestion. The C1,2C antibody recognises the 
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following sequence at the carboxy terminus of the ¾ fragment: Pro-Gly-Thr-Pro-Gly-Pro-
Glu-Gly (Billinghurst et al., 1997); this sequence will not be digested by trypsin as this 
protease is only able to cleave at the carboxyl side of lysine and arginine (Olsen et al., 
2004). To ensure trypsin digestion did not alter the antibody recognition site, reference 
standards with concentrations of 4.16 nmoles/ml and 1.37 nmoles/ml were heated and 
digested with trypsin before being assayed for C1,2C. Absorbance readings for trypsin 
digested standards were very similar (on average 1.06 times greater) to those for undigested 
standards; indicating that trypsin digestion does not affect the antibody binding site and 
therefore is suitable for extraction of the neoepitope from tendon tissue.       
The absorbance of the reference standards supplied with the kit was used to calculate a 
standard curve. This was not linear so curve fitting software (GraphPad Prism, Version 5, 
GraphPad Software Inc., California, USA) was used. Mean absorbance was plotted on y-
axis versus Log10 concentration on x-axis. Non-linear regression was performed to fit an 
appropriate curve, using the sigmoidal dose-response (variable slope) function (Figure 6-6) 
and the concentration in the samples was calculated. The assay is a competitive 
immunoassay, therefore sample concentration is inversely proportional to the absorbance 
measured. The collagen content of the trypsin digested samples was measured using an 
assay for hydroxyproline as described in chapter 4 and the concentration of the ¾ fragment 
was expressed per mole of collagen to correct for any difference in collagen content and 
digestion efficiency between the tendon samples.      
 
Figure 6-6: Non-linear curve fitting was performed and the concentration of C1,2C present in the samples 
was calculated from the equation for the curve using GraphPad Prism (Version 5). 
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6.2.3. Statistical Analysis 
Statistical significance was assessed using a linear fixed effects model in SPlus (Version 
6.1, Insightful) with horse as a grouping factor. Data were tested for normality using 
Kolmongorov-Smirnoff test (Minitab, Version 15) and correlation with age was assessed 
for each tendon using Pearson Product Moment Correlation and Spearman Rank correlation 
(SPSS, Version 14). All data are displayed as mean ± SEM. 
6.3. Results 
Concentration of the markers of collagen synthesis and degradation in the SDFT and 
CDET, and correlation of these markers with horse age are shown in Table 6-1.  
 Mean ± SEM Correlation with age (r) 
 SDFT CDET SDFT CDET 
Pro-collagen 
(Units/mg tissue) 
(n = 14) 
43.09±14.85 198.68±37.47
*** 
0.189 -0.429 
ICTP (ng/mg 
tissue) 
(n = 32) 
86.09±7.31 448.21±104.89
***
 -0.651
§§§
 -0.499
§§
 
C1,2C (mM/M 
collagen) 
(n = 32) 
12.65±0.71 15.49±0.86
*
 0.458
§
 0.056 
Table 6-1: Concentration of marker of collagen synthesis and degradation in the SDFT and CDET (mean ± 
SEM). 
*
Indicates significant difference from SDFT: 
*
p<0.05;
 **
p<0.005, 
***
p<0.001; 
§
Indicates significant 
correlation with age: 
§
p<0.05; 
§§
p<0.005, 
§§§
p<0.001. 
6.3.1. Collagen Synthesis 
Pro-collagen was detected in all CDET samples analysed, and was not detected in some 
SDFT samples. Correspondingly, levels of pro-collagen extracted from the matrix were 
significantly higher in the CDET than in the SDFT (p=0.0008) (Figure 6-7). Pro-collagen 
levels did not change significantly with age in either tendon; although there was a trend 
towards decreased pro-collagen levels in the CDET, this was not significant (p=0.1, r=-0.4) 
(Figure 6-8). Furthermore, there was no significant correlation between pro-collagen at the 
protein level and expression of Col1A2 at the mRNA level (data presented in chapter 5).  
177 
 
 
Figure 6-7: Concentration of pro-collagen in the SDFT and CDET (mean ± SEM) n = 14. * Indicates 
significant difference relative to the SDFT. 
 
Figure 6-8: Pro-collagen concentration as a function of horse age in the SDFT and CDET from 14 horses. 
Pro-collagen concentration was not significantly correlated with horse age in either tendon type. 
6.3.2. Collagen Degradation 
ICTP was detected in the majority of tendon samples extracted with GuHCl. The RIA used 
showed good repeatability, with an average variation of 4.84% between duplicate samples. 
Levels of ICTP extracted from the matrix were significantly greater in the CDET when 
compared to the SDFT (p<0.0001) (Figure 6-9); and decreased significantly with age in 
both tendons (p<0.0001) (Figure 6-10). 
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Figure 6-9: Concentration of ICTP in the SDFT and CDET (mean ± SEM) n = 32. * Indicates significant 
difference relative to the SDFT. 
 
Figure 6-10: Concentration of ICTP extracted from the SDFT (♦) (A) and CDET (×) (B) as a function of 
horse age. A linear equation was found to give the best fit (p<0.0001, r=-0.64 and p<0.000, r=-0.50 for the 
SDFT and CDET respectively). The amount of ICTP extracted from the matrix was significantly greater in 
the CDET than in the SDFT (p<0.001). 
 
Levels of ICTP extracted from the SDFT showed a significant negative correlation with 
levels of the AGE pentosidine (p<0.001) (Figure 6-11) but there was no correlation 
between ICTP and pentosidine concentration in the CDET. 
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Figure 6-11: Correlation of ICTP levels with pentosidine concentration in the SDFT, r=-0.65, p<0.001. 
The C1,2C neoepitope was detected in all tendon samples. The ELISA used showed good 
repeatability between duplicate samples, with a mean variation of 6.77%. Levels of the 
C1,2C neoepitope in the matrix were found to be significantly higher in the CDET than in 
the SDFT (p=0.007) (Figure 6-12); and accumulated with age in the SDFT (p=0.008) but 
not in the CDET (Figure 6-13). 
 
Figure 6-12: Concentration of C1,2C neoepitope (mM/M collagen) in the SDFT and CDET (mean ± SEM) n 
= 32. * Indicates significant difference relative to the SDFT. 
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Figure 6-13: Concentration of C1,2C as a function of horse age in the SDFT and CDET. C1,2C concentration 
increased significantly with age in the SDFT (p=0.007, r=0.458) and showed no correlation with age in the 
CDET. 
C1,2C levels were significantly correlated with pentosidine levels in the SDFT (p=0.02) 
(Figure 6-14), but showed no relationship with pentosidine concentration in the CDET. 
There was also no correlation between C1,2C concentration and mRNA or protein levels of 
the collagenase MMP-13 in either tendon. 
 
Figure 6-14: Correlation of pentosidine concentration with C1,2C concentration in the SDFT (r=0.41, 
p=0.02). 
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6.4. Discussion 
The results of this chapter show that transcription of the type I collagen gene (measured in 
the previous chapter) results in translation into pro-collagen protein and that MMP-13 (and 
other MMPs) are functional within the tendon matrix. The levels of pro-collagen show that 
collagen synthesis at the translational level is greater in the CDET than in the SDFT and 
does not decrease with age in either tendon, reflecting differences identified at the 
transcriptional level. The amount of matrix collagen degradation is also greater in the 
CDET than in the SDFT and corresponds with the higher levels of message for, and protein 
levels of matrix degrading enzymes in this tendon. These results support the hypothesis 
tested in this chapter, which stated that the rate of collagen turnover at the protein level 
would be greater in the CDET than in the SDFT.   
6.4.1. Methods Used to Assess Collagen Synthesis and Degradation 
Previous studies have assessed the rate of collagen synthesis in equine tissues using a 
commercially available competitive RIA that recognises PICP (Orion Diagnostica, Finland) 
(Price et al., 1995a; Price et al., 2001). However, this kit is no longer manufactured and so 
two alternative enzyme immunoassay kits were tested for cross-reactivity with the horse 
(Takara procollagen Type I C-peptide EIA, Takara Bio Inc., Japan; MicroVue CICP EIA 
kit, Quidel). These commercially available kits are designed to assess PICP levels in human 
serum. The EIA manufactured by Takara Biosciences appeared to recognise the PICP 
sequence in equine samples in this study but showed extremely high variability between 
duplicate samples (up to 50%), suggesting it is not specific for PICP in the horse. The EIA 
manufactured by Quidel was tested in this study using horse and human serum samples; 
levels were successfully detected in human serum but the kit failed to recognise equine 
PICP. Collagen production in equine tendon tissue was therefore assessed in a semi-
quantitative manner using Western blotting. A primary antibody that recognises the amino 
terminal pro-peptide of type I collagen has been validated previously for use in the horse 
(Young et al., 2009b). Western blotting requires a high level of optimisation to determine 
the appropriate amount of sample that should be loaded on the gels, dilution and incubation 
time for primary and secondary antibodies, washing procedure and x-ray exposure time. 
The resultant blots produced four bands with molecular weights ranging from 150 to 200 
kDa; these are likely to correspond to α1(I) and α2(I) pro-collagen chains with both the N- 
and C-terminal pro-peptides still attached and pro-collagen chains where the C-terminal 
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pro-peptide has been removed. The area of the band corresponding to the α2(I) chain with 
both pro-peptides attached was used as a marker of collagen synthesis as this band was the 
clearest in most samples and collagen synthesis was assessed at the transcriptional level by 
measuring Col1A2 mRNA levels. In a few cases excess sample was loaded onto the gel 
such that bands on resulting blots were too large to quantify accurately (see Figure 6-4). 
Due to time constraints it was not possible to re-assay all samples and so band size was 
measured as the minimum amount present in several CDET samples. As this results in 
underestimation rather than overestimation, the difference in collagen synthesis between 
the SDFT and CDET may actually be greater than reported in this chapter.  In future 
experiments it would be prudent to assess total protein content in the samples (Smith et al., 
1985) and load a known amount of protein onto the gel for electrophoresis, which would 
allow more accurate quantification of pro-collagen levels. Alternatively, after separation of 
the protein by electrophoresis mass spectrometry could be used to accurately measure the 
concentration of the pro-collagen molecules within tendon. 
Assessment of collagen degradation in the SDFT and CDET was possible with 
commercially available assays; the ICTP assay has been validated for use with horse serum 
(Price et al., 1995a) and has been used previously to measure ICTP levels in equine tendon 
extracts (Birch et al., 2008b). Denaturation and extraction of tendon with GuHCl results in 
the separation of the soluble and insoluble fractions of the matrix; intact collagen will 
remain in the insoluble pellet whereas collagen that is not cross-linked into the matrix will 
be separated from the insoluble collagen, along with non-collagenous proteins. Any 
difference in extraction efficiency between tendon types may therefore affect the final ICTP 
concentration; it is possible that a proportion of the higher levels of ICTP in CDET extracts 
are due to greater levels of soluble collagen in this tendon as a result of different crosslinks 
present in the matrix. No previous studies have used the concentration of C1,2C to assess 
collagen degradation within tendon; the concentration of this fragment is normally used to 
assess the degradation of type II collagen. However, the sequence recognised by the 
primary antibody at the cleavage site is identical in collagen types I and II, therefore this 
EIA can also be used to assess degradation of type I collagen (Sukhova et al., 1999). This 
EIA has been validated previously for use with equine tissue (Billinghurst et al., 2004). 
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6.4.2. Collagen Synthesis 
As hypothesised, levels of pro-collagen were greater in the CDET than in the SDFT, 
indicating that the rate of collagen synthesis is greater in the low strain positional CDET. 
This supports the data presented in chapters 4 and 5, which show the cells in the CDET 
synthesise more mRNA for collagen type I than those in the SDFT, resulting in a lower 
half-life of the collagenous matrix in the CDET. However, the large difference in pro-
collagen content is somewhat surprising as there was not a significant difference in 
expression of Col1A2 once the difference in DNA content between the tendons had been 
corrected for. This and the lack of any correlation between expression of the Col1A2 gene 
and pro-collagen protein levels give an indication of the complexity of the processes 
involved in collagen synthesis. These data suggest that the level of translation of Col1A2 
mRNA into protein is greater in the CDET than in the SDFT. In contrast to the hypothesis, 
the rate of collagen synthesis did not decrease significantly with age in either tendon. This 
supports the gene expression data and suggests that the ability of the cells to synthesise 
matrix components does not decrease with increasing horse age.  
These data are supported by several previous studies which have assessed collagen 
synthesis in human and equine tendon. An immunohistochemical study reported that 
collagen synthesis decreased in mature SDFTs compared to foetal tendons, whereas 
collagen synthesis increased in mature CDETs compared to immature tendon, resulting in 
overall greater levels of pro-collagen in the mature CDET than in the SDFT (Young et al., 
2009b). The pro-collagen levels reported in this previous study were approximately four 
times greater in the CDET than in the SDFT, which is similar to the values reported in this 
chapter. Collagen pro-peptide concentration in human Achilles peritendinous tissue has 
been assessed in response to exercise; it has been reported that levels of PICP decrease 
immediately after a bout of exercise but are increased 72 hours after exercise (Langberg et 
al., 1999). Training for a period of 4 weeks resulted in a sustained increase in peritendinous 
PICP levels (Langberg et al., 2001). Changes in pro-collagen peptides have also been 
reported in injured tendons; PINP levels decreased in the soluble fraction of injured 
Achilles tendons when compared to non-injured controls (Eriksen et al., 2002). 
Interestingly, results from another study indicate that normal and injured tendons respond 
differently to the same exercise programme; levels of PICP were elevated in the tissue 
surrounding previously injured tendons in response to eccentric exercise, whereas levels did 
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not change in uninjured tendons (Langberg et al., 2007), suggesting that the cell response to 
loading may be altered in injured tendons.  
These studies indicate that, contrary to previous studies which have proposed that cells 
within mature energy storing tendons are inactive (Smith et al., 2002a), cells within tendon 
show a basal level of turnover and are able to respond to exercise induced alterations in 
loading by increasing collagen production. Furthermore, studies have not identified a 
decrease in collagen synthesis, as assessed by measuring the concentration of PICP and 
PINP in Achilles tendon extracts, with increasing subject age (Eriksen et al., 2002), and 
immunohistochemical labelling of PINP and PICP was relatively high in both normal and 
ruptured mature Achilles tendons (Pajala et al., 2009), suggesting that collagen synthesis is 
maintained in aged tendons. However, unlike in other tissues such as bone and muscle, 
exercise does not result in alterations in tendon mechanical properties in the energy storing 
tendons in mature animals (Birch et al., 1999b; Birch et al., 2008a; Legerlotz et al., 2007; 
Smith et al., 1999). Whilst fibrillogenesis that occurs during tendon development has been 
studied extensively, the mechanisms of collagen turnover and repair in mature tendon are 
poorly understood. Although collagen is synthesised in response to exercise, this does not 
mean that it will be incorporated into the functional tendon matrix; rather it is possible that 
unless repair is required, the majority of the newly synthesised collagen is degraded as 
increasing the collagen content of energy storing tendons such as the equine SDFT and 
human Achilles would increase the stiffness of these tendons, decreasing their energy 
storing capacity. Extensive remodelling of the tendon would also result in a transient 
decrease in mechanical properties, which would actually further increase the risk of injury. 
In a similar manner, although pro-collagen molecules were present at low levels in most of 
the SDFT samples assessed, they may be degraded rather than be incorporated into the 
matrix. It is possible the increase in collagen production in tendon in response to exercise is 
to enable the repair of micro-damaged collagen molecules but does not result in an overall 
increase in tendon strength or stiffness. The data presented in this and previous studies has 
not identified a decrease in collagen protein production with increasing age, suggesting that 
the increased collagenous matrix half-life in aged tendons is not due to a decreased ability 
of the cells to synthesise structural matrix proteins. 
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6.4.3. Collagen Degradation 
The higher levels of markers of collagen degradation in the CDET support the conclusions 
from the previous chapters that collagen degradation occurs more rapidly in the low strain 
positional CDET than in the high strain energy storing SDFT. Levels of ICTP were 
approximately 6 fold higher in the CDET than in the SDFT, and decreased with increasing 
age in both tendons. These data are supported by previous findings (Birch et al., 2008b), 
which reported that levels of ICTP were 5 fold greater in the CDET than in the SDFT. 
Several studies have used ICTP levels to assess alterations in collagen degradation within 
tendon that occur with exercise or injury. Levels of ICTP have been found to increase in 
synovial fluid from patients with torn rotator cuff tendons (Tajana et al., 2009), however 
analysis of the insoluble fraction of ruptured Achilles tendons found no difference in ICTP 
levels when compared to controls (Eriksen et al., 2002). ICTP has also been measured as a 
marker of collagen turnover in the Achilles tendon in response to training; ICTP 
concentration in peritendinous tissue increased transiently at the beginning of a training 
program, and then decreased to pre-training levels (Langberg et al., 2001), suggesting an 
initial increase in collagen degradation at the start of a training program, possibly acting to 
repair micro-damage caused in the initial training period. ICTP levels have also been 
reported to decrease with increasing age in the insoluble fraction of the matrix of Achilles 
tendons, both in ruptured and normal tendons (Eriksen et al., 2002). Assessment of ICTP in 
the insoluble fraction of the matrix is a measure of mature crosslink concentration rather 
than collagen degradation and this study may therefore indicate a disruption in crosslink 
formation with increasing age. The alterations in ICTP levels with exercise and injury 
indicate that tenocytes in mature tendon are able to degrade and remodel the matrix.  
C1,2C levels were higher in the CDET than in the SDFT, again suggesting an overall 
greater level of collagen turnover in the low strain positional tendon. The C1,2C data 
indicate that approximately 1.5% of the collagen within the matrix of the CDET is cleaved, 
this figure is irrespective of horse age. In contrast, C1,2C concentration increased 
significantly with age in the SDFT; in the youngest horse assessed 0.9% of the collagen 
within the SDFT had been cleaved whereas in the oldest horse this figure increased to 
1.9%. These data contradict the results presented in chapter 4 that show that collagen half-
life increases with increasing horse age. Taken together these results could be explained by 
an accumulation of partially degraded collagen within the matrix. GuHCl extraction is not 
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able to remove the partially cleaved collagen resulting in a decline in ICTP levels whereas 
trypsin digestion releases the partially cleaved collagen which has accumulated with 
increasing age in the SDFT. The C1,2C levels measured in this chapter may be an 
underestimation as other enzymes present in the matrix would tend to digest the newly 
exposed neoepitope. Partially degraded collagen that remains in the matrix would still be 
subjected to age related changes such as glycation and aspartate racemization hence an 
increased collagen half-life is apparent. 
6.4.4. Effects of Accumulation of Partially Degraded Collagen within Tendon 
Matrix 
This accumulation of collagen fragments within tendon matrix is likely to be due to 
increased resistance to degradation as a result of modifications that occur to the 
extracellular matrix with age. Glycation results in the formation of AGEs between the 
collagen molecules, which causes an increase in the stiffness and strength of the matrix in 
artificially glycated tendons in vitro (Reddy et al., 2002; Reddy 2004) and also as a result 
of ageing or diabetes in vivo (Avery and Bailey 2005; Monnier et al., 2008). Enzymatically 
derived crosslinks are only able to form at the telopeptide regions of the collagen 
molecules, whereas glycation can occur throughout the triple helical region (Avery and 
Bailey 2005). This has important implications for collagen degradation as collagen 
molecules may be partially degraded by collagenases but the ¾ and ¼ fragments may 
remain cross-linked into the matrix (Figure 6-15) and so may be more resistant to 
degradation by other degradative enzymes present within tendon.  
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 Figure 6-15: Accumulation of partially degraded collagen within a collagen fibril as a result of non-
enzymatic glycation. Lysyl oxidase mediated crosslinks are represented by black lines; glycated crosslinks are 
represented by red lines; black arrows represent the site of collagenase cleavage. Adapted from Diab et al. 
(1996).  
Increased resistance to degradation with increasing age is not unexpected. There is 
considerable experimental evidence to support decreased digestibility of collagen with 
increasing age, the fraction of collagen than could be extracted from skin samples by pepsin 
digestion decreased as a function of age (Schnider and Kohn 1981), indicating an increased 
resistance to degradation with increasing subject age. Furthermore, glycated type II 
collagen shows greater resistance to degradation by collagenases in vitro than non-glycated 
collagen (DeGroot et al., 2001; Verzijl et al., 2000a). Formation of AGEs within tendon 
has also been shown to affect the molecular stability of collagen in response to tensile 
overload; immature bovine tail tendon showed a significant decrease in collagen thermal 
stability when overloaded, whereas the decrease in thermal stability in older bovine tail 
tendon, which contained a greater concentration of crosslinks, was reduced (Willett et al., 
2010). It has been proposed that the decrease in thermal stability in response to overloading 
occurs as a result of disruption of the structure of the collagen fibrils, such that there is an 
increase in the conformational freedom of the collagen molecules, increasing the potential 
for proteolysis (Willett et al., 2008). This would suggest that collagen within the high strain 
SDFT would be more susceptible to degradation than the low strain CDET. However, the 
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data presented here indicates the collagenous matrix in the SDFT is more resistant to 
degradation than that in the CDET. The longer half-life of collagen molecules within the 
SDFT identified in chapter 4 means that there is a greater potential for AGE formation in 
this tendon. Increased levels of crosslinking in glycated collagen would mean that 
overloading would result in maintenance of collagen structure, such that there would be 
minimal increases in the potential for proteolysis. The data presented in this chapter show 
that increased pentosidine levels are correlated with decreased extractability of ICTP and 
increased C1,2C levels within the matrix of the SDFT, suggesting levels of this AGE 
contribute to the accumulation of partially degraded collagen in high strain energy storing 
tendons. Interestingly, pentosidine showed no correlation with the markers of collagen 
degradation in the CDET, suggesting glycation does not affect the resistance of the matrix 
to degradation in this tendon.  
6.5. Conclusions 
 Collagen synthesis at the level of translation is lower in the high strain energy storing 
SDFT than in the low strain positional CDET.  
 Matrix collagen degrading enzymes are functional within both tendons but the higher 
levels in the CDET result in an overall greater rate of collagen degradation in this 
tendon.  
 Accumulation of markers of collagen degradation within the SDFT matrix suggests 
that the collagenous matrix becomes more resistant to degradation with increasing age, 
leading to a reduced rate of repair.  
 This increased resistance to complete degradation is likely to be related to the increase 
in age related matrix modifications including the formation of AGEs in aged tendon, 
which results in the accumulation of partially degraded collagen within the matrix.  
 Accumulation of partially degraded collagen within the SDFT matrix could have a 
deleterious effect on tendon mechanical properties, decreasing the ability of the tendon 
to resist force and therefore resulting in an increased risk of tendon injury in aged 
individuals. 
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7. Tendon Cell Phenotype is Altered by Cell Environment 
7.1 Introduction 
The data presented in the previous chapters of this thesis show that there is a difference in 
cell phenotype between the functionally distinct superficial digital flexor tendon (SDFT) 
and common digital extensor tendon (CDET). This difference is most apparent in the 
expression of genes that code for collagen type I and decorin; cells in the low strain 
positional CDET express higher levels of the Col1A2 gene whereas those in the high strain 
energy storing SDFT express more mRNA for decorin. Correspondingly, the ratio of 
collagen type I to decorin expression is approximately four times greater in cells from the 
CDET than those from the SDFT and therefore this ratio is a potential marker that could be 
used to differentiate between cells from functionally distinct tendons. There is also a 
difference in the potential of the cells to degrade tendon matrix; SDFT tenocytes produce 
more message for enzymes able to degrade the non-collagenous matrix (MMP-3) whereas 
cells in the CDET express higher levels of collagenases (MMP-13). This difference in 
matrix synthesis and degradation is maintained at the protein level; collagenous proteins 
have a greater half life in the SDFT (see chapter 4). In contrast, turnover of the non-
collagenous matrix occurs at a more rapid rate in the SDFT than in the CDET, based on 
estimates of non-collagenous protein half life. Due to their distinct functions, the SDFT and 
CDET experience different amounts and rates of deformation; strains of up to 16% have 
been recorded in the energy storing SDFT (Stephens et al., 1989), whereas maximum strain 
in the positional CDET has been estimated as 2.5% (Birch et al., 2008b). Therefore, cells in 
the SDFT are likely to experience greater strain than those in the CDET. 
Previous work has identified differences in matrix composition and turnover both between 
different tendons and within regions of tendon that undergo different loading conditions. It 
has been reported that levels of matrix degrading enzymes are greater in the injury prone 
supraspinatus tendon than in the biceps brachii tendon, which is injured rarely (Riley et al., 
2002). Studies have also shown that there are significant differences in matrix composition 
between regions of tendon that experience tensile loading and areas that are placed under 
compressive load (Lin et al., 2005b; Rees et al., 2000). These studies indicate that the 
mechanical environment the cells experience may be an important determinant of cell 
phenotype.  
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However, it has not been established if the difference in phenotype between cells from 
functionally distinct tendons is due to the different levels and rates of strain that the cells 
experience in vivo or if it is pre-set during tendon development. Studies have shown that 
mature tenocytes are able to respond to application of mechanical load, both in vivo and in 
vitro (Archambault et al., 2002; Banes et al., 1999a; Langberg et al., 2001; Miller et al., 
2005). It is therefore more likely that the distinct phenotype exhibited by cells from 
functionally distinct tendons is due to the different strains the resident tenocytes experience 
during normal function in vivo rather than being in-built. Cell phenotype in functionally 
distinct tendons can be investigated first by exposing tenocytes from the SDFT and CDET 
to the same conditions and second by exposing tenocytes to strains they would not 
experience in vivo and measuring alterations in gene expression. 
Although the SDFT experiences strains approximately six times greater than those 
experienced by the CDET (16% compared to 2.5%), it cannot be assumed that the tenocytes 
in the SDFT are deformed six times more than the cells in the CDET. Tendon response to 
strain is dependent on cell matrix interactions (Ingber 1997) and the material properties of 
the tendon (Cheng and Screen 2007). Strain distribution within tendon is heterogeneous and 
complex; at high strains the majority of cells within a tendon will experience strains that are 
much lower than the strain experienced by the tendon as a whole. Studies have shown that 
when a strain of 8% is applied to tendon fascicles the strain experienced by the resident 
tenocytes rarely exceeds 2% (Screen et al., 2003; Screen et al., 2004). However, finite 
element analysis suggests that there are areas of stress concentration within tendon; 
tenocytes residing within these areas may experience higher strains, approaching, and even 
possibly exceeding, those experienced by the whole tendon (Screen and Evans 2009). 
Furthermore, there is also evidence to suggest that during loading tenocytes experience 
high compressive strains due to the exudation of water from within the fascicles (Cheng 
and Screen 2007). 
The majority of studies that have investigated the effect of applied mechanical strain on 
tenocyte phenotype in vitro have placed cells in an environment very different to that which 
they experience in vivo, both in terms of the mechanical and physiochemical environments. 
This may have a significant effect on cell activity; it has been shown that tendon cell 
phenotype in culture is not stable but changes with increasing passage number (Yao et al., 
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2006). Therefore results should be interpreted with caution when attempting to predict the 
effect of strain on tenocyte phenotype in vivo. Loading tenocytes within their normal matrix 
allows maintenance of cell matrix interactions and so is more representative of the 
conditions the cells will experience when exposed to load in vivo. However, whole tendons 
are large structures which cannot be maintained in culture conditions without loss of cell 
viability therefore most studies investigate the effect of load on tendon cell phenotype by 
dissecting fascicles from the tendon and exposing them to load in vitro (Maeda et al., 2009; 
Maeda et al., 2007). This involves cutting the tendon, a process which will affect the 
hierarchical structure of the tendon and therefore alter the manner in which strain is 
transferred throughout the fascicle. Further, making an incision into healthy tendon may 
induce a damage response. The medial accessory extensor tendon (MAET) is situated on 
the medial border of the CDET and has a much smaller cross sectional area compared to the 
SDFT and CDET. Furthermore, it is possible to dissect this tendon free from the border of 
the CDET without damaging its structure, making it ideal for use as scaffold for the 
application of mechanical load to tenocytes. No previous studies have used the MAET to 
expose tenocytes to strain and no studies have investigated the properties of this tendon and 
compared these to the SDFT or CDET.  
7.1.1. Aims and Hypothesis 
The aims of this chapter were firstly to determine if removing SDFT and CDET tenocytes 
from their in vivo environment and culturing these cells in the same environment would 
result in a loss of their distinct phenotypes. Tendon cell phenotype was assessed by 
measuring the expression of key matrix proteins and degradative enzymes in 2D monolayer 
culture and compared to the in vivo data presented in chapter 5. The second aim was to 
determine if tendon specific phenotype could be restored by culturing cells in an 
environment more similar to native tendon tissue. This was achieved by seeding cells in 3D 
collagen gels and assessing levels of gene expression. The final aim was to subject cells to 
an unfamiliar strain environment and determine if their phenotype is altered. The MAET 
was subjected to high and low levels of strain and differences in gene expression were 
assessed. It was hypothesised that tendon specific phenotype is due to the different in vivo 
cell environment and therefore culturing cells in monolayer in the absence of mechanical 
load would result in significant alterations in cell phenotype and differences between SDFT 
and CDET tenocytes would be lost. Culture of cells in collagen gels was hypothesised to 
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result in a phenotype more similar to that seen in native tendon tissue. In contrast, explant 
culture of the MAET would allow maintenance of tendon phenotype and application of 
high mechanical load would result in up-regulation of genes associated with SDFT tenocyte 
phenotype. Specifically, high strain levels were hypothesised to result in a significant 
decrease in the ratio of type I collagen to decorin expression. 
7.2 Materials and methods 
7.2.1. Cell culture 
The SDFT and CDET were collected from 5 horses aged six to ten years euthanased for 
reasons other than tendon injury at a commercial equine abattoir. Cells were extracted from 
the tendon tissue on the same day as euthanasia as described by Birch et al. (1997a). A 
section of tendon (approximately 1 cm length) was removed from the mid-metacarpal 
region of the tendon and washed in sterile PBS (x3). The tissue was then rinsed in sterile 
PBS plus antibiotics (100 µg/ml streptomycin and 200 U/ml penicillin) and fungizone (5 
µg/ml amphotericin). The outer tissue was trimmed away and the remaining tissue 
transferred to a clean tube. The tissue was washed 3 times in sterile PBS plus antibiotics 
and fungizone. The tissue was then transferred to a clean tube in sterile PBS plus antibiotics 
and fungizone and into the laminar flow cabinet. Samples of tendon tissue (approximately 1 
mm
3) were placed in Petri dishes and covered with a sterile glass coverslip. Dulbecco’s 
modified Eagle’s medium (DMEM; Gibco, Invitrogen Corporation, Paisley, UK) 
supplemented with 10% foetal calf serum (FCS; Invitrogen Corporation) plus antibiotics 
(streptomycin (100 µg/ml) and penicillin (200 U/ml)) and fungizone (amphotericin (5 
µg/ml)) was added to each Petri dish, which were then incubated in a humidified incubator 
at 37 ºC with 5% CO2. Once the cells had emerged from the tissue and reached confluence, 
the medium and tissue were removed and cells were released with 0.05% trypsin in sterile 
phosphate buffered saline (PBS) with 0.02% EDTA and 0.01% Phenol Red. Cells were 
transferred to 25 cm
2
 tissue culture flasks and cultured in DMEM (5 ml) with 10% FCS 
plus antibiotics (as above). Cells at passage 2 were frozen in vials of 0.5 x 10
6
 cells in 0.5 
ml 90% FCS plus 10% dimethyl sulphoxide (DMSO) and stored at -196 ºC in liquid 
nitrogen. 
When required, vials of cells were thawed and cultured in DMEM supplemented with 10% 
FCS and antibiotics (as above) in 25 cm
2
 tissue culture flasks. Media was changed after 24 
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hours to remove DMSO. Cells were grown to confluence before passaging; flasks were 
washed with sterile PBS and cells were released with 0.05% trypsin in sterile PBS with 
0.02% EDTA and 0.01% Phenol Red and transferred to 75 cm
2
 tissue culture flasks where 
they were re-suspended in DMEM supplemented with 10% FCS and antibiotics (15 ml). 
When the cells reached confluence at passage 4 they were released from the flasks with 
trypsin solution and an equal amount of media was added. The cell suspension was 
centrifuged (1000 g, 5 min.) and the resulting pellet was re-suspended in 1 ml media. An 
aliquot (20 µl) was removed and mixed with an equal amount of trypan blue for a live/dead 
stain. Cell number was determined using a cytometer. Cell viability was in excess of 90%. 
Flasks contained an average of 1.01x10
6
 (±1.41x10
4
) cells. Cells were re-pelleted by 
centrifugation and re-suspended in media to give a concentration of 5x10
6
 cells per ml 
DMEM. 
7.2.2. 2D and 3D Cell Culture 
Collagen gels were set containing 5x10
5
 cells in a 1 ml gel (Eastwood et al., 1994). A 
solution was made up containing 0.8 ml rat tail tendon collagen in 0.1 M acetic acid (First 
Link, West Midlands, UK)  and 0.1 ml 10x minimum essential medium (Gibco). This was 
neutralised by the addition of sterile filtered 5 M NaOH, using the colour change from 
yellow to cirrus pink as an indication the correct pH had been reached (Cheema et al., 
2003). Cell suspension (0.1 ml containing 5x10
5
 cells) was added to the neutralised 
collagen solution and this was allowed to gel in a 12 well plate for 30 minutes at 37 ºC. 4 
ml DMEM supplemented with 10% FCS was then added to cover each gel. Cells from the 
same passage were seeded in 25 cm
2
 tissue culture flasks at a density of 5x10
5
 cells per 
flask (monolayer) in 5 ml DMEM plus 10 % FCS. Cells in monolayer and in collagen gels 
were allowed to stabilise for 48 hours before the media was changed to DMEM 
supplemented with 1% FCS, antibiotics and ascorbic acid (50 µg/ml). Monolayers and gels 
were incubated for 24 hours before Tri Reagent solution was added to release the cells from 
the tissue culture flasks and lyse the gels. The media was removed from the gels and 
monolayers and Tri reagent was added directly to the tissue culture flasks (1 ml Tri reagent 
per 10 cm
2
 surface area); the cell lysate was passed through a pipette several times to 
homogenise the sample. Gels were blotted on tissue paper and placed in Tri Reagent (2.5 
ml per gel); the gels were passed through a pipette several times to homogenise the 
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collagen gel. Samples were left to stand at room temperature for at least 5 minutes before 
being frozen at -80 ºC. 
7.2.3. Loading Experiments 
7.2.3.1 Harvesting of the MAET 
The CDET and surrounding tissue were harvested from 12 horses euthanased for reasons 
other than tendon injury at a commercial equine abattoir. Forelimbs were collected on three 
separate occasions in order that the loading experiments could be carried out on the same 
day as harvesting. The MAET was dissected free from the medial border of the CDET 
(Figure 7-1). MAETs were excluded if they were either too thick or thin, or were fused to 
the CDET at the medial edge. The MAETs were washed (see below) and placed into 
culture or RNAlater on the same day as euthanasia.   
 
Figure 7-1: Location of the medial accessory extensor tendon (MAET). A: Proximal end of the CDET 
showing location of MAET on the medial border of the tendon. B: The MAET has been dissected free of the 
CDET proper. 
7.2.3.2 Molecular Composition and Histological Parameters of the MAET 
Preliminary work was undertaken to assess the molecular composition and histological 
parameters of the MAET along the length of the tendon and these data were compared with 
the CDET proper. The MAET appeared similar to the CDET in structure, consisting of 
longitudinal bundles of collagen fibres with elongated cells situated between the fibres 
(Figure 7-2). The collagen, DNA and GAG content of the MAET did not differ along the 
length of the tendon and was not significantly different from the CDET (Birch H.L., 
unpublished data). 
A 
B 
CDET 
Medial accessory extensor 
tendon 
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Figure 7-2: Longitudinal haemotoxylin and eosin stained section of CDET (A) and MAET (B). 
7.2.3.3 Loading Protocol 
The MAETs were divided into three sections approximately 65 mm in length. One tendon 
section from four horses was immediately placed in RNAlater in order to compare gene 
expression with the CDET and SDFT. The remaining strips were washed in three times in 
sterile PBS with antibiotics (streptomycin (100 µg/ml) and penicillin (200 U/ml)) and 
fungizone (amphotericin (5 µg/ml)). Strips of tendon were clamped into the custom made 
loading cassette (Figure 7-3) (Dudhia et al., 2007) and each strip was bathed in 2 ml 
DMEM supplemented with 1% FCS, antibiotics, fungizone and ascorbic acid as above.  
 
Figure 7-3: Cassette with four separate chambers for strain application to tendon strips. Each tendon strip was 
held in place by a clamp at each end (A). The top block of the cassette was bolted securely onto the base 
block. Medium was applied via the tubing on access ports over each chamber (B). UCP; upper clamp plate. 
The strips of MAET were divided into three experimental groups; unloaded, low strain 
(2%) and high strain (12%). Tendon strips in the unloaded group were clamped into the 
chambers in the loading cassette but were not loaded during the culture period. The strips in 
the low strain group were clamped into the cassette which was placed in the modified 
servohydraulic materials testing device (Figure 7-4) (Zwick-Roell GmbH & Co, Ulm, 
A B Side Bar 
Mounting 
Hole 
UCP 
A B 
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Germany) and were conditioned under cyclical strain of 2% at a frequency of 1 Hz for 20 
hours. Tendons in the high strain group were exposed to cyclical strain of 12% at a 
frequency of 1 Hz for 20 hours. For each strip in the experimental groups, a section from 
the same MAET was maintained in normal tissue culture conditions for the same time 
period to act as a paired control. 
 
Figure 7-4: The loading cassette was placed onto the hydraulic ram via the mounting holes. Once the cassette 
was in place the side bars were removed, which allowed the upper clamp plate to slide relative to the lower 
body when strain was applied. The top end of each chamber was open to the humidified atmosphere of the 
incubator.  
After the loading protocol was completed strips were removed from the loading cassette 
and the middle 2 cm section of each strip was placed in RNAlater. Samples were stored at 4 
ºC for 24 hours before being stored at -20 ºC. MAET strips were then flash frozen in liquid 
nitrogen, reduced to a fine powder by the use of a dismembrator (2500 rpm, 2 min., 
Sartorius, Germany) and placed in Tri reagent solution (approx 100 mg/ml), which was 
stored at -80 ºC until required. 
7.2.4. Assessment of Cell Phenotype 
Messenger RNA was extracted from the samples stored in Tri reagent solution; mRNA 
from 2D and 3D culture experiments was extracted by the use of Qiagen RNeasy kits with 
an additional on-column DNA digestion step as described in chapter 5. An isopropanol 
precipitation was used to extract mRNA from the mechanically loaded MAET strips; 
198 
 
sample supernatants were mixed with choloroform (200 µl), vortex mixed and allowed to 
stand at room temperature for 10 minutes before being centrifuged (16 000 g, 4 ºC, 15 
min.). The upper aqueous layer containing the mRNA was removed to a clean tube and an 
equal volume of isopropanol was added. Samples were incubated at room temperature for 5 
min. and centrifuged for 10 min. (16 000 g, 4 ºC). The isopropanol was poured off and the 
tubes were inverted to allow the RNA-containing pellet to dry. The pellet was washed in 
70% ethanol (1 ml, made up in 0.1% DEPC water) and centrifuged for 5 min. (16 000 g, 4 
ºC). Tubes were inverted and allowed to dry completely. The mRNA was reconstituted in 
25 µl 0.1% DEPC water. RNA concentration was determined using a NanoDrop 
spectrophotometer and up to 1 ng RNA was reverse transcribed to cDNA using M-MLV 
reverse transcriptase and random primers according to the manufacturer’s instructions 
(Promega). Samples were stored at -20 ºC prior to quantification of gene expression. The 
expression of Col1A2, decorin, MMP-3, MMP-13, scleraxis, tenascin-C and tenomodulin 
was assessed using real time PCR assays in a 96 well plate format, with 5 µl cDNA (diluted 
1 in 9), 12.5 µl SYBR green master mix (Applied Biosystems), 2.5 µl forward and reverse 
primers (3 µM) and 5 µl d H2O per well. The cycling conditions were 10 min. polymerase 
activation at 95 ºC followed by 40 cycles at 95 ºC for 15 sec. and 60 ºC for 60 sec. A 
dissociation step was then performed to check primer specificity. Primer sequences are the 
same as used in chapter 5, with the addition of tenomodulin: forward primer- 
5’ACGTGACCATGTATTGGATCAATC3’; reverse primer- 
3’CACCATCCTCCTCAAAGTCTTGT5’ (Taylor et al., 2009). Tenomodulin expression 
was expected to be low in the cultured cells, so more concentrated cDNA (diluted 1 in 2 
rather than 1 in 9) was used to measure tenomodulin expression by cultured cells. Gene 
expression data were expressed relative to MRPS7 and HIRP5 expression levels, which 
were identified as the most stably expressed genes in equine tendon (see Chapter 5). Data 
were analysed using Sequence Detection Systems Software v2.1 (Applied Biosystems, 
Warrington, UK.). 
7.2.5. Statistical Analysis 
None of the gene expression data were normally distributed when analysed using the 
Kolmongorov-Smirnoff test for normality (Minitab, Version 15) and therefore data were 
analysed using non-parametric tests in SPlus. The effect of cell culture on gene expression 
was determined using Kruskal-Wallace rank sum tests; if the results of this were significant 
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post-hoc analysis was carried out using an exact Wilcoxon rank-sum test. To determine the 
effect of culture on gene expression in the MAET linear mixed effects analysis was used, 
with horse as a grouping factor. All data are displayed as mean ± SEM.   
7.3 Results 
7.3.1. Gene Expression in 2D and 3D Cell Culture 
Average gene expression normalised to MRPS7 and HIRP5 is shown in Table 7-1. For 
comparison, the in vivo data reported in chapter 5 are displayed on the expression graphs 
for each gene. Expression of Col1A2 did not differ between tenocytes from the SDFT and 
CDET in 2D or 3D culture (Figure 7-5).  Compared to in vivo data, Col1A2 expression was 
increased by tenocytes cultured in monolayer (p≤0.003). Culturing cells in 3D gels did not 
result in a significant change in Col1A2 expression when compared to 2D culture, although 
there was a trend towards decreased expression in both cell types; SDFT tenocytes cultured 
in collagen gels showed significantly higher levels of Col1A2 compared to in vivo data 
(p<0.0001), whereas CDET tenocytes cultured in 3D expressed similar levels of Col1A2 
when compared to in vivo results (p=0.3) (Figure 7-5). 
 
Figure 7-5: Col1A2 expression (mean ± SEM) in vivo (n = 32), in monolayer culture and in 3D collagen gels 
(n = 5) in tenocytes from the SDFT and CDET. * indicates significant difference relative to the SDFT. 
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 Gene Expression (mean ± SEM) 
Gene SDFT CDET 
In vivo Monolayer 3D Gel In vivo Monolayer 3D Gel 
Col1A2 34.93±7.23 258.76±39.32* 104.19±20.34λ 78.46±13.83β 303.57±83.12* 121.77±58.81 
Decorin 1343.42±302.85 21.16±5.23* 38.92±10.47λ 483.48±53.23β 24.83±9.66* 31.65±11.42λ 
MMP-13 0.16±0.12 0.33±0.12 10.36±5.15λα 0.72±0.13β 4.42±1.69* 91.55±55.70λα 
MMP-3 3.52±0.83 4.52x10-3±1.73x10-3* 12.23x10-3±4.39x10-3λ 1.39±0.30β 24.36x10-3±13.86x10-3 36.78x10-3±15.8x10-3λ 
Scleraxis 3.79±0.99 0.40±0.15 0.34±0.14 1.48±0.22β 0.33±0.09 0.47±0.16 
Tenascin 1.86±0.49 6.60±2.21* 2.10±0.46α 1.24±0.28 19.94±7.94* 4.44±1.09 
Tenomodulin - 9.72x10-5±2.06x10-5 24.9x10-5±9.74x10-5 - 1.79x10-3±1.51x10-3 29.08x10-5±9.37x10-5 
Col1A2:DCN 0.047±0.01 14.21±2.4* 3.61±1.29λα 0.18±0.016β 32.30±23.23* 4.19±0.72λα 
 
Table 7-1: Gene expression levels by tenocytes from SDFT and CDET in vivo (n = 32), and in 2D (monolayer) (n = 5) and 3D (collagen gel) (n = 5) culture systems. * 
indicates significant difference between in vivo expression levels and monolayer; 
λ
 indicates significant difference between in vivo data and 3D gels; 
α
 indicates 
significant difference between gene expression in monolayer and gels; 
β
 indicates significant difference between SDFT and CDET gene expression in vivo. 
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There was no difference in expression of decorin between cell types, either when cultured 
in 2D or 3D (Figure 7-6). Decorin synthesis was significantly down-regulated by both cell 
types when cultured in monolayer (p<0.0001). There was a trend towards increased decorin 
expression when cells were cultured in 3D gels compared to monolayer culture but this was 
not significant; expression of decorin was significantly lower in SDFT and CDET tenocytes 
cultured in 3D than expression levels measured in vivo (p≤0.0003) (Figure 7-6). 
 
Figure 7-6: Decorin expression (mean ± SEM) in vivo (n = 32), in monolayer culture and in 3D collagen gels 
(n = 5) in  SDFT and CDET tenocytes. * indicates significant difference between the SDFT and CDET. Data 
are plotted on a Log10 scale. 
Expression of MMP-13 did not differ between SDFT and CDET tenocytes, either in 2D or 
3D culture, although there was a trend towards increased MMP-13 expression in cells from 
the CDET in 3D culture (p=0.06). Expression of MMP-13 was increased in cells from the 
SDFT and CDET cultured in monolayer compared to in vivo data (p=0.005) (Figure 7-7). 
Culture of cells in 3D gels caused an upregulation of MMP-13 production in both tendons 
compared to in vivo data and when compared to 2D culture (p≤0.016) (Figure 7-7).  
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Figure 7-7: MMP-13 gene expression (mean ± SEM) in vivo (n = 32), in monolayer culture and in 3D 
collagen gels (n = 5) in tenocytes from the SDFT and CDET. * indicates significant difference between the 
SDFT and CDET. Data are displayed on a Log10 scale. 
There was no difference in MMP-3 expression between cell types when cultured in either 
monolayer or gel (Figure 7-8). Expression of MMP-3 decreased significantly in SDFT 
tenocytes cultured in monolayer compared to in vivo data (p=0.001) but was not altered in 
CDET tenocytes. Culturing cells in 3D resulted in a trend towards increased MMP-3 
expression compared to expression levels in monolayer, but this was not significant (Figure 
7-8); cells expressed lower levels of MMP-3 in 3D culture than in vivo (p=0.02).  
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Figure 7-8: Expression of MMP-3 (mean ± SEM) in vivo (n = 32), in monolayer culture and in 3D collagen 
gels (n = 5) in tenocytes from the SDFT and CDET. * indicates significant difference between the SDFT and 
CDET. Data are plotted on a Log10 scale. 
There was no difference in the amount of scleraxis expressed by cells from the SDFT or 
CDET in 2D or 3D culture. Scleraxis expression was significantly down-regulated when 
cells were cultured in 2D (p≤0.04) or 3D (p≤0.04) when compared to in vivo data (Figure 
7-9), and values were not significantly different between the different culture conditions 
(Figure 7-9).  
 
Figure 7-9: Scleraxis expression (mean ± SEM) in vivo (n = 32), in monolayer culture and in 3D collagen 
gels (n = 5) in tenocytes from the SDFT and CDET. * indicates significant difference between the SDFT and 
CDET. 
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Tenascin-C expression was not significantly different between cell types in either culture 
system (Figure 7-10). Tenascin-C expression was increased when cells were cultured in 
monolayer compared to the in vivo data (p≤0.02) (Figure 7-10). 3D culture resulted in a 
decrease in expression compared to 2D culture, although this was only significant in cells 
from the SDFT (p=0.008).  
 
Figure 7-10: Tenascin-C expression (mean ± SEM) in vivo (n = 32), in monolayer culture and in 3D collagen 
gels (n = 5) in tenocytes from the SDFT and CDET. 
Tenomodulin expression was very low in cultured cells, and was undetectable in some 
samples. There was no difference in tenomodulin expression in cells from the SDFT or 
CDET, and no difference in expression levels between 2D and 3D culture systems (Figure 
7-11). 
 
Figure 7-11: Tenomodulin expression (mean ± SEM) in tenocytes from the SDFT and CDET (n = 5) cultured 
in 2D and 3D culture systems. 
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There was no significant difference in the ratio of Col1A2 to decorin expressed by cells 
from the SDFT and CDET in either culture system (Figure 7-12). The ratio of Col1A2 to 
decorin expression was significantly greater in 2D culture than in vivo (p<0.0001) (Figure 
7-12). Culturing cells in 3D resulted in a decrease in the ratio when compared to 2D culture 
(p≤0.02) but levels were still significantly increased when compared to in vivo data 
(p≤0.0001).  
 
Figure 7-12: Ratio of Col1A2 to decorin expression (mean ± SEM) in vivo (n = 32), in monolayer culture and 
in 3D collagen gels (n = 5) in cells from the SDFT and CDET. * Indicates significant difference relative to the 
SDFT. Data are displayed on a Log10 scale. 
7.3.2. Comparison of MAET, SDFT and CDET Gene Expression 
As expected, gene expression was comparable between the MAET and CDET, with similar 
expression of Col1A2, decorin, MMP-13, resulting in a similar Col1A2 to decorin ratio in 
these tendons (Figure 7-13). However, the expression of MMP-3 was significantly greater 
in the MAET than in the CDET (p=0.01) as was the expression of tenascin-C (p=0.004), 
whereas expression of scleraxis was significantly lower in the MAET than in the CDET 
(p=0.007) (Figure 7-14). When gene expression data from the MAET were compared to the 
gene expression data from the SDFT (presented in chapter 5), it was found that there was 
no significant difference in the expression of Col1A2, decorin or MMP-3 between these 
tendons, although there was a trend towards increased Col1A2 expression (p=0.07) and 
decreased decorin expression (p=0.05) in the MAET compared to the SDFT (Figure 7-13). 
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Correspondingly, the ratio of Col1A2 to decorin expression was significantly greater in the 
MAET compared to the SDFT (p=0.002). Expression of MMP-13 (p=0.001) and tenascin 
(p=0.009) was significantly greater in the MAET than in the SDFT, whereas scleraxis 
expression was significantly lower (p=0.0001) (Figure 7-14). 
  
Figure 7-13: Expression (mean ± SEM) of Col1A2 and decorin (A – data displayed on Log10 scale) and ratio 
of Col1A2 to decorin expression (B) in the SDFT (n = 32), CDET (n = 32) and MAET (n = 4). * Indicates 
significant difference between SDFT and MAET. 
 
Figure 7-14: Expression (mean ± SEM) of MMP-3, MMP-13, scleraxis and tenascin in the SDFT (n = 32), 
CDET (n = 32) and MAET (n = 4). * Indicates significant difference between SDFT and MAET; 
α
 Indicates 
significant difference between CDET and MAET. 
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7.3.3. Effect of Culture on Gene Expression in the MAET 
Maintaining MAETs in organ culture for 24 hours did not result in significant alterations in 
gene expression, with statistically similar expression of Col1A2, decorin, MMP-3 and -13, 
scleraxis, tenascin and tenomodulin between cultured tendons and in vivo data. There was, 
however, a trend towards decreased decorin gene expression in cultured tendons (p=0.06) 
(Figure 7-15). 
 
Figure 7-15: Expression (mean ± SEM) of genes coding for matrix proteins and degradative enzymes in 
native MAET tissue and after a 24 hour culture period under normal tissue culture conditions and when 
clamped into the loading cassette (n = 4). Data are displayed on a Log10 scale. * Indicates significant 
difference between normal culture conditions and clamping. 
7.3.4. Effect of Clamping the MAET into the Loading Cassette 
Clamping the MAET into the chambers of the loading cassette and culturing for a period of 
24 hours in the absence of load did not result in significant alterations in cell phenotype 
(Figure 7-15). There was no significant difference in expression of Col1A2, decorin, MMP-
3, MMP-13, scleraxis and tenascin-C between MAETs cultured for 24 hours in a 6 well 
plate and those clamped into the chambers and incubated within the loading cassette in the 
absence of load. Correspondingly, there was no difference in the ratio of Col1A2 to decorin 
expression between groups. The only gene that was affected by clamping was tenomodulin, 
which was significantly up-regulated in MAETs clamped into the loading cassette (p=0.04).   
7.3.5. Effect of Cyclical Strain on Gene Expression 
There was no difference between the gene expression in the low strain and high strain 
groups and so the data from these groups were combined to determine if there was a 
general loading effect. Cyclical loading did not result in significant alterations in gene 
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expression compared to unloaded controls; there was no difference in the expression of 
genes coding for matrix structural proteins Col1A2 and decorin, or corresponding 
degradative enzymes MMP-3 and -13 between groups (Figure 7-16). Cyclic loading also 
did not affect the ratio of Col1A2 to decorin expression. Scleraxis expression was 
significantly up-regulated in loaded samples compared to controls (p=0.002), whereas 
expression of tenascin-C and tenomodulin was not significantly affected by the loading 
protocol (Figure 7-17). 
 
Figure 7-16: Expression of key matrix proteins and degradative enzymes did not differ between strained and 
unstrained groups (mean ± SEM) n = 4. Data are plotted on a Log10 scale. 
 
Figure 7-17: A – Scleraxis expression in loaded and unloaded MAETs. B – Tenascin-C and tenomodulin 
expression in loaded and unloaded MAETs (mean ± SEM) n = 4. * Indicates significant difference relative to 
the unstrained control. 
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7.3.6. Effect of Acidosis on Gene Expression 
Due to problems with the CO2 supply to the incubator during the low strain loading cycle, 
both the unloaded and loaded samples were exposed to high levels of CO2 for the duration 
of this experiment. Comparing the unloaded controls in the low strain group with those in 
the high strain group therefore allows the effect of acidosis on gene expression to be 
determined. High CO2 levels were found to significantly up-regulate decorin expression 
(p=0.04) and there was also a trend towards increased MMP-3 expression in tendons 
exposed to a high concentration of CO2 (p=0.06) (Figure 7-18). Acidosis did not have a 
significant effect on the expression of Col1A2, MMP-13, scleraxis, tenascin or 
tenomodulin. There was also no difference in the ratio of type I collagen to decorin 
expression. 
 
Figure 7-18: Expression levels of decorin and MMP-3 in MAETs exposed to normal carbon dioxide levels 
and high carbon dioxide levels (mean ± SEM) n = 4. * Indicates significant difference relative to normal CO2 
levels. 
7.4 Discussion 
The results of this chapter show that culture of tenocytes from the SDFT and CDET in 
monolayer caused the cells from these functionally distinct tendons to lose the phenotypic 
differences identified in chapter 5, and these differences were not restored when cells were 
cultured in 3D collagen gels. In contrast, organ culture of the MAET resulted in 
maintenance of cell phenotype and application of high strains to the MAET did not result in 
significant alterations in cell phenotype as assessed by measuring gene expression. 
7.4.1. Effect of 2D culture on Tenocyte Phenotype 
In support of the hypothesis, differences in gene expression exhibited by tenocytes from the 
functionally distinct SDFT and CDET in native tendon tissue were lost when cells were 
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removed from their in vivo environment.  It is well established that culture of cells in 
monolayer results in significant alterations in cell phenotype when compared to native 
tissue (Almarza et al., 2008; Darling and Athanasiou 2005; Schwarz et al., 1976; Stoll et 
al., 2010). Tenocytes maintained in 2D culture have been shown to de-differentiate rapidly; 
it has been found that human Achilles tenocytes cultured to passage 8 synthesised 
significantly lower amounts of decorin compared to those at passage 1 and increased the 
ratio of type III to type I collagen synthesis (Yao et al., 2006). This supports the data 
presented in this chapter which identify a greater than 100 fold decrease in decorin 
expression at passage 5 in cells from both the SDFT and CDET. In addition, it has been 
previously shown that culture of immature rabbit Achilles tenocytes resulted in decreased 
decorin expression with increasing passage number (Bernard-Beaubois et al., 1997) and 
cultured human tenocytes up-regulated collagen type I synthesis and down-regulated 
decorin synthesis when compared to native tendon tissue (Almarza et al., 2008; Stoll et al., 
2010). The alterations in expression of matrix proteins identified in this and other studies 
show that monolayer culture causes cells to increase collagen synthesis and decrease 
proteoglycan production, resulting in an increase in the ratio of type I collagen to decorin 
expression and suggesting a loss of tenocyte specific phenotype. However in other studies 
fibroblasts that exhibit a different phenotype in vivo have been shown to maintain these 
differences in monolayer culture. Dermal fibroblasts proliferated more rapidly and 
synthesised lower levels of collagen and GAG than tendon fibroblasts cultured under the 
same conditions (Evans and Trail 1998). 
7.4.2. Effect of 3D Culture on Tenocyte Phenotype 
As hypothesised, culture of SDFT and CDET tenocytes in 3D collagen gels resulted in a 
phenotype more similar to the phenotype seen in native tendon tissue. Previous studies 
have attempted to maintain cell phenotype in vitro either by culturing cells in 3D high 
density cultures or embedding cells within constructs. Culture of tenocytes at high densities 
maintains cell phenotype over a 14 day culture period, with stable expression of type I 
collagen and scleraxis (Schulze-Tanzil et al., 2004). However, this study did not compare 
in vitro cell phenotype with that in native tendon. Comparison of the 3D high density 
culture system and monolayer culture with native tendon tissue found that the high density 
culture system resulted in a phenotype more similar to that expressed in native tendon, 
although there were still significantly lower levels of scleraxis and higher levels of type III 
211 
 
collagen compared to native tendon (Stoll et al., 2010). Embedding tenocytes within 3D 
constructs has also been explored as a method of maintaining tenocyte phenotype in vitro; it 
has been reported that tenocytes seeded in poly[lactic-co-glycolic-acid] matrices exhibit a 
phenotype more similar to native tendon when compared to monolayer and high density 
culture (Stoll et al., 2010). In addition, seeding tenocytes in collagen gels resulted in 
decreased cell proliferation and type I collagen production compared to monolayer cultures 
(Lamberti and Wezeman 2002). Culture of corneal, dermal and tendon fibroblasts in 3D 
collagen gels also resulted in the maintenance of the distinct phenotypes these cell types 
exhibit in vivo (Doane and Birk 1991). These results support those reported in this chapter, 
which suggest that culture of tenocytes in 3D collagen gels results in a phenotype more 
similar to that seen in tendon tissue. However, significant differences were still present in 
the expression levels of decorin, MMP-3, MMP-13 and scleraxis between native tendon 
tissue and in 3D culture, showing that phenotype is not regained in 3D conditions.   
7.4.3. Effect of Culture on Cells from Functionally Distinct Tendons 
In contrast to cell phenotype in native tendon tissue, tenocytes from the SDFT and CDET 
cultured in 2D and 3D systems showed similar levels of expression for all the genes 
assessed. These results are supported by a study that reported that in vitro, human flexor 
and extensor tenocytes had similar morphology and produced similar amounts of protein 
(Evans and Trail 2001). In contrast, it has also been reported that cells from the CDET 
synthesise significantly less collagen (Young et al., 2009b) and collagen degrading 
enzymes than those from the SDFT (Hosaka et al., 2010). However, these experiments 
were performed at either passage 2 or 3; it is possible that phenotypic differences between 
cells from flexor and extensor tendons are present at low passage numbers but are lost after 
further passaging. These studies also obtained cells by out-growing from tendon explants; 
therefore these contrasting findings are probably not as a result of the method used to 
obtain cells. Loss of phenotypic differences between SDFT and CDET tenocytes in vitro 
suggests that the distinct phenotype these cells exhibit in their native tissue is not an 
inherent property of the cells but instead is likely to be due to differences in the mechanical 
and physiochemical environment they experience in vivo. 
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7.4.4. Effect of Culture on Markers of Tenocyte Phenotype 
Scleraxis, tenascin-C and tenomodulin are all potential markers of tendon cell phenotype 
(Taylor et al., 2009). However, none of these genes are expressed exclusively by tenocytes 
and scleraxis is expressed at similar levels in vivo in other connective tissues such as bone 
and muscle (Jelinsky et al., 2010), therefore it is of limited use as a marker of tendon cell 
phenotype. Tenomodulin is expressed in tendon at levels approximately 5-fold greater than 
in other tissues, but expression decreases rapidly in culture; it could not be detected in 
equine SDFT tenocytes at passage 1 or passage 5 (Taylor et al., 2009), and was strongly 
repressed when rat tenocytes were grown in 2D primary culture and in organ culture 
(Jelinsky et al., 2010). This is similar to the low levels of tenomodulin expressed by SDFT 
and CDET tenocytes reported in this chapter. It would be of value to assess tenomodulin 
expression by cells from the SDFT and CDET in native tendon tissue to be able to compare 
this with the in vitro data presented in this thesis. Previous work has found that tenocytes 
from the equine SDFT express relatively high levels of tenomodulin, both in developing 
and mature tendons (Taylor et al., 2009). Tenomodulin is a modulator of tenocyte 
proliferation and fibril formation (Docheva et al., 2005) and so the low levels reported in 
culture may have a detrimental effect on cell activity. Scleraxis expression was 
significantly down-regulated in 2D and 3D culture conditions, scleraxis is a transcription 
factor (Schweitzer et al., 2001) that is able to modulate collagen synthesis (Lejard et al., 
2007); therefore the loss of scleraxis and tenomodulin expression provides further evidence 
to show that cell culture results in a loss of tenocyte phenotype. 
This thesis proposes that the ratio of collagen to decorin expression can be used as a marker 
of phenotype to differentiate between cells from functionally distinct tendons. The data 
presented in chapter 5 identifies a difference in this ratio between the functionally distinct 
SDFT and CDET when in vivo levels were assessed; however, when cells from these 
tendons are placed in culture, they de-differentiate rapidly. In 2D culture, there is an 
increase in synthesis of type I collagen and a decrease in decorin synthesis. When cells are 
placed in 3D constructs, the ratio decreases but still remains significantly greater than it is 
in native tendon tissue. It is not surprising that cell phenotype alters when the cells are 
placed in culture; as they are in an environment very different to that which they would 
experience in vivo. They are no longer embedded within a collagenous matrix and therefore 
there will lack cell matrix interactions, a factor which has been shown to alter gene 
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expression in vitro (Lavagnino and Arnoczky 2005). Cell to cell interactions will also 
differ; in culture cells will be in contact with many more cells than they would be in native 
tendon, which has a relatively low cell density. It has been shown that alterations in cell 
communication pathways results in the perturbation of tenocyte proliferation and collagen 
synthesis (Banes et al., 1999b). Further, culture of cells in the absence of mechanical load 
for a significant period of time may result in programmed cell death (Egerbacher et al., 
2008).  
In addition, the physiological environment is likely to have an important effect on cell 
phenotype; cells are likely to experience different levels of oxygen, temperature and 
nutrients in vitro than in native tendon tissue. In vitro experiments maintain cells at 37 ºC 
with 21% O2 and 5% CO2 and bathe the cells in nutrient rich media, whereas it has been 
shown that in vivo tenocytes, particularly those in the SDFT, are exposed to a wide range of 
temperatures (Wilson and Goodship 1994), and are likely to experience low oxygen levels 
due to poor blood supply (Birch et al., 1997a). It is possible that differences in oxygen 
levels are enough to alter cell phenotype; it has been shown that culture of porcine 
tenocytes in hypoxic conditions enhances proliferation capacity and decreases MMP-1 
expression (Zhang et al., 2010). The poor blood supply may also result in low nutrient 
levels in the core of the tendon, a factor which may also affect cell proliferation and 
collagen synthesis (Schwarz et al., 1976). It has also been shown that culturing SDFT 
explants in growth factor rich media resulted in increased expression of collagen and 
COMP (Schnabel et al., 2007). High density cell culture has been shown to partially 
maintain tenocyte phenotype, possibly as a result of low oxygen levels due to the high cell 
numbers (Schulze-Tanzil et al., 2004; Stoll et al., 2010). In support of this, exposure of the 
MAET to high CO2 levels resulted in increased expression of decorin and a trend towards 
decreased MMP-3 expression, which may result in increased proteoglycan levels within the 
matrix. The increased decorin expression in response to increased CO2 levels suggests that 
low oxygen levels may cause tenocytes to shift towards a phenotype associated with high 
strain energy storing tendons; it is likely that in vivo cells from the SDFT experience lower 
oxygen levels than their counterparts in the CDET as the SDFT has a larger CSA than the 
CDET.  
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7.4.5. Tendon Organ Culture 
Tendon organ culture maintains tenocytes within their extracellular environment, meaning 
that they are less likely to alter their phenotype. In addition, when strain is applied the 
amount of cell deformation that occurs is likely to be similar to that which occurs in vivo 
due to the maintenance of matrix structure. However, it is impossible to maintain whole 
tendons in culture as tendon diameter is too great to allow diffusion of oxygen and nutrients 
to the core, which would result in cell death. For this reason, studies often involve loading 
isolated tendon fascicles, groups of fascicles or explants of tendon tissue (Abreu et al., 
2008; Dudhia et al., 2007; Maeda et al., 2009; Maeda et al., 2007; Screen et al., 2005b). 
However, fascicle removal is technically difficult and risks physically damaging the 
structure or allowing the tissue to dry. Explant culture is analogous to wounding the tendon 
and so the cells may exhibit a damage response and alter their gene expression. Fascicle 
and explant culture potentially result in changes in cell phenotype as a result of removal 
rather than loading conditions. Furthermore, the multi-composite structure of tendon results 
in a heterogeneous distribution of strain throughout the tendon (Screen and Evans 2009), 
meaning that it is very difficult to establish strain levels that are physiologically relevant as 
not all cells within a tendon will experience the same strain. Studies indicate that the 
majority of cells experience deformations lower than the overall strain that is applied to the 
tendon, and strains generally do not exceed 2% (Screen et al., 2003). Studies that have 
exposed tendon fibroblasts to strain of up to 12% in vitro (Wang et al., 2003) may therefore 
be exposing cells to strains that they would never experience in their native environment. 
Loading of the MAET therefore represents a novel method for investigating the effect of 
mechanical load on tenocyte phenotype as the MAET can be isolated without the need for 
longitudinal incisions to be made in the tendon. As expected, cells in the MAET exhibit a 
phenotype that is similar to that seen in the CDET. Further, the ratio of Col1A2 to decorin 
expression is similar in the MAET and CDET, and approximately fourfold greater than that 
in the SDFT. However, expression of scleraxis is lower in the MAET than in the SDFT, 
whereas expression of tenascin-C and MMP-3 is higher. The low levels of scleraxis are not 
surprising as expression of this gene is modulated by loading; the MAET is not likely to 
experience high strains as it is a vestigial tendon. The higher levels of MMP-3 and tenascin-
C suggest that cells in the MAET may be more metabolically active than those in the SDFT 
and CDET. Although previous work has shown that gene expression in tendon mid-
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substance may be affected by clamping the ends of the tendon (Rempel and Asundi 2007), 
culture of the MAET within the loading cassette in the absence of load did not result in 
significant alterations in gene expression when compared to MAETs cultured under normal 
culture conditions. Therefore, MAETs cultured under normal culture conditions were used 
as paired controls for the loading experiments.  
Maintenance of the MAET in culture does not result in the significant alterations in gene 
expression that were identified when culturing SDFT and CDET tenocytes in 2D or 3D. 
Expression of tenascin-C and tenomodulin were not altered in either loaded or unloaded 
MAETs compared to in vivo data; both these genes have been proposed as markers of 
tenocyte phenotype and therefore these results suggest that tenocyte phenotype is 
maintained. In contrast, previous studies have reported that tendon explant culture results in 
alterations in gene expression, including decreased tenomodulin expression (Jelinsky et al., 
2010) and increased MMP-3 and -13 expression (Leigh et al., 2008). These studies used 
tendon fascicles; it is possible the changes in gene expression are as a result of the 
dissection process rather than unloading. However, these studies also used culture periods 
of up to 48 hours; longer periods of loading are likely to result in greater alterations in gene 
expression. The only gene that was affected by the loading protocol applied in this study 
was scleraxis; it is well established that expression of this gene can be modulated by 
mechanical load (Eliasson et al., 2009; Farng et al., 2008; Kuo and Tuan 2008). Scleraxis 
has been shown to up-regulate collagen synthesis (Lejard et al., 2007) and cell proliferation 
(Shukunami et al., 2006), and so it is possible that exposing the MAET to cyclic load for a 
longer period of time would result in increased cell proliferation and collagen synthesis. 
Other studies have reported that relatively short loading periods (10 minutes) result in 
significant alterations in the expression of type III collagen and degradative enzymes 
(MMP-3 and -13) in tendon fascicles (Maeda et al., 2009), whereas loading fascicles for 24 
hours resulted in increased collagen synthesis (Maeda et al., 2007). However, these studies 
used fascicles from rat tail tendons which are not load bearing and therefore only likely to 
experience very low strains, therefore their response to applied load may be different from 
that of the MAET. 
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7.4.6. Effect of Mechanical Load on Cells from Functionally Distinct 
Tendons 
The SDFT and CDET experience different strain levels and rates and so tenocytes from 
these tendons may respond in a different manner to similar levels of mechanical load. One 
of the aims of this work was to determine the if high strains caused cells in the MAET to 
shift towards a phenotype normally associated with cells from the SDFT; however due to 
low sample numbers no difference was apparent and therefore data from the low and high 
strain groups were combined for statistical analysis. Therefore it was only possible to 
determine the effect of strain, rather than different levels of strain on cell phenotype. 
Several studies have investigated the effects of mechanical load on monolayer tenocyte 
cultures. One study reported that tenocytes cultured from the SDFT and CDET respond 
differently to mechanical load; strain caused an increase in collagen oligomeric matrix 
protein (COMP) production by cells from both tendons, but the level of the increase was 
greater in cells from the SDFT than in those from the CDET (Goodman et al., 2004). It has 
also been shown that specific tendons exhibit a distinct response to stress deprivation; 
collagenase expression was increased in both stress deprived rat Achilles and supraspinatus 
tendons, but the magnitude of upregulation was greater in the supraspinatus tendon 
(Thornton et al., 2008). However, it has also been reported that exposing human flexor and 
extensor tenocytes to load elicits a similar response in terms of cell proliferation and 
collagen synthesis (Evans and Trail 2001). These contrasting results show that further 
research is required to determine if cells from functionally distinct tendons respond 
differently to the same levels of strain. These experiments need to be undertaken in an 
environment similar to that of native tendon which allows physiologically relevant strains 
to be applied. The MAET would be a suitable scaffold for this; cells could be implanted 
into decellularised MAETs and subsequently loaded. 
The data presented in this chapter show that both the physiochemical and mechanical 
environment have a significant effect on cell phenotype. It may therefore be a combination 
of differences in strain levels, oxygen, temperature and pH that result in the difference in 
phenotype seen between the cells from the high strain SDFT and low strain CDET. To 
confirm the hypothesis that tenocyte phenotype is due to the in vivo environment rather 
than inherent differences in cell type further experiments are required to determine the 
effect of applying different levels of mechanical load to SDFT and CDET tenocytes. 
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7.5 Conclusions 
 Cells from the SDFT and CDET de-differentiated rapidly in monolayer culture and no 
longer exhibited distinct phenotypes as assessed by the ratio of collagen type I to 
decorin expression. 
 Culture of tenocytes in 3D collagen gels resulted in a shift in phenotype towards that 
seen in native tendon tissue, but did not restore the ratio of collagen type I to decorin 
expression. 
 The different cell phenotype exhibited by cells from functionally distinct tendons 
appears to be as a result of the distinct environment these cells experience in vivo 
rather than being pre-set during development. 
 The MAET is a suitable scaffold to expose tenocytes to mechanical load in vitro, while 
maintaining the cells in an environment similar to that which tenocytes would 
experience in vivo.   
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8. General Discussion and Conclusions                                          
8.1. Introduction 
The data presented in this thesis have improved the understanding of normal matrix 
turnover in functionally distinct tendons and provided a novel insight into the changes that 
occur with ageing. It is well established that tendon injury occurs as a result of gradual 
accumulation of micro-damage to the tendon matrix, resulting in an increased risk of 
tendon injury in aged individuals (Clayton and Court-Brown 2008; Fung et al., 2010b; Hess 
2010; Riley 2004) although the nature of the damage is not clear. Specific tendons are 
known to be more susceptible to injury than others; high strain energy storing tendons such 
as the equine superficial digital flexor tendon (SDFT) and human Achilles tendon are 
injured far more frequently than low strain positional tendons (equine common digital 
extensor tendon (CDET), human anterior tibialis tendon) (Ely et al., 2009; Hess 2010). 
Other tendons are also prone to injury; the patellar tendon, which may also function as an 
energy store, is subject to overuse injury in the human often as a result of sporting activity 
(Tan and Chan 2008). There is also a high incidence of pathological changes to rotator cuff 
tendons such as the supraspinatus; this tendon does not contribute to energy storage and 
injury is thought to occur due to compression of the tendon rather than repetitive tensile 
loading (Thornton et al., 2008). However, even though the mechanism of injury is likely to 
differ between tendons, the pathological changes that occur within the matrix are similar 
between the Achilles, patellar and supraspinatus tendons (Riley 2005; Tan and Chan 2008).  
It would be logical to assume that tendons exposed to high stresses and strains would have 
a greater capacity for matrix turnover in order to repair micro-damage, however previous 
work suggests that the matrix in the high strain SDFT is turned over at a slower rate than in 
the low strain CDET (Birch et al., 2008b). The reasons for this low rate of matrix turnover 
have not been established previously, and it is not clear why specific tendons are more 
prone to injury than others or why the incidence of injury increases with subject age. This 
thesis tested the hypothesis that tenocyte metabolism is programmed by the strains the cells 
experience in vivo meaning that high strain energy storing tendons have a lower rate of 
matrix turnover than low strain positional tendons and that this declines further with 
increasing age in both tendon types. In support of the hypothesis the data presented in this 
thesis have shown that turnover of the collagenous fraction of tendon matrix is greater in 
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the CDET than in the SDFT. However turnover of the non-collagenous matrix components 
occurs at a faster rate in the SDFT than in the CDET. In contrast to the hypothesis tested, 
this work has also shown that the ability of cells to synthesise key matrix proteins and 
degradative enzymes is not decreased in aged tendons. Rather, older tendons may be more 
susceptible to injury as they have reduced mechanical integrity which is due to an 
accumulation of partially degraded collagen within the matrix of energy storing tendons. 
This may be due to an increased resistance to degradation caused by age related 
modifications to the matrix such as glycation and racemization.  
8.2. Matrix Turnover Differs between Functionally Distinct Tendons 
The rate at which extracellular matrix is synthesised and degraded varies according to 
tissue type; collagen in soft tissues such as the heart and lung is turned over at a relatively 
rapid rate (Gineyts et al., 2000; McAnulty and Laurent 1987). In contrast, collagen within 
bone and tendon is metabolised at a much slower rate (Gineyts et al., 2000; Neuberger et 
al., 1951). This is not altogether surprising as tendon has a relatively low cellularity 
compared to other collagenous tissues. However it might be expected that tendons with a 
greater cellularity, such as the SDFT, would have a higher turnover rate than those with a 
lower cell number, such as the CDET, but the data presented previously (Birch et al., 
2008b) and in this thesis show that the opposite is true. Determination of matrix age within 
a tissue is difficult; previous studies have used the incorporation rate of radioactive proline 
or hydroxyproline into collagenous-rich tissues as a marker of the rate of matrix turnover 
(Laurent 1987; Neuberger et al., 1951). However this is a very invasive and costly 
procedure and experiments have to be undertaken over a considerable period of time. 
Further, it is difficult to use this method to determine tendon matrix turnover as the proline 
would be incorporated at a very low rate. More recent studies have assessed matrix age by 
measuring the accumulation of spontaneously occurring matrix modifications; this requires 
tissue samples from subjects with a wide age range. Pentosidine is a well established 
marker of matrix age but it is not possible to estimate matrix protein half-life by measuring 
the concentration of pentosidine within a tissue. However, matrix half-life can be estimated 
by determining the rate of aspartic acid racemization. The work presented in this thesis has 
shown for the first time that the turnover of matrix components differs between functionally 
distinct tendons. 
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Assessment of the age of the tendon matrix as a whole by measuring pentosidine 
accumulation and the rate of D-aspartate racemization (see chapter 4) showed that there 
was no difference in matrix age between the functionally distinct SDFT and CDET. This 
does not support the hypothesis tested in chapter 4, which predicted that the accumulation 
of these age related matrix modifications would be greater in the energy storing tendons, 
reflecting a lower rate of turnover in these tendons. The deep digital flexor tendon (DDFT) 
had the highest pentosidine and D-aspartate levels, and correspondingly matrix half-life 
was the longest in this tendon. It was not possible to group the positional DDFT or energy 
storing suspensory ligament (SL) with the CDET or SDFT respectively in terms of matrix 
composition, age or gene expression. Tenocytes from the DDFT and SL exhibit a 
phenotype intermediate between tenocytes from the SDFT and CDET. When the matrix of 
the SDFT and CDET was separated into its collagenous and non-collagenous components a 
difference in the rate of matrix turnover was identified; with greater collagen turnover in 
the positional CDET and a faster rate of turnover of the non-collagenous matrix in the 
energy storing SDFT. This gives an insight into function of the different components of the 
matrix within functionally distinct tendons. 
8.2.1. Collagen is Turned Over More Rapidly in Positional Tendons 
As the most abundant component of tendon matrix, collagen is the major determinant of 
tendon mechanical properties. The hierarchical structure of the collagen within tendon 
facilitates the transfer of large forces; the majority of tensile load is transmitted through the 
tendon by the collagen fibrils and studies have shown that collagen content, fibril number 
and fibril diameter are the main determinants of tendon stiffness and strength (Derwin and 
Soslowsky 1999; Parry 1988; Rigozzi et al., 2009; Robinson et al., 2004a). Further, studies 
have shown that collagen fibrils experience heterogeneous strains throughout the tendon, 
which can markedly exceed the strain experienced by the whole tendon in some areas 
(Cheng and Screen 2007; Snedeker et al., 2006), suggesting that some regions within the 
tendon are more prone to injury than others. Therefore the ability of cells to turnover the 
collagenous fraction of tendon extracellular matrix has important consequences for tendon 
repair and maintenance of tendon mechanical properties. 
At the transcriptional level, cells from the functionally distinct tendons in the equine 
forelimb exhibit differences in their ability to synthesise and degrade collagenous matrix 
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proteins. In support of the hypothesis tested in chapter 5, the data show that the cells in the 
SDFT produce less message for synthesis of collagen and collagen degrading enzymes than 
their counterparts in the rarely injured CDET. This difference is also apparent at the 
translational level; the data presented in chapters 5 and 6 show that tenocytes in the CDET 
synthesise approximately four times more pro-collagen than those in the SDFT, and CDET 
tenocytes also synthesise greater amounts of the collagenase MMP-13. This results in an 
older collagenous matrix in the SDFT, with a half-life almost six times greater than that in 
the CDET (chapter 4). Although at first these data appear counterintuitive, it is possible that 
the collagenous fraction of the matrix comprising the SDFT is protected from extensive 
remodelling after maturity; it has been suggested previously that continual turnover of 
collagen fibrils in tissues with a supportive role would be a disadvantage as this may 
weaken the tissue transiently and increase the risk of injury (Laurent 1987). Further, energy 
storing tendons require specific mechanical properties for efficient energy storage and 
return; significantly increasing the stiffness of the SDFT in response to exercise would 
decrease its energy storing capacity. However, this relatively low rate of collagen turnover 
would mean that once micro-damage has occurred to the collagen fibrils the rate of repair is 
likely to be slow and therefore more micro-damage may accumulate, resulting in an 
increased risk of injury with ageing. In addition, the high collagen half-life will result in the 
accumulation of age related modifications to the collagenous matrix, including increases in 
the concentration of advanced glycation end products and the extent of amino acid 
racemization.  
The rate of collagen turnover depends not only on the ability of cells to synthesise collagen 
and matrix degrading enzymes, but also on the resistance of the matrix to degradation. 
Fibrillar collagen is more resistant to degradation than collagen in solution (Slatter et al., 
2008). Differences in fibril diameter between tendons may therefore affect the 
susceptibility of the collagen molecules to degradation; the SDFT has a lower mass average 
fibril diameter than the CDET (Birch 2007), suggesting fibrils within this tendon would be 
more susceptible to degradation than those in the CDET. However, the data presented in 
this thesis indicate that collagen degradation occurs more rapidly in the CDET. The 
resistance of matrix collagen to degradation may also be affected by the levels of enzymatic 
crosslinks; although pentosidine levels were similar between tendons there may be other 
enzymatic crosslinks present at higher levels within tendon. However, the precise effect of 
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specific enzymatic crosslink concentration on the susceptibility of fibrillar collagen to 
degradation has yet to be determined.  
8.2.2. Turnover of Non-Collagenous Proteins is Greater in Energy Storing 
Tendons 
Although the main protein that comprises tendon extracellular matrix is type I collagen, 
tendons also contain varying amount of non-collagenous proteins, of which proteoglycans 
are the most abundant. Proteoglycans are hydrophilic and their role in tissues such as 
cartilage is to increase hydration to enable tissues to resist compression (Roughley 2006). 
Proteoglycans within tendon also play an important role in determining tendon water 
content (Screen et al., 2006), are important regulators of collagen fibrillogenesis (Scott 
1995) and are also thought to contribute directly to tendon mechanical properties. While 
tendon mechanical strength is determined mainly by the collagen content and organisation, 
it is thought that proteoglycan content affects the rate of stress-relaxation and may aid in 
the transfer of strain between fibrils (Brent et al., 2003; Gupta et al., 2010; Robinson et al., 
2004b). Studies have shown that a large degree of deformation occurs outside the collagen 
fibrils (Puxkandl et al., 2002), suggesting that the non-collagenous tendon matrix also 
experiences significant levels of strain and therefore is likely to be damaged if high strains 
are experienced by the tendon. 
The energy storing SDFT has higher glycosaminoglycan levels than the positional CDET, 
indicating a greater concentration of proteoglycans in this tendon. In contrast to the 
hypothesis tested in chapter 5, assessment of gene expression showed that the cells from the 
SDFT produced more mRNA coding for proteoglycan synthesis and degradation than those 
in the CDET. Correspondingly, there was also greater potential for degradation of the non-
collagenous matrix in the SDFT at the protein level, with greater concentrations of enzymes 
able to degrade proteoglycans and glycoproteins in this tendon. This leads to a difference in 
the half-life of the non-collagenous matrix in functionally distinct tendons; the non-
collagenous proteins in the SDFT had a half-life of 2.2 years whereas those in the CDET 
had a half-life of 3.5 years (see chapter 4). It has previously been established that 
proteoglycans are metabolised more rapidly than collagen in tendon, and it is thought that a 
certain level of proteoglycan turnover is important for tissue homeostasis (Rees et al., 2000; 
Rees et al., 2009; Smith et al., 2008), but no previous studies have investigated the turnover 
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of non-collagenous proteins in tendons with different functions. It is likely that the 
difference in the turnover of the non-collagenous matrix between the SDFT and CDET is 
related to the different functions of these tendons. The SDFT and CDET are loaded at 
different strain levels and rates; proteoglycans are likely to play a more important role in 
transfer of strain between fibrils at high strain levels as experienced by the SDFT, at which 
the extension mechanism is dominated by fibre sliding relative to one another rather than 
fibre extension (Puxkandl et al., 2002; Screen et al., 2004) and therefore proteoglycans 
within the matrix of the high strain energy storing SDFT are more likely to be damaged, 
and require repair, than those in the low strain positional CDET. 
Interestingly, other studies have shown a decrease in the potential for degradation of the 
non-collagenous matrix components in tendinopathy, with decreased expression of the 
stromelysins (Ireland et al., 2001; Jones et al., 2006). It is possible that the cells prioritise 
remodelling of the collagenous matrix in tendons that exhibit pathology; possibly to the 
detriment of the non-collagenous matrix. This is likely to have important consequences for 
the integrity of high strain energy storing tendons; accumulation of proteoglycan fragments 
in this tendon may decrease the efficiency of strain transfer between collagen fibrils and 
contribute to the poor quality of matrix repair. 
8.3. Effect of Ageing on Tendon Matrix Turnover 
In general, it is thought that cell activity declines with ageing in many tissues. It is well 
established that ageing results in a gradual decline in muscle mass (Lexell et al., 1988; 
Narici et al., 2008). Myosin heavy-chain synthesis rate has been shown to decrease with 
increasing age suggesting cells within aged muscle are less able to remodel this contractile 
protein (Balagopal et al., 1997). Studies have also shown that ageing results in a decrease in 
the myosin content of heart muscle but an increase in collagen content, which results in 
fibrosis and inefficient function (Varagic et al., 2001); this may be as a result of alterations 
in cell phenotype with ageing. Chondrocytes have also been shown to exhibit alterations in 
phenotype with ageing; cells express lower levels of type II collagen and aggrecan (Acosta 
et al., 2006) and become senescent in cartilage from aged individuals (Martin and 
Buckwalter 2002). It is well established that the risk of tendon injury increases with 
increasing age (Clayton and Court-Brown 2008; Kasashima et al., 2004), suggesting that 
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there is a decrease in tendon mechanical integrity in aged individuals. However, no 
previous studies have determined if this is due to an age-related decline in cell activity. 
In contrast to the hypothesis tested in this thesis, the gene expression data show that 
synthesis of key matrix proteins and degradative enzymes does not decrease with increasing 
horse age at the transcriptional level. Measurement of collagen synthesis and levels of 
matrix degrading enzymes at the protein level show that synthesis of proteins required for 
matrix synthesis and degradation is maintained in aged tendons in the equine forelimb. 
However, cells must also be able to respond appropriately to cytokines and growth factors 
in order to increase metabolic activity if an injury does occur; it is possible that this 
response is decreased in aged tenocytes and further work should be undertaken to assess 
this. Assessment of actual collagen degradation showed that partially degraded collagen 
accumulates within the matrix of the SDFT with increasing age, suggesting that the 
collagenous matrix becomes more resistant to degradation in aged tendons. Taken together, 
these data suggest that the increase in collagen matrix half-life with increasing age is not 
due to a decrease in cell activity but appears to be due to increased resistance of the matrix 
to degradation, which may be attributed to the accumulation of spontaneous matrix 
modifications. This is likely to reduce tendon mechanical integrity and may account for the 
increased risk of tendon injury in aged individuals.  
8.4. Effect of Age Related Matrix Modifications 
Age related modifications to the matrix may affect tendon mechanical integrity by a variety 
of pathways. The accumulation of AGEs has been shown to have a significant effect on 
tendon mechanical properties, resulting in increased stiffness and strength (Reddy et al., 
2002; Reddy 2004). The data presented in chapter 4 shows that the AGE pentosidine and 
the percentage of D-Aspartic acid accumulate linearly with age in both energy storing and 
positional tendons, however previous studies have not identified an increase in strength or 
stiffness of the SDFT with increasing horse age (Birch 2007). AGEs may have a deleterious 
effect on tendon mechanical properties in aged individuals as their presence within the 
matrix increases the resistance of collagen to enzymatic degradation (DeGroot et al., 2001; 
Mott et al., 1997; Schnider and Kohn 1981; Verzijl et al., 2000a), therefore inhibiting the 
repair of damaged collagen and leading to accumulation of partially degraded collagen 
within the matrix. There is also evidence to suggest that glycation has an inhibitory effect 
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on collagen fibrillogenesis; it has been reported that soluble collagen incubated with 
glucose forms unstable fibres with low levels of enzymatic crosslinks in vitro (Guitton et 
al., 1981). While newly synthesised collagen molecules would not be glycated it is likely 
that incorporation of new collagen into fibrils as part of the repair process would be 
hampered if high levels of glycated crosslinks were present in the mature fibril. Little is 
known about the mechanisms of matrix turnover within tendon; it has not been established 
whether whole fibrils are removed and replaced or if damaged collagen molecules can be 
repaired without remodelling of the entire fibril, therefore it is not possible to fully 
determine the extent of the effect of age related changes to the matrix on tendon mechanical 
properties. However, these studies suggest that both collagen degradation and subsequent 
repair can be inhibited by age related matrix modifications, resulting in an accumulation of 
partially degraded collagen within the matrix which would have important consequences 
for matrix integrity and resulting mechanical properties.  
Accumulation of damaged collagen within the matrix may also alter cell-matrix 
interactions, resulting in localised unloading of cells within damaged fibrils. Cells require a 
certain strain threshold or ‘set point’ to function normally and therefore stress deprivation 
may result in an abnormal cell phenotype; cells in stress deprived tendons express higher 
levels of degradative enzymes (Arnoczky et al., 2008b; Gardner et al., 2008), exhibit 
altered morphology and may undergo apoptosis (Egerbacher et al., 2007). AGEs can also 
directly affect cell matrix interactions, resulting in a decrease in the ability of cells to attach 
to the collagenous matrix (Liao et al., 2009; Paul and Bailey 1999). AGE crosslinks are 
able to form at lysine and hydroxylysine residues throughout the collagen triple helix, but 
form preferentially on hydroxylysines 434 on the α1(I) chain and 453, 479 and 924 on the 
α2(I) chain (Sweeney et al., 2008). Hydroxylysine 479 is in close proximity to the cell 
interaction domain on the collagen fibril and modelling studies have shown that glycation 
at this site would be likely to affect collagen-ligand interactions (Sweeney et al., 2008). 
AGEs that form between arginine residues, such as pentosidine, are also likely to influence 
cell matrix interactions, as the binding site Arg–Gly–Asp is recognised by the α1β1 and 
α2β1 matrix integrins, which form a link between the cell and collagen molecules 
(Tuckwell and Humphries 1996). In support of this, it has been reported that increased 
glycation of arginine in vitro results in a decrease in cell adhesion and proliferation (Paul 
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and Bailey 1999). Alterations in cell phenotype combined with micro-damage 
accumulation will further increase the risk of gross injury with increasing age. 
In addition to altering fibrillogenesis and cell-matrix interactions, there is also evidence to 
suggest that synthesis and degradation of matrix molecules can be directly modulated by 
the presence of advanced glycation end products (AGEs). It has been reported that articular 
chondrocytes synthesise lower levels of type II collagen and collagen degrading enzymes in 
artificially glycated cartilage when compared to non-glycated controls (DeGroot et al., 
2001). Another study has reported that human dermal fibroblasts (HDFs) cultured in 
glycated collagen lattices produce lower levels of MMP-1 compared to HDFs cultured in 
non-glycated collagen lattices, and while MMP-2 production was not affected by glycation, 
inhibition of MMP-2 by TIMPs-1 and -2 was significantly increased (Rittie et al., 1999). In 
addition, cells were less able to contract glycated collagen lattices, presumably due to 
increased stiffness as a result of glycation (Rittie et al., 1999). In contrast, a more recent 
study using an in vitro model of glycated skin found that glycation of type I collagen with 
ribose caused an increase in collagen, collagenase and MMP-2 and -9 synthesis (Pageon et 
al., 2007). These results indicate that, in addition to increasing the resistance of the matrix 
to enzymatic degradation, the presence of AGEs within aged tendon matrix may also have a 
direct cell effect on the synthesis and degradation of matrix proteins. 
8.4.1. Effect of Age Related Matrix Modifications on Cell Activity 
Interestingly, it has been shown that young and old fibroblasts cultured in an in vitro skin 
model showed no differences in histological and functional properties (Michel et al., 1997). 
In a comparable manner fibroblasts from UV damaged skin, which has high levels of 
partially degraded collagen, have a similar capacity for type I pro-collagen production to 
cells from sun protected skin (Varani et al., 2001). However, culture of fibroblasts on 
partially degraded collagen resulted in decreased cell proliferation and type I collagen 
production (Varani et al., 2001). Furthermore, it has been shown that collagen extracted 
from the tail tendons of young and old mice has different structural properties; fibril 
formation occurred at a slower rate in collagen from aged tendons, and the resulting fibrils 
were thinner and less organised that those formed by collagen extracted from the tail 
tendons of younger mice (Damodarasamy et al., 2010). In addition, culture of fibroblasts 
within 3-D gels formed by the polymerisation of collagen from young and old tendons 
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resulted in the differential expression of several genes (Damodarasamy et al., 2010). This 
study suggests that the decreased ability of aged collagen to polymerise readily in vitro may 
be due to defects in collagen at the molecular level. An in vitro study has found that mature 
tenocytes cultured in 3D constructs produce homogeneous collagen fibrils similar to those 
formed by embryonic tendon cells (Bayer et al., 2010), suggesting that the poor 
regenerative potential in mature tendon is as a result of factors other than a decrease in 
intrinsic cell function.  Taken together, these data suggest that the accumulation of micro-
damage and resultant decrease in matrix integrity that is a common feature in aged 
collagenous tissues including tendon is due to changes in the structure and properties of the 
extracellular matrix. These changes may cause alterations in cell activity rather than ageing 
causing a decrease in the intrinsic ability of the cells to synthesise and degrade the matrix. 
These results may also partially explain the large variations in tendon mechanical properties 
between individuals. Tendon mechanical properties are not correlated with parameters such 
as horse body weight or exercise history (Birch 2007); it would be of interest to determine 
if these mechanical properties are related to the extent of partially degraded collagen within 
the matrix. 
The presence of AGEs within the matrix does not only affect turnover of the collagenous 
proteins, pentosidine has been shown to form in cartilage proteoglycans (Pokharna and 
Pottenger 1997). DeGroot et al. (1999) also identified an inverse relationship between 
pentosidine levels and synthesis of proteoglycans by articular chondrocytes in vitro, 
suggesting that increased AGE levels may decrease cell synthetic capacity. It is likely that 
the non-collagenous matrix of the CDET contains a higher concentration of AGEs in older 
tendons than that of the SDFT due to the differences in non-collagenous protein half-life 
between these tendons, but this requires further investigation. Studies have reported that 
glycation decreases the fidelity of collagen proteoglycan binding as proteoglycan binding 
regions overlap with preferred glycation sites on the collagen molecule (Reigle et al., 
2008).  
It is likely that glycation plays a larger role in the increased resistance to enzymatic 
degradation than amino acid racemization. While the racemization of amino acids is a 
useful marker of protein age the effect on mechanical properties is likely to be small. 
Molecular dynamics simulations suggest that the intermediate formed in the racemization 
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reaction is energetically unfavourable within the constraints of the collagen triple helix and 
therefore racemization is likely to be confined to the telopeptide regions of the molecule 
(van Duin and Collins 1998). In any case, the amounts of the D form of aspartic acid 
compared to the L form are very small. Studies have demonstrated that if racemization did 
occur in the collagen triple helix it could have a significant destabilising effect (Punitha et 
al., 2009; Shah et al., 1999); however it should be noted that these experiments were 
conducted on small collagen-like helices in a dilute solution which represents a completely 
different chemical environment to fibrillar collagen in tendon. Therefore the magnitude of 
triple helix destabilisation is likely to be different in a collagen fibril, where collagen 
molecules interact strongly with the neighbouring molecules, than in solution where 
interactions between collagen molecules will be much weaker. Racemization of the aspartic 
acid residues in the telopeptide region may however alter the conformation of enzyme 
cleavage sites within the region (Ritz-Timme and Collins 2002). This could result in a 
decrease in the ability of MMP-3 to unwind the C-terminal telopeptide, a process which is 
essential for cleavage of triple helical collagen (Chung et al., 2004). Racemization also 
occurs in non-collagenous proteins and the rate constant of racemization is greater in 
aggrecan than collagen (Maroudas et al., 1998). It is likely there are fewer stereochemical 
restrictions within the non-collagenous matrix proteins, and so the succinamide 
intermediate would be able to form more readily in proteoglycans than in collagen. A 
greater level of D-Asp accumulation in proteoglycans may also result in perturbations in 
the rate of proteoglycan turnover, such that proteoglycan fragments also accumulate within 
the matrix. This is an area that requires further investigation. 
The accumulation of partially degraded collagen within tendon matrix is likely to decrease 
mechanical integrity and therefore increase the risk of tendon injury by several pathways. It 
is logical to assume that the presence of collagen fragments within the matrix would result 
in decreases in tendon strength and stiffness as the transfer of strain between collagen 
fibrils would be impaired. This may also place additional strain on intact areas of the 
matrix, increasing the risk of further damage occurring. In addition, damaged collagen 
within the matrix may result in localised alterations in cell matrix interactions. This is likely 
to result in unloading of cells in areas of matrix where partially degraded collagen has 
accumulated. It is well established that stress deprived cells show alterations in their 
mechanostat set point and upregulation of degradative gene expression (Arnoczky et al., 
230 
 
2008b; Arnoczky et al., 2007; Lavagnino et al., 2006). Alterations in cell phenotype may 
further hamper matrix repair and therefore also increase micro-damage accumulation. 
Although overall levels of pentosidine are similar between the SDFT and CDET, it is likely 
that, in the SDFT, a greater proportion of the pentosidine is present in the collagenous 
matrix as the half-life of this fraction of the matrix is significantly greater than in the 
CDET. While the levels of pentosidine are relatively low (1 per 70 collagen molecules in 
the tendons assessed) the recently discovered lysine-arginine crosslink derived from 
glucose; namely glucosepane, reaches levels comparable to those of the lysyl oxidase 
derived crosslinks (1-5 moles/mole collagen) (Sell et al., 2005), and there may be other, as 
yet unidentified glycated crosslinks that accumulate with age in tendon.  
8.5. Effect of Culture on Phenotype of Cells from Functionally Distinct 
Tendons 
The data presented in chapter 7 show that maintaining cells from the functionally distinct 
SDFT and CDET in culture results in alterations in tenocyte phenotype. The differences in 
phenotype between tenocytes from the SDFT and CDET that were identified in vivo were 
lost when the cells were cultured in monolayer and in 3D collagen gels. In culture the 
tenocytes produced more message for collagen synthesis and downregulated decorin 
synthesis. This resulted in an approximate 300 fold increase in the ratio of type I collagen 
to decorin. It is likely the alterations in tenocyte phenotype in culture are in response to 
changes to the cells’ mechanical and physiological environment. These results highlight the 
importance of maintaining cells within an environment that is similar to that which they 
would experience in vivo in order to obtain physiologically relevant results. Culturing 
SDFT and CDET tenocytes within a 3D collagen gel resulted in a decrease in the ratio of 
collagen type I to decorin expression towards normal levels, although the ratio was still 
approximately 50 fold greater than in vivo. These experiments were carried out in the 
absence of load, it is possible that mechanically loading these 3D constructs would result in 
a cell phenotype closer to that seen in vivo. 
In order to maintain tenocyte phenotype in vitro cells need to be cultured in an environment 
that replicates their native tendon tissue both physiologically and mechanically. Therefore, 
the most rational approach would be to culture whole tendons under dynamic loading 
conditions. However, the cross sectional area of most tendons is too great to allow adequate 
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diffusion of nutrients to the centre, which would result in loss of cell viability. Tendons 
with a small cross sectional area tend to be too short to clamp at either end for mechanical 
loading. However, the medial accessory extensor tendon (MAET) has a small cross 
sectional area and is also long, making this tendon suitable as a scaffold for mechanically 
loading tenocytes in their native environment. The preliminary data presented in chapter 7 
of this thesis indicates that maintenance of this tendon in the absence of load for a short 
period of time does not result in a significant alteration in cell phenotype. Further, loading 
of the MAET in organ culture does not cause alterations in gene expression, with the 
exception of the load inducible gene scleraxis. This suggests that this culture system 
maintains cells within an environment that is physiologically and mechanically similar to 
native tendon tissue and therefore is a more suitable system than culturing cells in 
monolayer or in artificial scaffolds. Interestingly, changes to the physiological environment 
in terms of carbon dioxide levels had a significant effect on decorin gene expression both in 
loaded and unloaded MAETs, a result that requires further investigation.  
8.6. Tendon Cell Phenotype is Determined by In Vivo Strain 
Environment 
Taken together, the results presented in this thesis indicate that tenocyte phenotype is 
determined by the strains the cells are exposed to in vivo, and therefore phenotype is altered 
in response to changes in strain experienced by the cells rather than being pre-set during 
tendon development. It is clear that cells from the functionally distinct tendons in the 
equine forelimb are phenotypically different, especially in terms of proteoglycan and 
collagen turnover. This corresponds to differences in the in vivo strain environment; the 
greatest difference in gene expression was seen between the SDFT, which experiences the 
highest strains and the CDET, which is exposed to the lowest strains. The DDFT and SL 
experience moderate levels of strain in vivo; correspondingly cells from these tendons 
exhibited gene expression patterns between those of the SDFT and CDET. This difference 
is maintained at the protein level, resulting in different rates of matrix turnover in the SDFT 
and CDET. Furthermore, culture of SDFT and CDET tenocytes in the absence of 
mechanical strain caused the cells to adopt a phenotype that was no longer different from 
cells from the other tendon, but was distinct from the phenotype measured in vivo. This 
evidence of phenotype plasticity lends support to studies that have shown that cell 
phenotype can be altered by exposing cells to varying mechanical and physiological 
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conditions. However to answer this question fully further work needs to be undertaken to 
elucidate the effect of altered strains on SDFT and CDET tenocyte phenotype. 
8.7. Implications for Prevention and Treatment of Tendon Injury 
The data presented in this thesis also have important implications for development of 
successful treatment programmes for tendon injuries in both the horse and human. The 
majority of non-surgical treatment protocols for tendinopathy target cell activity (see 
chapter 1) but the data presented in this thesis suggest that age related tendinopathy is not a 
cell mediated problem. Rather, the matrix becomes more resistant to repair due to age 
related modifications such that in aged individuals the degraded collagen cannot be 
removed completely. Areas of repaired matrix are generally disorganised; it is likely that 
partially degraded collagen is present alongside the new matrix as it cannot be fully 
degraded and removed. Preliminary studies have shown that cell-based therapies result in 
lower rates of re-injury than conservative treatment methods (Smith 2008; Young et al., 
2009a). These treatments may be effective in young animals with relatively low levels of 
AGE accumulation and fragmented collagen within the tendon matrix. However, it is likely 
the efficacy of these methods would decrease in aged tendons as matrix repair would be 
hampered by the presence of AGEs and partially degraded collagen, but as yet this has not 
been assessed. An alternative approach would be to develop treatments that prevent or 
reverse the accumulation of AGEs and partially degraded collagen; possibly by the use of 
AGE inhibitors or AGE-breakers. AGE inhibitors are currently being developed for use to 
prevent soft tissue dysfunction associated with diabetes, primarily targeting the vascular 
system (Huijberts et al., 2008; Susic 2007). However, it has been reported that although 
AGE-breakers are able to cleave model AGEs in vitro, they are unable to cleave AGEs in 
glycated rat tail tendon in vivo (Yang et al., 2003). In contrast, another study has reported 
that diabetic rats fed a supplement reported to reverse AGE accumulation had lower AGE 
levels and a higher percentage of soluble collagen within tail tendons when compared to 
diabetic controls (Jagtap and Patil 2010). These studies indicate that AGE inhibitors may be 
a potential treatment for tendinopathy but this area requires much further investigation. It is 
likely that methods aimed at preventing accumulation of micro-damage within the matrix 
will be more successful than attempting to reverse AGE formation and subsequent 
accumulation of damaged collagen. It would be difficult to target degradation of damaged 
collagen without detrimental effect to the healthy matrix. A greater understanding of tendon 
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matrix biology and mechanics, especially with regard to role of proteoglycans within the 
matrix and their interactions with collagen, is required to further understand the initiation 
and progression of tendinopathy. In general, research into tendon matrix biology has thus 
far been limited as it has been assumed by many that tendons are simple structures with the 
simple function of transferring force from muscle to bone. The data presented in this thesis 
and by others show that, contrary to these assumptions, tendon has a high degree of 
complexity and specificity in terms of function, matrix composition and turnover and cell 
phenotype.  
8.8. Why is Collagenous Matrix Turnover Low in Injury Prone Tendons? 
It seems counterintuitive that the horse has evolved to have a low rate of collagen turnover 
in the SDFT as this predisposes this tendon to injury, both in elite athletes and the general 
equine population. However, the mechanical properties of energy storing tendons must be 
maintained within a narrow range of strength and stiffness for efficient energy storage and 
return, therefore extensive remodelling of these tendons would be detrimental to their 
energy saving function. In addition, remodelling in response to micro-damage may weaken 
the tendon transiently during the repair process, further increasing the risk of damage to 
healthy matrix. The horse has evolved long limbs with correspondingly long tendons in 
order to be able to travel at high speeds to evade predators; use of the horse in racing over a 
pre-defined distance with additional weight in the form of tack and rider will place much 
higher stresses and strains on the tendons than would be experienced in the undomesticated 
horse. While it is clear that some degree of exercise is essential for development of 
optimum tendon properties, the additional demands placed on equine athletes expose the 
energy storing tendons to excessive forces. Exercise is therefore likely to accelerate the age 
related changes seen in equine tendon; it is possible that in addition to causing micro-
damage, exercise also results in impaired tenocyte function due to changes in the cells’ 
physiochemical environment such as hyperthermia and hypoxia. The possible causes and 
factors contributing to age related tendinopathy are shown in Figure 8-1. 
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Figure 8-1: Flow chart showing the possible causes and factors contributing towards the development of age 
related tendinopathy in the SDFT. 
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8.9. Future Work 
The data presented in this thesis have provided a valuable insight into the specialisation of 
functionally distinct tendons resulting from differences in the rate of turnover of matrix 
components and the nature of age related tendinopathy in energy storing tendons. However 
there is much more that is still to be determined in terms of tendon matrix turnover, 
tenocyte phenotype and the pathways that result in tendon degeneration. There are several 
ways in which the data presented here could be used as a starting point for further studies. 
Although the equine SDFT and human Achilles tendon have similar functions, the turnover 
of collagen in Achilles tendon has not been assessed and so further work should be 
undertaken to determine if this tendon has a lower rate of matrix turnover than positional 
tendons. It would be of value to determine the extent of advanced glycation end product 
accumulation in the collagenous and non-collagenous fractions of the matrix; this could be 
achieved by assessing pentosidine levels in the Guanidine-HCl extracted tendon tissue. In 
addition, levels of other AGEs present at greater concentrations in the matrix, such as 
glucosepane, could be assessed. The effect of AGE levels on the resistance of the matrix to 
degradation could also be assessed by incubating tendon explants with reducing sugars and 
correlating AGE levels with collagenase digestion time. The methods used in this thesis 
were only able to assess levels of mature crosslinks in equine tendon as immature 
crosslinks do not fluoresce naturally; in order to measure levels of immature crosslinks the 
crosslinks need to be derivatized with a compound such as ninhydrin (Sims and Bailey 
1992) after separation of the crosslinks by ion exchange chromatography. Measurement of 
immature crosslinks in tendons from a group of horses with a wide age range would give an 
indication of changes in the rate of crosslink formation with age, and therefore contribute to 
the overall understanding of tendon matrix turnover. 
The effect of ageing on cell activity could be assessed further by determining if cells within 
aged tendon become senescent by measuring telomere length and levels of β-galactosidase 
(Martin and Buckwalter 2002). It is also important to determine if aged cells are able to 
respond to increased levels of growth factors and cytokines as this will affect their ability to 
respond appropriately when an injury does occur. 
Tendon mechanical properties show large variations between individual horses, and are not 
correlated with parameters such as horse age and body weight (Birch 2007). It is therefore 
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important to determine if tendon mechanical properties are correlated with half-life of the 
collagenous and non-collagenous matrix components or with the concentration of AGEs 
within the different fractions of the matrix. In addition, mechanical properties may be 
correlated with markers of collagen degradation; it would be logical to assume that tendons 
with high levels of partially degraded collagen within the matrix would be weaker than 
tendons in which collagen fragments had not accumulated to a great extent. Mechanical 
testing of tendon at the fascicular level could also be of use to determine where within the 
matrix micro-damage occurs and how it accumulates; this work is currently being 
undertaken. 
The non-collagenous fraction of tendon matrix is also susceptible to age related glycation 
and racemization; therefore it is possible that proteoglycans within the matrix also become 
more resistant to degradation in aged tendons. This could be assessed by measuring the 
accumulation of decorin fragments within the matrix as a function of age. Although the 
half-life of the non-collagenous matrix is greater in the positional CDET this tendon has a 
lower GAG content than the energy storing SDFT and therefore the concentration of 
proteoglycan fragments may also be greater in the SDFT than in the CDET. 
This thesis has validated the MAET for use as a scaffold in vitro. Further work is currently 
being undertaken to determine the effect of decellularising this strip of tendon using 
previously published methods (Ingram et al., 2007), and implanting different tendon cell 
types by injecting cells into the centre of the tendon as well as seeding cells on the surface 
(Tischer et al., 2007). This study will therefore determine if tenocytes from the SDFT and 
CDET respond in the same manner to different loading protocols, or if exposing cells from 
the SDFT to strains normally experienced by cells in the CDET would cause them to 
become similar in phenotype to native CDET cells and vice versa. Use of the MAET as an 
in vitro scaffold gives the opportunity to control both the cells’ mechanical and 
physiochemical environment. Further studies could determine the effect of altering the 
temperature, oxygen and carbon dioxide levels during the loading programme; these are 
likely to have a significant impact on tenocyte phenotype although it is difficult to assess 
these variables in vivo. The effect of glycation on cell phenotype could also be assessed by 
incubating decellularised MAETs with reducing sugars before injecting cells into the 
tendon.   
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8.10. Conclusions 
 The rate of matrix turnover differs between functionally distinct tendons. Although in all 
tendons the non-collagenous matrix is turned over more rapidly than the collagenous 
matrix, cells from high strain energy storing tendons have a greater ability to synthesise 
and degrade non-collagenous matrix proteins, whereas cells from low strain positional 
tendons have a greater ability to turnover the collagenous matrix than their counterparts 
in high strain energy storing tendons. 
 The ability of tenocytes to synthesise matrix proteins and degradative enzymes does not 
decrease with increasing age, either at the transcriptional or translational level. 
 Tendon extracellular matrix becomes more resistant to degradation with increasing age 
in injury prone energy storing tendons, resulting in an accumulation of partially 
degraded collagen within the matrix. 
 Age related tendinopathy may therefore be due to an accumulation of collagen 
fragments within the matrix, which result in a decrease tendon mechanical integrity, 
rather than a decrease in cell activity with increasing age. 
 Tendon cell phenotype is determined by the mechanical and physiochemical 
environment within the tendon milieu rather than being pre-set during tendon 
development.  
 The medial accessory extensor tendon is suitable for use as a scaffold to study the effects 
of alterations in mechanical and physiological environment on cell phenotype in vitro. 
 Tendon is a complex dynamic structure with properties that differ according to precise 
function, change in response to mechanical and physiological environment and are 
modified with increasing age. 
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